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ABSTRACT
Sudden cardiac arrest (SCA) is a leading killer in the United States. A  large number of 
patients experience SCA outside of hospitals where there is an inherent delay in treatment due to 
slow first response times. In the out-of-hospital setting, ventricular fibrillation (VF)-induced SCA 
(VF-SCA) is the most common context in which the event manifests. VF leads to chaotic electrical 
and hence contractile function of the heart resulting in loss of cardiac output causing ischemia. 
Left untreated, electrical activity rapidly deteriorates, culminating in complete electrical failure or 
asystole. Survival rates for patients found in asystole are a mere 1%: asystole is a death sentence. 
Despite the high event and death rates of VF-SCA, little is known concerning the mechanisms of 
electrical failure. This dissertation represents the first concerted effort to understand the 
pathophysiology of electrical failure. The work contained herein can be divided into three 
projects. These projects were conducted in whole animal and isolated whole heart models of VF- 
SCA. The first is a detailed examination of the complex patterns of electrical failure in VF-SCA. I 
found a highly complex pattern of electrical failure spanning the intra- and interchamber 
heterogeneities in three-dimensions. Second, I investigated the contributions of two canonical yet 
untested theories of electrical failure during VF-SCA: hyperkalemia and ATP-sensitive potassium 
channel (KATP) opening. I reached the surprising conclusion that neither hyperkalemia nor KATP 
opening—individually or combined—can explain the pattern of electrical failure in VF-SCA. Third, 
I investigated the effect of increasing metabolic demand on electrical failure during VF-SCA 
through increased p-adrenergic stimulation and excitation rate. The findings point toward a 
necessity to reexamine current resuscitation protocols. Specifically, the use of epinephrine (an a- 
and p-adrenergic agonist) may promote electrical failure during treatment of VF-SCA leading to 
increased mortality.
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CHAPTER 1 
BACKGROUND
1.1____Ventricular Fibrillation Induced Sudden Cardiac Arrest
Sudden cardiac arrest (SCA) is a leading killer with the number of victims totaling over
300,000 per annum in the U.S. alone [1-4] and accounts for 50% of deaths due to cardiovascular 
disease [5]. The defining feature of SCA is the loss of cardiac output that results in global 
ischemia. There are two primary pathways in which loss of cardiac output occurs. One, a 
progressive decrease in heart rate leading to electromechanical dissociation, eventual total 
electrical silence (asystole), and death. This pathway is called a bradyarrhythmia. The second 
pathway, is the induction of ventricular fibrillation (VF) via a triggering event. VF is characterized 
by chaotic electrical activity which leads to disorganized myocardial contraction (often described 
as a bag of worms) resulting in loss of cardiac output and ischemia. Left untreated, VF-induced 
SCA (VF-SCA) leads to a progressive deterioration of electrical activity culminating in asystole 
and death.
Although sudden cardiac death affects a diverse population—young, old, sick and 
healthy—a majority of cases occur in patients with no prior history of heart disease but who 
manifest risk factors highly predictive of SCA: such as, hyperlipidemia, hypertension, as well as 
age, lifestyle, and history of smoking [1, 6, 7]. Because these conditions tend to be chronic and 
patients do not require hospitalization, approximately 80% of patients experience SCA outside of 
hospitals (OHSCA) [5]. Indeed, the SCA patients with no prior history of cardiovascular disease 
represent the majority of sudden death cases. Furthermore, while bradyarrhythmias are common 
in patients with prior heart disease, VF-SCA is the most common mode of OHSCA [1, 2, 8-10].
2In the out-of-hospital setting, the onset of SCA is sudden and treatment must occur 
immediately to be effective. Indeed, defibrillation immediately following VF onset has an 
approximately 90% success rate [11] with an accompanying high survival rate [12]. If treatment is 
delayed following onset of VF-SCA, survival probability plummets to approximately 60% in the 1st 
minute decreasing an additional 5% each minute [13] reaching an overall survival rate of 5% to 
20% [5, 14, 15]. If patients are unlucky enough to be found in asystole, survival probability is an 
even more dismal, less than 1%. [15, 16] Thus the primary problem in treating OHSCA is the time 
delay between onset and arrival of emergency medical services (EMS). EMS arrival time can vary 
greatly by location but even in highly efficient systems can take several minutes leading to the low 
survival probability of OHSCA patients overall [17-21]. In order to improve survival rates in 
OHSCA two approaches can be pursued: 1) decreasing the time to first response and 2) extending 
the time window for viable resuscitation.
For decades various methods for decreasing time to first intervention have been pursued. 
Prior to 1960 the treatment for OHSCA was open chest cardiac massage after EMS had brought 
the patient to the hospital. Cardiac massage was rarely attempted and even more rarely successful 
[22, 23]. In 1956, Paul Zoll performed the first successful external defibrillation on man [24, 25], 
making possible the treatment of VF. Years later the external cardiac defibillator was miniaturized 
enough to allow EMS to carry them into the field. Although the portable defibrillator significantly 
shortened time to first intervention, the time delay from OHSCA onset to initial shock was still 
relatively long. Around the same time (1960) protocols for effective cardiopulmonary resusciation 
(CPR) were developed by a group at Johns Hopkins Hospital which were shown to significantly 
improve survival compared to previous methods which were largely ineffective [26, 27]. The 
usage of CPR was quickly spread to the public and has served as both a bridge to EMS arrival, a 
core component of hospital treatment, and the frontline of SCA treatment [5, 28]. In recent years, 
the invention and implementation of the automatic external defibrillator (AED) has allowed 
administration of defibrillatory shocks by the lay public, further decreasing time to first response 
[11, 17, 29]. Today, AED placement is ubiquitous in most public venues, work places, and are even 
available for the private home.
In parallel to efforts to decrease time to first response, substantial work has been done to
3extend the window for viable resuscitation. The most notable outcome of this effort was the 
development of the Advanced Cardiac Life Support (ACLS) guidelines [28] which outlines the 
optimal process, based on current evidence, for resuscitation. These guidelines provide the 
framework in which resuscitation is performed by medical professionals and is constantly 
updated based on extensive research into optimizing parameters such as CPR compression rate 
and depth, defibrillation energy and waveform, as well as additional interventions such as 
therapeutic hypothermia [30-35].
Although efforts to both decrease time to first response and extend time of viable 
resuscitation have resulted in substantially improved survival outcomes from SCA compared to 
the days in which open chest cardiac massage was the standard of care, survival rates are still 
unacceptably low [5, 14, 15]. One potential reason for this is the increased prevalence of patients 
found in asystole in recent years [36-39]. Combined with the fact that first response time has 
remained similar or decreased at the same time, this observation points to a change in the time 
course of OHSCA in the general population. Unfortunately, very little is known concerning the 
mechanisms of electrical decline and failure. Efforts to-date in treating VF induced OHSCA have 
focused on optimizing parameters for current treatments despite the fact that some of these 
interventions may have no beneficial effect or even be harmful.
For example, therapeutic hypothermia reentered the spotlight as a promising therapeutic 
approach following the observation that an OHSCA victim found in extreme hypothermia 
survived three hours of cardiac arrest [40]. While a large amount of resources have been spent on 
optimizing the parameters and developing devices for therapeutic hypothermia, little work has 
been done to understand the mechanism of protection additionally treatment is accompanied by 
significant risk. Specifically, a recent study published in the New England Journal of Medicine 
calls into question the beneficial effects of mild therapeutic hypothermia [41]. Another example 
can be seen in current ACLS guidelines, which assume return of spontaneous circulation (ROSC) 
as a primary endpoint indicative of beneficial outcome and catecholamine administration as a 
means to achieve this goal [28]. Yet, evidence exists that improved ROSC may not be an accurate 
predictor of long-term survival; specifically in the case of epinephrine treatment [42-44]. 
Literature suggests additional considerations must be made. Lacking are the mechanistic insights
4to understand why survival probability decreases so rapidly in OHSCA and why different 
interventions improve survival probability. If mechanistic insights could be gained, targeted 
therapeutic strategies could be developed to address shortcomings in current treatments or target 
the beneficial mechanisms of current therapeutic strategies while avoiding the detrimental side 
effects.
This dissertation is one step in the effort to develop a mechanism based treatment and 
focuses on a narrow, but highly important facet of OHSCA: namely, the mechanism of electrical 
failure post initiation of OHSCA in the context of VF and accompanying ischemia, or VF-SCA. The 
difficulty of a mechanistic approach is the complexity of the task and time required to develop a 
treatment. Understanding the entire pathophysiology of OHSCA is complex and multifaceted 
even when only the heart is considered separately from the rest of the organism. Thus, these 
efforts should be made in parallel to improving current treatment paradigms which provide short­
term small improvements in survival rates. The goal of this dissertation was to first scrutinize the 
currently accepted, yet previously untested paradigm for the mechanism of electrical failure in 
VF-SCA and second, to develop an updated theory for the mechanisms of electrical failure.
Prior to the work presented in this dissertation, studies concerning electrical failure in 
VF-SCA have been limited to characterization of the process of electrical decline and neither the 
mechanisms giving rise to heterogeneous electrical decline nor asystole were well understood. 
Indeed, the state of knowledge consisted of the observation that left untreated, VF-SCA 
manifested as an increasingly heterogeneous decline in transmural electrical activity leading to 
eventual asystole [45-52]. It is thought that the development of electrical heterogeneities 
contributes to reduced defibrillation success through formation of reentrant pathways, and 
reinitiation of VF on reperfusion leading to a positive feedback loop in which VF becomes more 
and more difficult to treat as time elapses, culminating in asystole and death. One study directly 
implicated the anatomical distribution of Purkinje fibers in the development of the transmural 
component of heterogeneous electrical decline. The study found that ablating the Purkinje 
system, which is limited to the endocardium in canine hearts, resulted in loss of transmural 
heterogeneities in electrical activity [50]. Further evidence for the role of the Purkinje system in 
the transmural heterogeneities during LDVF can be seen by comparing porcine and canine hearts.
5While Purkinje fibers are limited to the endocardium in canine hearts, porcine hearts have 
Purkinje fibers throughout the myocardial wall. As Tabereaux et al. predicted, porcine hearts do 
not develop a transmural electrical gradient during VF-SCA. Nevertheless, electrical deterioration 
occurs, defibrillation becomes progressively more difficult, and VF-SCA culminates in asystole 
[45-50]. Thus, the localization of Purkinje fibers appears to modulate the pattern of electrical 
decline but have little to do with the mechanism of electrical failure. A pertinent question is, why 
the endocardial localization of Purkinje fibers result in a transmural gradient. If indeed Purkinje 
fibers are the source of activity during VF-SCA why does electrical propagation initiated on the 
endocardium not reach the epicardium in canine hearts?
The key to understanding the primary mechanisms of electrical failure lie in the changes 
that occur as an acute response to VF-SCA and the resultant metabolic challenge. In other words, 
one must understand how the heart adjusts to the lack of oxygen, nutrients, and waste removal. 
In the acute setting of OHSCA where death occurs within minutes it is unlikely that changes in 
gene and protein expression play primary roles since such changes are typically measured in 
hours [53]. It is far more likely that ion channel permeabilities along with ionic and metabolic 
imbalance—which can respond to changes in the time frame of minutes, seconds, or even 
milliseconds—play major roles. To develop a valid hypothesis, it is critical to understand how 
electrical activity in the heart is generated at the single cell level and scale up to the whole heart 
and how this electrical activity is affected by conditions present during VF-SCA.
1.2 Electrical Activity in the Heart
1.2.1 Cellular Electrophysiology
At a fundamental level, cell excitability can be understood by a few key concepts: 1) 
electrochemical gradients, 2) gating of sarcolemmal permeability to ions, and 3) energy 
metabolism for system maintenance. Figure 1.1 shows a schematic diagram for major contributors 
to each of these components in the cardiac myocyte. The ion concentrations inside and outside 
the cell are listed to right of the diagram (values obtained from Luo & Rudy 1991 [54]). Major ion 
channels for K+ (red) Na+ (blue) and Ca++ (green) are shown along with major pumps and
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F igu re 1.1: Schematic diagram of a cardiac myocyte. Typical extracellular ion concentrations are 
listed to the right. Green indicates Ca++ handeling components, blue Na+, red K+, and orange Cl-. 
Purple indicates major components of metabolism. Cellular compartments are separated by black 
and labeled accordingly. These components can be catagorized broadly into three functions for 
the maintenance of electrical excitability: 1) The electrochemical gradient listed to the right. 2) 
Gating of sarcolemmal permeability, predominantly regulated by ion channels. 3) System 
maintenance through energy production and expenditure via pumps and metabolic pathways.
exchangers. The primary metabolic pathways for energy production (i.e., glycolysis, p-oxidation, 
and Krebs cycle) along with proteins involved in metabolite trafficking, the electron transport 
chain, and the F0-F1 ATP synthase (purple). The black lines indicate lipid bilayers separating 
compartments in the myocyte; namely the cytosol, sarcoplasmic reticulum (SR), and 
mitochondria. The myofibrils are responsible for contraction and are the major consumers of 
energy. The following subsections describe in some detail the conceptual framework by which 




The cell membrane acts as a nonconductive barrier preventing free flow of ions. The 
balance of ions in the intra- and extracellular spaces determine the electrochemical gradient and 
provides the driving force necessary for ion movement through pore forming proteins. Steady- 
state membrane potential (Vm), or sarcolemmal potential can be calculated using the Nernst
equation given the sarcolemma is permeable to only a single ion.
V  R T ^m = —  In 
zF
(1)
where R is the universal gas constant, T is the temperature in degrees Kelvin, z is the ion valence, 
and [C]o and [C]i are the ion concentrations outside and inside the cell, respectively. This is called 
the Nernst potential, also referred to as the reversal potential, for the specific ion and indicates 
the potential at which ion influx and efflux are in equilibrium. When the sarcolemma is 
permeable to additional ions the Goldman-Hodgkin-Katz equation (GHK) is used, instead, to 
determine the steady state Vm.
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where PCi+ and PAj- are the permeabilities of cations and anions, respectively, and [C]i and [C]o 
indicate the concentrations of ions inside and outside the cell, respectively. It can easily be seen 
that as permeability to all but one ion approaches zero the equation is simplified to the Nernst 
equation. Also apparent is the possibility to hyper polarize or depolarize Vm without altering the 
electrochemical gradients—given at least two ions have reversal potentials that are separated— 
which is critical for allowing rapid Vm transition between the Nernst potentials for differing ions 
during electrical activity. For example, if initially the sarcolemma is permeable only to potassium 
ions (K+) Vm becomes the reversal potential for K+ (approximately -90 mV for myocytes). If 
permeability to sodium (Na+) suddenly increases Vm rapidly approaches the reversal potential for 
Na+ (approximately 55 mV) reaching a Vm dependent on the ratios of K+ and Na+ permeability. 
The caveat being the GHK equation represents steady state Vm since membrane capacitance is not 
considered. Conceptually it can be thought of as the larger the permeability to an ion relative to 
other ion permeabilities the closer the Vm to that ion’s reversal potential.
81.2.1.2 Sarcolemmal Permeability to Ions
Hodgkin and Huxley proved that the major component of electrical excitability in 
neurons was rapidly changing ion permeability which was later shown to be regulated by ion 
channels. The permeability of these ion channels to their respective ions can be very complex [55­
61]. In the simplest conceptual framework ion channels can be thought to exist in three states, 
open, closed, or inactivated. Occupancy of each state can be a function time, Vm, and ligand 
binding. Hodgkin and Huxley showed that the current through the membrane in the whole cell 
could be described as a function of both time and Vm as follows:
‘  -  C , dVm + g „„n fh (V m -  V„a) + gKn‘ (Vm -  VK) + g, (V, -  V,) (3)
dt
dL
—  = a L (1 -  L) -  " L  (4)
dt
! l -  —  (5)
L
L
where I  is current per unit area, Cm is the membrane capacitance, gL is the maximal conductance 
for each ion given L has a value between 0 and 1 and represents the proportion of channels in the 
activated (m for the Na+ channels in equation 3 and n for the K+ channel in equation 3) or 
inactivated (h for the Na+ channel in equation 3) state, L» are steady state values for m, n and h at 
voltage Vm with time constant "l, and aL and ! l  are the rate constants for activation and 
deactivation, respectively. To obtain a better conceptual understanding of the behavior of, for 
example, the Na+, channel various parameters can be characterized experimentally through 
voltage clamp techniques and fitted to the equations above. As an example see Zhang et al. who 
showed the behavior of the cardiac Na+ channel (Nav1.5) [62]. Mathematical descriptions can be 
developed for any ion channel and through these types of visualizations one can begin to 
understand the behavior of ion channels in excitable cells. It is important to note that while ion
9transporters and pumps can also produce currents that are relatively small in comparison to ion 
channel currents; their major roles are the maintenance of the electrochemical gradient and 
hence the driving force.
1.2.1.3 Energy Metabolism
Electrochemical gradients and ion channel gating is sufficient to produce action 
potentials (APs), yet even with the relatively small number of ions required to produce the 
necessary current for each AP, there would be eventual rundown of the system during which the 
electrochemical gradient gradually diminishes if pumps were inactive. Thus, cardiomyocytes 
utilize energy through pumps, transporters, and exchangers to maintain electrochemical 
gradients to prevent system rundown. Energy can be obtained from the electrochemical gradient, 
as in the case of the Na+-Ca++ exchanger (NCX) where the driving force of Na+ is utilized to 
extrude Ca++ from the cell. On the other hand, pumps typically utilize hydrolysis of intracellular 
ATP for energy as in the case of the Na+-K+ pump extruding Na+ and importing K+ against their 
gradients. Thus, through energy utilization the electrochemical gradients for each ion is 
maintained, preventing systemic rundown, and making repeated, sustained, electrical activity 
possible.
ATP production in myocytes occurs from two sources as seen in Figure 1.1: glycolysis and 
aerobic respiration (p-oxidation does not independently produce ATP). Glycolysis produces a 
relatively small amount of ATP from free glucose or glucose derived from cellular glycogen stores. 
Aerobic respiration, on the other hand, produces a much larger quantity of ATP from pyruvate 
obtained through glycolysis or acytyl-co-A through p-oxidation. The key point is that aerobic 
respiration (36 ATP/glucose) is much more efficient than glycolysis (2 ATP/glucose) at producing 
energy but aerobic respiration requires oxygen (O2) [63, 64] which is absent during VF-SCA. 
Furthermore, ATP can also act as a ligand regulating ion channel function creating further 
implications for direct effects of metabolism on electrical activity (see Section 1.3.3).
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1.2.1.4 The Cardiac Action Potential
Combining the conceptual framework of the GHK equation and Hodgkin and Huxley’s 
ion channel gating framework provides a mathematical understanding for the rise of APs. By 
rapid transition of membrane permeability to different ions over time, the Vm rapidly shifts 
towards the Nernst potential of one ion and then another: the consequence is the generation of a 
finely tuned electrical signal that can be used for cellular communication or controlling cellular 
function. Energy production and utilization plays a key role in maintaining this system allowing 
ongoing electrical activity without systemic rundown.
In the heart, the basic cardiac action potential (AP) takes the form seen in Figure 1.2. The 
shape is determined primarily by the currents illustrated, which can be divided into inward 
currents (Figure 1.2 above) and outward currents (Figure 1.2 below). Inward currents—or source 
currents—are mostly Na+ and calcium (Ca++) currents and depolarize the cell. Outward currents— 
or sink currents—are mostly K+ currents and polarize the cell. The balance of source and sink 
currents determine Vm at each time point and hence electrical excitability of the cell. In general, a 
differing combination of currents is active during each phase of the cardiac AP indicated by the 
numbers 0 through 4 (center panel Figure 1.2). At rest the Vm of the cardiomyocyte is established 
by currents through the inward rectifier K+ channel (/k0 , hence the resting membrane potential 
(Vrest) is established near the K+ reversal potential (-90 mV). As the cell depolarizes the open 
probability of Na+ channels is increased leading to a positive feedback loop with large inward 
current and rapid depolarization of the membrane (phase 0) approaching the reversal potential of 
Na+. Due to the rapid inactivation of the Na+ current (/Na) and the subsequent activation of the 
transient outward K+ current (/to) the downward notch at the top of phase 1 is produced. The 
activation of L-type Ca++ current (/CaL) combined with the activation of the rapid component of 
the outward K+ current (Ik-) produces phase 2, or the plateau phase, where the Vm reaches 
somewhere between the Ca++ and K+ reversal potentials. As /CaL inactivates and Ik- and the slow 
component of the outward K+ current (Iks) activates, leading to the repolarization phase, or phase
3, moving Vm back to phase 4 or rest [65].
The shape of the cardiac AP is important for two primary reasons. First, the relatively 





F igu re 1.2: The cardiac action potential and its primary components. Above in blue, source 
currents flow into the cell depolarizing the membrane. Center, the cardiac action potential with 
each of the four phases labeled. Below in red, sink currents flow out of the cell polarizing the 
membrane. The balance of source and sink currents determines cell excitability and the shape of 
the action potential.
from the SR leading to activation of the actin-myocin filaments (see Figure 1.1) and is thus 
essential for proper contractile activity of the heart [66]. Second, the long AP duration (APD) 
serves to increase the refractory period by delaying the timing of Na+ channel recovery from the 
inactivated to closed state. The prolonged refractory period reduces the propensity for reentrant 
arrhythmias by increasing the duration of electrical wavefronts preventing the propagating wave 
from reexciting tissue prematurely [66]. An alternate conceptualization is that a longer wavefront 
necessitates a longer path length for formation of reentry. The idea of reentrant arrhythmias is 
discussed in more detail in the following section.
1.2.3 Cardiac Arrhythmogenesis 
Both Ca++ signaling and refractory period are thought to play important roles in 










of a proarrhythmic trigger and substrate. This concept is illustrated in Figure 1.3 where the 
substrate is defined as a region of tissue with sufficient path length around a region of 
unidirectional electrical block (upper right) [66-68]. The region of block can be either functional 
or anatomical but must allow the electrical wavefront to anchor and rotate around the blocked 
area and reenter the original site. The path length for this reentrant wave must be sufficient so 
that the reentering wave does not encounter refractory tissue and annihilate. Path length can be 
modulated through the physical size of the circuit but can also be affected by refractory period 
and conduction velocity [66-68]. While anatomical block results from mechanisms such as scar 
tissue formation and ischemic myocardium, currents which generate early-after or delayed-after 
depolarizations (EADs and DADs, respectively, Figure 1.3 bottom row) are thought to be a 
common trigger for arrhythmias [66-68] by presumably resulting in regions of ectopic activity, 
complex wave interactions, and arrhythmias. Despite this theoretical framework exactly how VF 
is triggered in hearts is still unproven. VF causes loss of organized contraction, leading to 
ischemia with its accompanying lack of O2 delivery and waste removal. The resulting is a lack of 








F igu re 1.3: An illustration of the primary components leading to VF based on current theory. 
Top row: illustrates the need for a proarrythmic substrate in triggering reentrant arrhythmias. 
The top left indicates normal conduction around an anatomical feature. The top right shows the 
formation of a reentrant pathway due to the presence of an area of unidirection block. The path 
length must be sufficient that the wavefront does not collide with the wave tail and annihilate. 
Lower row: diagrams of EADs and DADs that are thought to be Ca++ mediated triggers of 
arrhythmias. Current theory points to a need for both proarrythimc substrate and trigger for the 
formation of reentrant arrythimas such as VF.
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1.3.3). Given the framework discussed above, I started with the premise of metabolic challenge 
Section 1.3.3). Therefore, I started with the premise of metabolic challenge as a consequence of 
VF-SCA and developed a hypothesis for electrical failure due to changes in electrochemical 
gradients and ion channel function.
1.3 Theoretical Mechanisms of Electrical Failure 
Principles of electrically excitable cells points to the balance of source and sink currents 
as determinants of electrical failure. Figure 1.2 illustrated the major currents that make up the 
cardiac action potential that can be divided into either inward (source) currents or outward (sink 
currents). The net current determines whether an AP fires. For the purposes of electrical failure at 
the cellular level one can specifically focus on the AP upstroke since the presence of the upstroke 
determines whether the cell is excitable. This concept can be extended to the tissue level where 
the presence or lack (conduction block) of AP propagation to neighboring cells is determined by 
the source currents flowing from excited cells to neighboring cells at rest and the sink currents 
present in those same cells.
1.3.1 Reduced Source Current-Hyperkalemia 
By examining phase 0 (see Figure 1.2) of the AP one can begin to understand potential 
causes for inexcitability. As previously stated, the resting potential is determined by the GHK 
equation (equation 2). At rest under normal conditions, Na+ and Ca++ conductances are very low 
which allows the GHK equation to be simplified to the Nernst equation (Equation 1) (Figure 1.4 
top left) for K+ leading to a Vrest of approximately -88 mV. At this state almost all Na+ channels are 
available for recruitment in AP firing (Figure 1.4 top center). Thus a well-polarized Vrest results in 
robust AP firing (Figure 1.4 top right).
During ischemia [K+]o accumulates [69, 70] leading to a reduction in source currents. 
Under the assumption that Na+ and Ca++ conductances remain approximately zero, this [K+]o 
accumulation leads to depolarization of the Vrest (Figure 1.4 lower left) which in turn leads to 






























v re s t= -71 mV
F igu re 1.4: The effects of hyperkalemia on AP firing. Left column: the GHK equation determines 
steady state Vm. At rest Na+ and Ca++ conductances are low meaning, Vrest will be determined by 
the Nernst potential of K+. Center column: the effect of Vrest Inb availability. Right column: the 
resulting AP. Upper row: under normal conditions [K+]o is low leading to a well polarized Vrest, 
large Na+ channel availability, and rhobust AP firing. During ischemia [K+]o accumulates 
depolarizing Vrest, reducing Na+ channel availability, and less robust AP firing. With sufficient 
[K+]o accumulation Na+ channel availability can be reduced sufficiently to cause electrical failure.
center) and reduced AP amplitude (Figure 1.4 lower right). If the Inb current is reduced 
sufficiently APs cannot fire at all. Thus, during ischemia there is reduced source current through 
increasing inactivation of Inb. Furthermore, hyperkalemia may contribute to heterogeneous 
electrical decline and failure through either heterogeneous [K+]o accumulation or due to 
heterogeneous Na+ channel expression or function throughout the heart. Cordeiro et al. showed 
heterogeneous Na+ channel function between the ENDO and EPI [71]. Specifically, it was shown 
that during ischemia although Inb density was not significantly different between ENDO and EPI, 
EPI cells displayed a more negative half-inactivation voltage suggesting reduced Inb availability on 
the EPI.
1.3.2 Ischemia Activated Potassium Channels 
In addition to decreased source current, sink current is thought to increase during 
ischemia through the activation of ischemia activated K+ channels. Of particular interest for the
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past few decades has been the ATP-sensitive K+ channel ( K a t p )  [72]. K a t p  channels in the 
ventricular sarcolemma form an octomeric structure comprised of four Kir6.2 pore forming 
subunits and four SUR2A regulatory subunits (see Figure 1.5A). K a t p  current ( / k a t p )  provides a 
direct link between metabolism and electrical activity since it is blocked by normal levels of [ATP]i 
and activated by high intracellular ADP concentration ([ADP]i) (Figure 1.5A). In addition, K a t p  
expression and/or function has been shown to be heterogeneous throughout the heart (left vs. 
right ventricle, ENDO vs. EPI) [69, 70]. Another potential mechanism for increased sink current 
during VF-SCA is the Na+-sensitive K+ channel (KNa). The molecular identity of KNa was 
determined a decade ago [73]. Thus far it has been shown that in the rabbit ventricles there is 
functional expression of KNa in the form of tetrameric Slo2.1 (Figure 1.5B). KNa presents an 
especially attractive possibility for increased sink current during VF-SCA since it creates a rate 
dependent increase in sink current: as activation rate increases intracellular Na+ concentration 
([Na+]i) increases resulting in more KNa current (/KNa) [74, 75]. Indeed, KNa opening should affect 
electrical activity in much the same way as K a t p  opening except that the effects would be greater 
at higher rates of excitation. In addition, evidence suggests that KNa can also sense [ATP]i 
potentially creating a direct link to metabolism as well [74, 75] although more recent evidence 
points to lack of ATP sensitivity of /KNa [76]. Furthermore, both / k a t p  and /KNa activation could 
substantially increase sink during ischemia due to their relatively large conductance (80 pS and 
180 pS, respectively) [77, 78]. With their large conductances and the lack of voltage and time 
sensitive gating, the result is a large increase in sink current during the AP (i.e., / k a t p  and /KNa are 
proportional to the difference between Vm and Ek).
1.3.3 Source-Sink Mismatch 
The result of hyperkalemia and ischemia activated K+ channel opening is the combination 
of decreased source current and increased sink current. Such imbalance of source and sink 
currents—called source-sink mismatch—increases propensity for conduction block and electrical 
failure. Figure 1.6 shows schematically how source-sink mismatch translates from the single cell 
to tissue in a one-dimensional tissue consisting of four cardiomyocytes. For electrical conduction
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Figure 1.5: Schematic representation of K a t p  and K\-:l channel gating. Both K a t p  and K\-:l are 
ligand gated and lack voltage and time sensitive gating. Furthermore, their large conductances 
and ATP sensitivity make them ideal candidates for linking metabolic stress with electrical failure. 
A .  K a t p  is an octomeric structure of four Kir6.2 pore forming subunits and four SUR2A regulatory 
subunits. Kir6.2 has a binding site for ATP that prevents pore opening. In the absence of ATP 
binding ADP can activate KATP; nevertheless, ATP binding even in the presence of ADP binding 
leads to loss of conductance. B . K\-:l is activated by [Na+]i which is thought to be increased during 
ischemia. During VF-SCA there is likely [Na+]i accumulation due to increased AP firing rate 
leading to a potential rate dependent increase in ischemic sink current.
to occur the AP firing in the first cell must be transmitted to each neighboring cell by depolarizing 
the neighboring cell’s Vm above threshold (indicated by the dashed lines). Under normal 
conditions (Figure 1.6 top pannel) source currents (indicated in blue) and sink currents (indicated 
in red) are in proper balance allowing the membrane potential of the first cell to reach threshold 
resulting in AP firing which creates electrotonic source currents that depolarize the neighboring 
cell sufficiently so it also reaches threshold and fires an AP. If there is a substantial decrease in 
source currents (Figure 1.6 second panel), as during ischemia through hyperkalemia and 
inactivation of I n b ,  the electrotonic source current to neighboring cells can be insufficient to 
depolarize Vm to threshold resulting in conduction block. If instead, there is a substantial increase 
in sink current (Figure 1.6 third panel), as during ischemia through activation of I k a t p  or I k n b , the 
electrotonic source current from the first cell is counteracted by the increased sink preventing Vm 
from depolarizing to threshold and thus resulting in conduction block. During ischemia both 
decreased source and increased sink are present, greatly increasing source-sink mismatch and 
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F igu re 1.6: Conceptual framework of source-sink mismatch in tissue. A figure of four myocytes 
forming a one dimensional tissue under various conditions of source-sink mismatch. Blue arrows 
indicate source currents, red arrows indicate sink currents, dashed lines indicate the threshold to 
which Vm must depolarized for AP firing to occur. The first panel shows normal conditions where 
the balance between source and sink allows neighboring cells to depolarize to threshold leading to 
AP propagation. The second panel indicates the consequences of reduced source current through 
mechanisms such as hyperkalemia leading to insufficient depolarization of neighboring cells 
resulting in conduction block. The third panel illustrates the result of increased sink current 
through mechanisms such as KATP or KNa activation which counteracts electrotonic source 
currents preventing depolarization to threshold and AP firing in neighboring cells. The fourth 
panel shows the combination of both decreased source and increased sink—as during ischemia— 




Shaw and Rudy investigated precisely this idea in silico by modeling the relationship 
between [K+]o and conduction velocity (CV) [79]. Their results indicate that gradually increasing 
[K+]o leads first to a range of [K+]o where CV is supernormal then falling off rapidly reaching 
conduction block at a [K+]o of approximately 14 to 15 mM. In addition, they modeled what occurs 
if there is extreme depletion of intracellular [ATP]i, much lower than bulk tissue [ATP]i depletion 
measured during ischemia [80]; nevertheless, these low [ATP]i may exist locally near the 
sarcolemma as suggested by Lamp and Weiss [81]. In effect, the model simulated the 
consequence of combined hyperkalemia and extreme /katp activation or large source-sink 
mismatch. The model predicted a left shift in the [K+]o necessary to cause conduction block, 
shifting the blocking [K+]o from 15 mM to approximately 10 mM. Shaw and Rudy concluded that
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hyperkalemia is the major factor determining conduction block while / k a t p  activation plays a 
relatively small role. Contrary to Shaw and Rudy’s conclusion about the small role of / k a t p ,  several 
studies suggest that under ischemia combined with pharmacological mitochondrial stress through 
the use of a protonophore which depolarized the mitochondrial membrane potential—aggravating 
mitochondrial stress during ischemia—conduction block and arrhythmias arise through the 
activation of / k a t p  without the presence of hyperkalemia [82-85]. This phenomenon has been 
called “metabolic sink block” and this mechanism is a key factor in conduction failure. Both the 
proposed mechanisms for electrical failure (i.e., hyperkalemia and K a t p  opening) are the products 
of simulations. Together, the findings above are inconclusive about what causes electrical failure 
during ischemia, although they do provide a starting point.
1.3.4 Rate and p-Adrenergic Stimulation 
The theories for electrical failure discussed above were developed in the general context of 
myocardial ischemia. Yet there are two factors present during VF-SCA that may accelerate 
electrical failure compared to ischemia alone. First, it is well known that VF leads to exceedingly 
high excitation rate reaching around 10 Hz without ischemia in canine hearts (see Chapter 3 for 
examples). In fact, high rate is an intrinsic characteristic of VF. Second, VF-SCA results in 
exposure to a high degree of p-adrenergic stimulation (P-AS) which is a consequence of 
endogenous catecholamine release, from adrenal glands and nerve endings in the myocardium, 
during ischemia—approximately 7-fold for norepinephrine during ischemia; furthermore, during 
procedures mimicking life saving resuscitation there is an approximately 100-fold increase in 
interstitial fluid catecholamine levels [86]. In addition, during clinical resuscitation ACLS 
guidelines recommend administration of epinephrine every 3-5 minutes [28]. Thus, especially in 
patients, the exposure to increased p-AS occurs from two routs. In addition, p-AS has a tendency 
to accelerate the frequency of VF further increasing excitation rate [87]. Figure 1.7 shows a 
schematic diagram of the complex potential consequences of increased excitation rate and p-AS 
leading to increased source-sink mismatch and hence electrical failure during VF-SCA.
The concept in Figure 1.7 is that increased rate or p-AS leads to both increased metabolic
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F igu re 1.7: Conceptual implications for the potentially detrimental effects of high excitation rate 
and p-AS present during VF-SCA. Increased rate and p-AS can lead to increased ionic imbalance 
and metabolic challenge. This in turn leads to increased I n b  inactivation and inschemia activated 
currents leading to source-sink mismatch and hence electrical failure. Each of these exacerbated 
changes may be linked through various mechanisms such as K a t p  and KNa activation. This figure 
serves to illustrate the complex interactions likely present and emphasizes the likelihood of the 
multifactorial nature of electrical failure in VF-SCA.
challenge and ionic imbalance that are themselves linked. For example, rate could modulate 
[Na+]i imbalance since the integral of In& over time (i.e., the quantity of Na+ ion influx) would 
increase. This in return could lead to greater energy expenditure by the Na+-K+ ATPase. As a 
consequence source current would be reduced through decreased Na+ driving force and sink 
could be increased through activation of iKNa promoting source-sink mismatch and electrical 
failure. As another example, p-AS leads to greater Ca++ cycling which requires greater energy 
expenditure leading to intracellular Ca++ ([Ca++]i) accumulation. Elevated diastolic [Ca++]i, in 
turn, could lead to increased mitochondrial challenge through mitochondrial permeability 
transition [88] promoting activation of I k a t p  again promoting source-sink mismatch and electrical 
failure. While Figure 1.7 is speculative, some hints exist in literature for the detrimental role of 
both high excitation rate and p-AS. First, Blake et al. showed that the deviation of the estimated 
K+ reversal potential ( E k )  from Vrest in a regionally ischemic dog heart was modulated by rate and 
extracellular Ca++ [89]. Such a deviation in Vrest and E k  would point to the emergence of a 
depolarizing current during ischemia that exacerbates source-sink mismatch and hence electrical 
failure (see Section 7.3.1 for a detailed discussion). Second, retrospective clinical studies show a
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potentially detrimental role of epinephrine treatment despite the increased occurrence of ROSC 
during resuscitation. Specifically, there are indications of reduced long-term survival to hospital 
discharge as a consequence of epinephrine treatment [42-44]. Third, the use of a p-adrenergic 
receptor antagonist, esmolol, in open-chest canine models of VF-SCA also point toward the 
detrimental role of p-AS in electrical failure by reducing the number of defibrillatory shocks 
necessary to achieve ROSC [86]. Thus, the literature points towards detrimental roles of high rate 
excitation and p-AS. Nevertheless, there has been no systematic examination of the independent 
and potentially synergistic roles of high rate excitation and p-AS in electrical failure nor is there 
insight into the mechanism of action during VF-SCA. In addition, my findings not only point to 
the detrimental roles of high rate excitation and p-AS in electrical failure but also in the 
promotion of ischemic arrhythmogenesis suggesting the critical role of abnormal impulse 
propagation rather than abnormal impulse formation (see Section 6.4.5 for details).
CHAPTER 2
OVERVIEW OF THE DISSERTATION
2.1 Motivation
The work in this dissertation was motivated by the desire to contribute meaningful 
advances in the understanding of electrical failure during VF-SCA. If a mechanism causing or 
even contributing to electrical failure could be identified such knowledge could impact 
interventions for clinical trials in resuscitation. Moreover, if electrical failure can be delayed 
through such interventions, perhaps survival rates can be improved; after all, survival rates for 
patients in asystole are much lower than those with some rhythm (See Section 1.1). The goal 
became to first understand the pathophysiology of VF-SCA. Based on the background discussed in 
Chapter 1, specific aims were developed to test each of the mechanisms discussed above using the 
isolated Langendorff perfused heart. The plan was to first determine the contribution of each 
mechanism to electrical failure during VF-SCA independently and second, to test the synergy that 
may exist between multiple factors. You will see through this dissertation that neither of the 
factors previously thought to cause electrical failure (hyperkalemia nor / k a t p )  are—independent or 
combined—sufficient to explain the pattern of electrical failure seen during VF-SCA. 
Furthermore, additional hypotheses were tested involving /KNa, excitation rate, and p-AS, which 
shed light on electrical failure but leave unanswered the additional mechanisms of electrical 
failure. In conclusion, I propose hypotheses to account for the missing mechanisms of electrical 
failure and the future work necessary to realize the goal for a clinical intervention.
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2.2 Projects
Below are concise descriptions of the four projects reported (Chapters 3 through 6) in this 
dissertation along with the original hypotheses on which the projects were based.
For project 1 I aimed to determine the transmural distribution of [K+]o during VF-SCA 
and assess its role in the distribution of VF rate and asystole during VF-SCA. I hypothesized that 
[K+]o would rise to higher levels in the subepicardium than in the subendocardium, reflecting 
transmural differences in ischemia-induced potassium efflux. I assessed the contribution of 
hyperkalemia to the heterogeneous electrical depression and inexcitability during VF-SCA by 
comparing the relationship between [K+]o and VF rate (VFR) during normoxemic VF and 
ischemic VF.
For project 2 I aimed to assess the role of K a t p  in electrical depression and asystole during 
VF-SCA. I hypothesized that the opening of K a t p  channels during VF-SCA contributes to 
heterogeneous electrical depression and asystole during VF-SCA (in accordance with the “sink 
block” mechanism) [82]. Hence, blockade of K a t p  would postpone electrical depression and 
asystole during VF-SCA. Moreover, pharmacological K a t p  activation in combination with 
hyperkalemia and normoxemic VF would not reproduce the pattern of electrical depression 
observed during VF-SCA.
For project 3 I sought to Assess the role of KNa in electrical depression and asystole during 
VF-SCA. I hypothesized that KNa blockade would delay heterogeneous electrical depression and 
asystole during VF-SCA (or rapid pacing and ischemia) similar to the outcome of K a t p  blockade. 
Moreover, the effects of KNa blockade would diminish at slower pacing rates.
For project 4 I aimed to determine the roles of high excitation rate and p-adrenergic 
stimulation in electrical depression and asystole during VF-SCA. I hypotheseized that both high 
excitation rate and p-AS independently promote electrical depression and asystole. Furthermore, 
the detrimental effects of high rate and p-AS would be additive in that combined they would 
further accelerate electrical failure. Moreover, the detrimental effect would be mediated by Ik n b  




Initially, it was necessary to establish the phenomenology of electrical failure in VFSCA. 
To achieve this I determined the time course and pattern of electrical deterioration and failure in 
open-chest and isolated Langendorff perfused canine heart models to establish a baseline for VF- 
SCA. Thereafter, the overall strategy for investigating the mechanisms of electrical failure in VF- 
SCA was 2-fold: 1) I investigated the role of each hypothesized mechanism independently during 
ischemia with VF or rapid pacing using an isolated heart model (Figure 2.1 above solid line); and 
2) I manipulated multiple factors simultaneously in a normally oxygenated langendorff perfused 
heart in an attempt to reproduce the characteristic electrical decline observed during VF-SCA 
(Figure 2.1 below solid line).
In Strategy 1 (Ischemic model), isolated hearts were exposed to global ischemic episodes 
lasting between 10 and 30 minutes by stopping the perfusion pump. [K+]o was monitored and ion 
channels were pharmacologically modulated. The goal of Strategy 1 was to determine the 
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F igu re 2.1: The two overall strategies used for projects in this dissertation (ischemic model and 
perfused model). The solid line indicates the time course of an experiment following cannulation 
till the end of VF-SCA. Above the solid line is illustrated the ischemic model where following 
interventions common to both models VF-SCA was simulated using a combination of VF or rapid 
pacing with ischemia. Below the solid line is illustrated the time course for the perfused model. 
Where VF-SCA was simulated using a VF or rapid pacing with graded hyperkalemia instead of 
ischemia. In each model various interventions were performed which are listed below the dashed 
arrow under preischemic interventions.
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pacing. In Strategy 2 (perfused model), isolated hearts were perfused with normal oxygenated 
solution while either in VF or under rapid pacing. Then perfusate composition was manipulated 
(i.e., K+ concentration or pharmacological interventions). The goal of Strategy 2 was to determine 
the mechanism, or combination of mechanisms, that best reproduced the characteristic electrical 
deterioration observed during the baseline study of VF-SCA (described in Chapter 3).
2.3.2 Experimental Setup
Hearts were obtained from pound dogs, purpose bread dogs, and New Zealand white 
rabbits of both sexes. Dogs weighed between 15 to 25 kg while rabbits weighed 1.75 ± 0.25 kg. The 
canine setup was designed for recirculation of a relatively small volume of blood (~700 mL) and 
the rabbit setup was designed for continuous perfusion with fresh Tyrode solution. In both setups 
gas composition and pH was controlled through a hollow fiber membrane oxygenator. Hearts 
were isolated through midline sternotomy and rapidly excised, placed in cold osmotically 
balanced saline, and rapidly cannulated. Perfusion was maintained at 140 ~ 200 mL/min for 
canine hearts and 30 mL/min for rabbit hearts. Hearts were placed in either a superfusion or 
vapor chamber for temperature maintenance during ischemia. Temperature was maintained at 37 
± 1 °C for both perfusion and superfusion.
2.3.3 Optical Mapping
Figure 2.2A shows a schematic diagram of the multichannel optical mapping setup 
developed for the work contained in this dissertation. The setup consists of red, green, and blue 
laser light sources with a holographic diffuser for beam expansion and smoothing (i.e., flattened 
Gaussian distribution of beam intensity), a multiband dichroic mirror for separation of excitation 
light from emission, an emission splitting dichroic mirror for separation of multiple emission 
spectra, band-pass or long-pass filters for isolation of the emission signal, and two CCD cameras 
for detection of the signals. The system has been used successfully with five fluorophores (Di-4 
ANEPPS, RH237, Rhod-2, TMRM, DCF) but was designed to accommodate additional 
fluorophores. For the work in this dissertation data collected only from Di-4 ANEPPS is shown
25
A A g M irro r
D ichro ic 
532  LP
D ichro ic  
473  LP A g  M irro r
\
S hu tte r S hu tte r S hu tte r
Ho lographic  
F M M I  D iffuser
500
c
550 600 650 
W avelength (nm)
700











F igu re 2.2: Optical mapping setup and analysis. A. Layout of components in optical mapping 
setup. Illustrates the simplicity and flexibility of the design that allows acquisition of fluorescence 
from a wide range of fluorophores and dual mapping capabilities. B. Di-4 ANEPPS fluorescence 
as a function of wavelength. The green vertical bar is the laser light, the gray box indicates the 
range of the bandpass filter in which light is collected. The solid line indicates the emission 
spectra at Vrest and the dashed line the emission at depolarized states. The difference in integral 
under the two curves gives the AP signal $F. C. Analysis work flow for optical data. A  fluorescence 
move obtained from the surface of the heart is analyzed one pixel at a time. Each pixel is filtered 
in space and time, inverted, and normalized by background fluorescence F. Two separate 
algorithms were used to detect various parameters, a wavefront detection algorithm and an 
impulse detection algorithm. From the results of these two algorithms maps of various 




with the detailed information concerning the optics used contained in the methods section of each 
relevant chapter. Di-4 ANEppS (pyridinium, 4-(2-(6-(dibutylamino)-2-naphthalenyl)ethenyl)-1- 
(3-sulfopropyl)-hydroxide is a zwitterion with a large hydrophobic region that binds to the cell 
membrane and changes excitation and emission wavelengths as it undergoes a conformational 
change in response to an electric field (Figure 2.2B). The change in emission wavelength of Di-4 
ANEPPS is recorded as a dimming in acquired fluorescence ($F, Figure 2.2C lower left) due to the 
reduced photon flux through the bandpass filter incident on the detector. Using this technique 
allows us to record electrical activity as if there were a 64 by 64 channel electrode array on the 
surface of the heart. In addition to the high density electrical recording, the signal from optical 
mapping of Di-4 ANEPPS gives direct information concerning the dynamic electrical behavior of 
the sarcolemma thus allowing measurements of parameters such as ApD and diastolic interval 
(DI) which can only be obtained through inference with traditional extracellular recording 
electrodes by measuring parameters such as activation recovery intervals. In addition, I was able 
to obtained high-density spatial information that allowed determination of inexcitable tissue and 
visualize the highly heterogeneous pattern of electrical depression and failure in response to 
uniform global ischemia.
The down sides of optical mapping are that motion from contraction can contaminate the 
signal, only signals from superficial layers are collected, large concentrations of dye can result in 
phototoxicity, the signal-to-noise ration is high compared to electrical recordings, and only 
relative changes in Vm can be measured. To minimize some of these pitfalls, the following 
precautions were taken. To reduce motion, hearts were either lightly pressed against the wall of 
the superfusion bath (canine hearts) or treated with an excitation-contraction uncoupler (rabbit 
hearts). Signal-to-noise was optimized by adjusting both the concentration of the dye and the 
intensity of illumination while attempting to minimize phototoxicity. To obtain information from 
the myocardial depth (greater than the first few hundred microns) I combined optical mapping 
with unipolar plunge needle electrodes (see Section 2.3.4). Figure 2.2C illustrates the data 
processing workflow. First, masks were created manually to exclude background and separate the 
LV and RV. Each pixel from the recorded movie yielded a series of APs. Signals were filtered in 
space and time, inverted, and normalized by background fluorescence.
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The filtered APs are then passed through two separate algorithms. Figure 2.2C (center 
column, upper panel) illustrates the wavefront detection algorithm. This algorithm detects the 
rate of AP upstroke, the maximum d$F/dt (proportional to dV/dt in the cardiac AP). This 
technique allows reliable detection of APs in the presence of motion artifact due to myocardial 
contraction since contraction occurs with a time delay following AP propagation. An area was 
considered silent/inexcitable if the max dV/dt did not exceed two times the max dV/dt of 
background noise. Figure 2.2C illustrates the impulse detection algorithm that allows detection of 
AP presence as well as some AP characteristics such as APD and DI. While the impulse detection 
algorithm provides more information concerning the APs, it is more easily contaminated by 
motion artifact. From these two algorithms, maps such as those illustrated in Figure 2.2C can be 
obtained. These maps can provide valuable spatial information concerning electrical activity at 
various time points during VF-SCA. Fluctuations that did not exceed both the local and global 
minimum were not counted as APs. Further details on the analysis of fluorescence data can be 
obtained in the relevant chapters.
2.3.4 Extracellular Potential Mapping
Extracellular potential was monitored by volume-conducted ECG and unipolar 
electrograms (EG) recorded using plunge needle electrodes made of fiberglass (10 leads 1.2 to 1.6 
mm interlead distance for canine hearts) to span the transmural wall [90]. Figure 2.3A shows a 
plunge needle electrode with sample EG recording across the transmural wall at 5 minutes of VF- 
SCA in a canine heart. Figure 2.3E shows an example of how plunge needles could be arranged in 
the myocardium to extract information both transmurally and laterally.
Using plunge needles allows the measurement of three-dimensional electrical activity in 
the heart. Figure 2.3C and D show example surface plots of measurements obtained from EG 
mapping. It can be seen that using plunge needle recordings the heterogeneous evolution of 
electrical deterioration can be observed both transmurally (Figure 2.3C) and laterally (Figure 
2.3D). Volume-conducted ECG recordings were used to determine time of asystole while EGs 
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F igu re 2.3: Plunge needle electrodes and recordings. A . An example plunge needle and unipolar 
EG recordings across the myocardial thickness at 5 minutes of VF-SCA. B. EG signal processing is 
performed by applying the Hilbert transform on the raw signal to obtain phase angles. Each 
transition of phase angle from 2% to -2% is marked on the raw signal. Next, amplitude is measured 
in the raw signal between each consecutive phase transition. If the amplitude does not meet 
threshold the phase transition is rejected. The remaining phase transitions indicate transition 
between cycles in local AP firing or electrical activity. C. Example of transmural surface plot of 
VFR as a function of myocardial depth and duration of VF-SCA. D. Example of lateral surface plot 
of VFR across the EPI. E. Example arrangement of plunge needles for three-dimensional 
mapping of electrical failure.
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ECG and EG recordings were amplified using a high impedance amplifier and fed to a 
multiplexing unit for data acquisition. Figure 2.3B shows the process of EG analysis. The Hilbert 
transform is applied to the raw signal, converting the signal to phase angles. Each transition from 
2% to -2% represents the start of a new cycle and is noted on the raw signal. Next, a minimum 
threshold amplitude is applied to the raw signal between phase transitions, thus ruling out small 
fluctuations and noise from being detected as activations. Each interval between remaining phase 
transitions represents an electrical activation in the local area. The lack of activation detection is 
interpreted as local electrical failure.
Like optical mapping, there are pros and cons of extracellular potential mapping. The 
benefit of ECG recordings is the ability to ascertain global rhythm and the occurrence of asystole, 
the down side is that there is no information about localized electrical activity from the single lead 
system used in the subsequent studies. EGs on the other hand provide more localized information 
and plunge needles can record information from deeper regions of the myocardium. The largest 
problem with plunge needles is the physical damage inflicted on the myocardial tissue, which 
produces immediate effects on the recorded electrical activity in the form of injury currents. To 
minimize injury current plunge needles were placed early in the experimental protocol and the 
injuries were allowed to recover for approximately half an hour. It is also difficult to know the 
exact volume from which measurements are obtained. Neither ECG nor EG recordings provide 
direct information about the APs and traditional methods for the inference of AP characteristics 
during normal rhythm (i.e., activation recovery intervals for APD) cannot be used during VF. 
Nevertheless, extracellular potentials provide useful insight into the nature of electrical failure as 
will be seen in the subsequent chapters.
2.3.5 Extracellular Potassium Mapping
K+ sensitive electrodes were constructed from a valinomycin based membrane [91] and 
housed in a hypodermic needle to protect the delicate membrane. Electrodes were calibrated pre- 
and post experimental protocol using the Nernst equation:
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K2 -  exp"In(K ,) + {V, -  V,)-R^C (7)
where K1 is the baseline [K+], K2 is the measured [K+], F is Faraday’s constant, R is the universal 
gas constant, T is the temperature in Kelvin, and C (a value which describes variability in the 
system) is determined experimentally pre- and postexperimental protocol using 3 and 10 mM KCl 
solution. Electrodes that fail to shift 30 ± 4 mV both pre- and postexperiment were rejected as 
broken and the data discarded. K1 was set to either the [K+] for Tyrode’s solution or the measured 
[K+] in the recirculating purfusate. Baseline [K+] was determined by a Nova8 ion analyzer (Nova 
Biomedical Waltham, MA U.S.A.). Using these calibrated K+ needles, I obtained transmural 
measurements of [K+]o at the ENDO, mid-myocardium (MID), and the EPI during VF-SCA. A 
description of the detailed approach to transmural measurements can be found in the methods 
section of Chapter 5.
2.4 Timeline of Study: Problems Encountered and Solutions Found 
By necessity the spatial and temporal pattern of electrical depression and failure needed 
to be determined prior to setting out what caused the pattern. As such, the open-chest canine 
heart was chosen as a starting point in the summer of 2008. The open-chest model represented a 
whole organism system, relevant to human subjects, for studying the consequences of VF-SCA 
while still allowing access to the heart with high-density data acquisition equipment. Initially, 
work was done to develop an optical mapping system capable of acquiring usable data from the 
open-chest animal. The hurdles for open-chest optical mapping were significant including the 
delivery of sufficient amounts of fluorophore to the heart, fluorophore toxicity, and the motion 
artifact due to contraction of the heart. I concluded that for mechanistic insight, especially 
utilizing pharmacological interventions or modulating extracellular ion concentrations, isolated 
hearts allowed much finer control of the environment. Thus, I performed simulated VF-SCA 
studies in isolated canine hearts that reproduced the characteristic patterns I observed in open- 
chest canine hearts, although the event timing was left-shifted (published in summer 2010,
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Chapter 3). From these efforts it was decided to use the isolated heart model to probe the 
mechanisms of electrical failure.
Concurrent to these efforts was the attempt to measure [K+]o in both the open chest and 
isolated canine hearts during VF-SCA using the valinomycin based K+ sensitive electrodes 
described above Although I started with the understanding that success rates for acquiring usable 
data would be low, I collected no usable data from the first 100 or so electrodes that were 
fabricated. I concluded that the epicardial layers on the surface of the canine heart were too thick 
to allow placement of the K+ electrodes without destroying them. Thus I developed the K+ needle 
electrode (described in detail in Chapter 5), which boosted my success rate for usable data 
acquisition from virtually 0% to approximately 80%. Sufficient data for transmural comparison of 
[K+]o accumulation during VFSCA was finally obtained in Spring 2012.
As I continued to collect [K+]o measurements, I started my work on testing the role of 
K a t p  in electrical failure using pharmacological interventions in VF-SCA using an ischemic model 
in the spring of 2009. The primary difficulty with this project was optimizing the concentration of 
the K a t p  channel blocker. The problem was that the role of K a t p  could only be observed with high 
concentrations that created a concern about nonspecific effects. This lead to a more than doubling 
of the number of experiments to show that the nonspecific effects could not account for the 
results of the K a t p  blocker. The results of this effort were published in summer of 2012 (Chapter 
4).
With the [K+]o data from the ischemic model in hand, in the spring of 2012 I set out to 
determine the role of hyperkalemia in electrical failure during VF-SCA. This was when the idea to 
use normal oxygenated perfusion instead of ischemia was developed. The idea was to exclude 
ischemia as a factor and see if the consequences of ischemia such as hyperkalemia or K a t p  
opening can reproduce the electrical pattern observed with ischemia. I then took the idea one step 
further and decided to combine the two conditions to see if I could reproduce what the leading 
theory at the time claimed was the mechanism of electrical failure. The results were negative. The 
long believed factors for electrical failure, namely hyperkalemia and K a t p  opening—individually or 
combined—did not reproduce the pattern of electrical failure during VF-SCA. There are additional 
factors at play. This result was published in summer 2013 (Chapter 5).
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The question since then has been, “What are the additional factors?” Although I had some 
hypotheses the large number of possible mechanisms made it impractical to pursue these studies 
in dogs. To allow higher data throughput I chose to transition to a rabbit model a plan to 
investigate promising mechanisms in the canine model in the future. The difficulty in 
transitioning was that rabbit hearts do not experience sustained fibrillation under normal 
conditions. My attempts to create a sustained VF model in rabbits instead led me to develop a 
model of simulated VF (i.e., rapid pacing and p-AS). Using th1is model I was able to prove the 
hypothesized roles of excitation rate and p-AS in electrical failure. Using this rabbit model of VF- 
SCA I have also tested the potential role of KNa and reproduced my findings for K a t p  (Chapter 6) 
and am in the process of investigating other hypothesized mechanisms of electrical failure 
(Chapter 7.3.1 Future Work).
2.5 Organization of the Remaining Chapters 
The following sections of this dissertation describe the results and conclusions of the 
effort described above. Chapter 3 is a reprint of my first publication (as cofirst author) in the 
American Journal of Physiology: Heart and Circulatory Physiology (AJP) in which I first 
established detailed three-dimensional phenomenology/pattern of electrical depression and 
failure in both in situ and ex vivo canine heart models of VF-SCA. Chapter 4 is a reprint of my 
second publication in AJP addressing the role of I k a t p  in electrical depression and failure in the 
isolated canine heart. Chapter 5 contains my most recent publication, also in AJP, addressing the 
combined effects of hyperkalemia and K a t p  activation in the isolated canine heart leading to the 
conclusion that additional mechanisms besides these two factors plays a key role in electrical 
depression and failure during VF-SCA. Chapter 6 is a manuscript currently in preparation 
elucidating the synergistic effects of p-AS and high excitation rate in promoting electrical failure 
in the isolated rabbit heart with insights into the mechanism. Chapter 7 contains conclusions 
drawn from this body of work, proposed mechanisms yet unproved and currently under 
investigation, future directions, and potential clinical implications for my findings.
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An important note is that each paper contained in Chapters 3 through 6 have been 
presented at American Heart Association’s annual Resuscitation Science Symposium where the 
work contained in Chapter 5 received a Young Investigator Award. In addition to the work 
featured in Chapters 3 through 6 (in which I played a primary role), Chapter 7 contains a 
discussion of work complimentary to this thesis in which I played an ancillary role.
CHAPTER 3
COMPLEX STRUCTURE OF ELECTROPHYSIOLOGICAL GRADIENTS 
EMERGING DURING LONG-DURATION VENTRICULAR 
FIBRILLATION IN THE CANINE HEART
The research in this chapter was published in the American Journal o f Physiology: Heart 
and Circulatory Physiology. Paul W. Venable, Tyson G. Taylor, Junko Shibayama, Mark Warren, 
and Alexey V. Zaitsev.: ‘Complex structure of electrophysiological gradients emerging during 
long-duration ventricular fibrillation in the canine heart.’ Am J Physio Heart Circ Physiol, 2010, 
299, pp. H1405-H1418. Reprinted with permission of the American Physiological Society.
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27, 2010; doi:10.1152/ajpheart.00419.2010.—Long-duration ventric­
ular fibrillation (LDVF) in the globally ischemic heart is a common 
setting of cardiac arrest. Electrical heterogeneities during LDVF may 
affect outcomes of defibrillation and resuscitation. Previous studies in 
large mammalian hearts have investigated the role of Purkinje fibers 
and electrophysiological gradients between the endocardium (Endo) 
and epicardium (Epi). Much less is known about gradients between 
the right ventricle (RV) and left ventricle (LV) and within each 
chamber during LDVF. We studied the transmural distribution of the 
VF activation rate (VFR) in the RV and LV and at the junction of RV, 
LV, and septum (Sep) during LDVF using plunge needle electrodes in 
opened-chest dogs. We also used optical mapping to analyze the Epi 
distribution of VFR, action potential duration (APD), and diastolic 
interval (DI) during LDVF in the RV and LV of isolated hearts. 
Transmural VFR gradients developed in both the RV and LV, with a 
faster VFR in Endo. Concurrently, large VFR gradients developed in 
Epi, with the fastest VFR in the RV-Sep junction, intermediate in the 
RV, and slowest in the LV. Optical mapping revealed a progressively 
increasing VFR dispersion within both the LV and RV, with a mosaic 
presence of fully inexcitable areas after 4 -8  min of LDVF. The 
transmural, interchamber, and intrachamber VFR heterogeneities 
were of similar magnitude. In both chambers, the inverse of VFR was 
highly correlated with DI, but not APD, at all time points of LDVF. 
We conclude that the complex VFR gradients during LDVF in the 
canine heart cannot be explained solely by the distribution of Purkinje 
fibers and are related to regional differences in the electrical depres­
sion secondary to LDVF.
ischemia; optical mapping; inexcitability
v e n t r i c u l a r  f i b r i l l a t i o n  (VF) is a major cause of sudden 
cardiac death. The spatiotemporal organization of VF evolves 
as global ischemia progresses and alters electrophysiological 
properties of the myocardium. Concurrent with the metabolic 
and electrophysiological changes, the chance of successful 
defibrillation and resuscitation diminishes with every minute of 
VF, approaching zero at —10 min after the onset of VF (31). 
unfortunately, the delayed response time of emergency med­
ical services often approaches the time when successful resus­
citation is unlikely. This perhaps explains the fact that the 
overall survival of victims of out-of-hospital cardiac arrest is a 
dismal 5% (14). The mechanisms determining successful de­
fibrillation and survival under these conditions remain poorly 
understood but may be related to the nature of the sources 
maintaining VF (reentrant or focal) and electrical depression
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caused by ischemia, culminating in a complete loss of electri­
cal response (asystole). The evolution of the organization of 
VF lasting 10-20 min in the globally ischemic heart [termed 
long-duration VF (LDVF)] has been the focus of several recent 
studies (2, 5, 8, 15, 19, 20, 27, 34, 42). These studies revealed 
large gradients in the VF activation rate (VFR) between the left 
ventricular (LV) endocardium (Endo) and LV epicardium (Epi) 
in the dog and the rabbit but not in the pig. In the rabbit heart, 
a transmural VFR gradient is present only in the LV but not in 
the right ventricle (RV) (42). Based on principal differences in 
the organization of Purkinje fibers in these species (exclusively 
Endo in the dog and rabbit vs. transmural in the porcine heart), 
as well as analysis of the directionality of the transmural wave 
propagation in the dog and pig, the differences in the organi­
zation of LDVF between the dog and pig were interpreted in 
terms of the leading role of focal activity (e.g., abnormal 
automaticity) arising from Purkinje fibers in maintaining ad­
vanced stages of LDVF (2, 8, 34). The idea of focal sources 
driving VF is a significant shift of the current paradigm of VF 
based on the notion of reentry in the form of spiral waves and 
may have important implications for defibrillation and resus­
citation during LDVF. Recently, an elegant study (19) using a 
transmural multilevel optrode in the LV showed that the 
gradient in VFR is mostly determined by the gradient in the 
diastolic interval (DI), whereas the action potential (AP) dura­
tion (APD) remains conserved across the LV wall as the LDVF 
evolves. This can be interpreted as evidence that a gradient of 
excitability and/or postrepolarization refractoriness occurs 
across the LV wall, which enables Endo to support more rapid 
activations during LDVF. The presence of such a gradient may 
be due to the transmural distribution of ionic channel properties 
unrelated to but coincidental with the distribution of Purkinje 
fibers. Thus, the question arises as to whether the sites of the 
fastest activation at advanced stages of LDVF are universally 
associated with Endo, where Purkinje fibers are localized in the 
canine heart.
In that regard, it is important to note that in addition to the 
transmural VFR gradient, optical mapping studies (4, 42) in the 
rabbit heart have revealed a large Epi VFR gradient between 
the RV (faster activation) and LV during LDVF. However, 
little is known about right-to-left gradients during LDVF in 
large mammalian hearts, in particular in the canine heart, 
which is considered to be the closest to the human heart in 
terms of the dynamics of LDVF (2). The purpose of this study 
was to provide a comprehensive description of both transmural 
and lateral [RV to septum (Sep) to LV] electrophysiological 
gradients during LDVF in the canine heart during the first 10 
min of LDVF using information from both transmural needle 
electrodes and high-resolution Epi optical mapping. From 
optical data, we analyzed the distribution of APD, DI, and 
sustained sources of activation in the RV and LV during
http://www.ajpheart.org 0363-6135/10 Copyright © 2010 the American Physiological Society H1405
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LDVF. Our results revealed an unprecedented complexity of 
electrophysiological gradients emerging during LDVF, with 
large heterogeneities both between chambers as well as locally 
within each chamber. Importantly, the magnitudes of inter­
chamber and intrachamber VFR gradients were comparable to 
the magnitude of the transmural gradient, with Epi sites at the 
RV-Sep junction being activated as fast as LV Endo. We also 
found that Epi right-to-left VFR gradients were determined by 
the gradients in DI amid relatively constant APD, which is 
similar to the pattern observed transmurally across the LV wall 
(19). We concluded that VFR gradients during LDVF in the 
canine heart cannot be fully explained by special properties of 
Purkinje fibers but may be universally determined by nonuni­
form electrical depression reflected in the prolongation of 
postrepolarization refractoriness and eventual loss of excitabil­
ity. We propose possible factors contributing to the highly 
nonuniform response of the canine heart to the stress imposed 
by LDVF and global ischemia.
METHODS
This investigation conformed with the National Institutes of Health 
Guide fo r  the Care and Use o f Laboratory Animals (NIH Pub. No. 
85-23, Revised 1996). The animal protocols were approved by the 
Institutional Animal Care and Use Committee of the University of 
Utah. A total of 19 dogs were used in this study (5 dogs for the 
multielectrode mapping of LDVF in situ, 10 dogs for the optical 
mapping of LDVF in isolated hearts, and 4 dogs for the assessment of 
regional differences in refractoriness during global ischemia in iso­
lated hearts).
Experiments in situ. Five dogs of either sex (30.8 ±  10.5 kg) were 
anesthetized with acepromazine (0.1 ml/10 kg) and pentobarbital 
sodium (32.5 mg/kg). Anesthesia was maintained through intravenous 
injections of pentobarbital sodium. Intubation was accomplished with 
a cuffed endotracheal tube, and mechanical ventilation was main­
tained at 10-15 cycles/min (tidal volume: 15-20 ml/kg). The heart 
was exposed via a midline sternotomy. The chest opening was 
covered with polyethylene film, and warm, humidified air was blown 
into the chest to maintain temperature at the surface of the heart 
between 35 and 37°C during LDVF. Lead I ECG was recorded 
continuously throughout the experiment. Blood gases, pH, electrolyte 
concentrations, and glucose were analyzed in arterial blood samples 
before the onset of VF. Plunge needle electrodes with 10 evenly 
spaced unipolar leads were manufactured in house following the 
design developed by Rogers et al. (30). Electrodes in the LV had an 
interlead distance of 1.6 mm, and those in the RV and Sep had an 
interlead distance of 1.2 mm. Three needle electrodes were inserted 
in the anterior RV, one in the Sep, and three in the anterior LV, as 
shown schematically in Fig. 1A. The distance between needles was 
10 -15 mm. Needles were placed along a transverse plane bisecting 
the heart approximately at half-distance between the apex and base. 
The Sep needle was placed just to the right of the left anterior 
descending coronary artery (LAD). VF was induced by a brief (~1 s) 
application of current from a 9-V battery to the RV outflow tract. 
Unipolar electrograms from all contacts of the needle electrodes were 
recorded continuously during the first 10 min of VF at a sampling rate 
of 1 kHz using a custom-made multichannel data-acquisition system, 
as previously described (35).
Electrode data analysis. Unipolar electrograms were analyzed 
using custom software developed in a Matlab framework. Activations 
were chosen as the maximum negative derivatives that exceeded a 
minimum of 3 V/s within a 20-ms search window, which is similar to 
previously described approaches (8, 9). VFR was calculated as the 
average number of activations per second over 10-s intervals taken at 
10 s after VF induction and at minutes 1-9 of LDVF. For simplicity, 
the first time point is referred to as minute 0 of LDVF.
Fig. 1. Schematic representation of the mapping modalities used in this study. 
A: approximate positions of the plunge needle electrodes. RV1, RV2, and RV3 
indicate electrodes in the right ventricle (RV). LV1, LV2, and LV3 indicate 
electrodes in the left ventricle (LV). The electrode in the anterior projection of 
the interventricular septum (Sep) is also shown. All electrodes were in the 
transverse plane located at approximately middistance between the base and 
apex. The epicardial (Epi) and midmyocardial (Mid) leads in the plunge needle 
electrodes are indicated, as is the endocardial (Endo) lead in the RV and 
LV electrodes. Deep indicates the lead in the Sep electrode that is the most 
distant electrode from Epi and is located in the depth of Sep. See text for more 
detail. B—D: three positions of the imaged area (circles) used in the optical 
mapping experiments. B: the imaged area mostly covers the LV with a narrow 
region of the RV. C: the imaged area covers approximately equal portions of 
the RV and LV. D: the imaged area mostly covers the RV with a narrow region 
of the LV. LAD, left anterior descending coronary artery.
Whereas the length of the RV and LV needles was constant and 
designed to span the largest thickness observed in the respective 
chambers of the canine heart, the actual thickness of the ventricular 
wall is highly nonuniform, especially in the RV. Thus, in some cases, 
plunge needle electrodes were longer than the wall thickness at the 
site of insertion. The contacts outside the ventricular wall were 
excluded from analysis based on the following criteria: 1) low VFR at
0 min of LDVF (slower by 5 Hz or more compared with the average 
VFR measured in all locations), 2) decrease of VFR to below 2 Hz 
within the first minute of LDVF, and 3) observation of a progressively 
decreasing electrogram amplitude toward more distal leads while 
maintaining the same morphology as more proximal leads in the same 
needle. In the latter case, the most proximal lead from the group of 
leads with identical morphology was designated as the Endo location 
in the needle. This approach could potentially falsely reject some of 
the true Endo leads in the RV and LV and thus underestimate the 
magnitude of the Endo-to-Epi difference in VFR, which, however, 
would not affect the main conclusions of this study (this issue is 
further discussed in Limitations). The position of the Epi lead could be 
easily ensured by visual inspection. After determination of the most 
distal lead in contact with the myocardial wall (Endo), the midmyo- 
cardial (Mid) lead was chosen as the one closest to being equidistant 
between Epi and Endo. Note that, unlike in RV or LV needles, the 
most distal recording site in the Sep needle was always in the depth of
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the Sep (see Supplemental Material, Supplemental Fig. 1).1 Accord­
ingly, in the Sep needle, we identified the Epi, Mid, and Deep sites for 
the purposes of analysis and comparison with RV and LV locations. 
At later stages of LDVF, some electrograms appeared to lack any 
local activation. However, due to a far-field signal always being 
present in unipolar electrograms, it was sometimes difficult to ascer­
tain a clear-cut case of complete loss of excitability. Therefore, local 
inexcitabilty was defined in unipolar electrograms when VFR fell 
below 0.5 Hz, whereas at least some other leads in the same experi­
ment exhibited fibrillatory activity with VFR >  4 Hz.
Experiments in isolated hearts. Hearts were obtained from dogs of 
either sex (n = 14, 27.5 ± 2.7 kg) after premedication, anesthesia, and 
surgery performed as described above. After isolation via a midline 
sternotomy, the heart was perfused in a Langendorff apparatus with a 
mixture of blood and Tyrode solution as described in detail in our 
previous publications (16, 43). Briefly, the blood-Tyrode mixture was 
oxygenated (5% CO2-95% O2), heated (37°C), and filtered using 
standard pediatric heart perfusion units from various vendors. The 
whole mixture was collected for recirculation with collector tubes 
inserted into the RV and LV via cuts in the appendages of the 
respective atria. The heart was then placed in a temperature-controlled 
bath with heated water-jacketed transparent glass walls. The bath was 
filled with warmed Tyrode solution, which was continuously pumped, 
without recirculation, at a rate 80-150 ml/min. The O2 content in the 
superfusate was removed by continuous gassing with a 95% N2-5% 
CO2 mixture. Temperatures in the LV cavity, superfusate, and water 
jacket were maintained at 37 ± 0.5°C during both normal coronary 
perfusion and ischemia. The gradient of temperature across the LV 
wall did not exceeded 1°C. Ten hearts were used for the optical 
mapping of LDVF. In four additional hearts, we performed pro­
grammed stimulation during global ischemia to access regional dif­
ferences in refractoriness (see Supplemental Figs. 6 -8).
Optical recordings. Optical mapping of activation during VF was 
performed using an electron-multiplied charge-coupled device camera 
(iXon DU-860D, Andor Technology, Belfast, UK) with a 6- or 12-mm 
objective lens (Computar, Commack, NY) at a resolution of 64 X 64 
pixels and frame interval of 2 ms. Excitation light came from a 
532-nm green solid-state laser (Coherent, Santa Clara, CA), and the 
fluorescent signal was filtered with a 640 ± 50-nm filter (Omega 
Optical, Brattleboro, VT). The voltage-sensitive dye di-4-ANEPPS 
(Molecular Probes, Carlsbad, CA) was delivered to the heart as a 
bolus via an injection into the aortic cannula. The field of view 
covered portions of Epi of the anterior RV, Sep, and LV. Even though 
the sites immediately adjacent to the LAD most certainly overlay the 
Epi projection of the Sep, the exact boundaries between the Sep and 
RV and LV free walls could not be reliably determined for the 
purposes of optical mapping. Therefore, in optical maps, we followed 
previously used approaches (4, 32, 42) and defined the area to the 
right of the LAD as the RV and the area to the left of the LAD as the 
LV (Fig. 1B). The size of the field of view varied between 40 X 40 
and 65 X 65 mm. Due to the relatively large size of the dog heart and 
curvature of the ventricular wall, it was not possible to have large 
portions of both ventricles simultaneously in the field of view. 
Therefore, optical mapping experiments were divided into three sub­
groups. In the first group (n = 4), the field of view predominantly 
covered the LV with a rim of the RV —15 mm wide. In the second 
group (n = 3), the areas to the right and left of the LAD were 
approximately equal. In the third group (n = 3), the field of view 
predominantly covered the RV with a rim of the LV —15 mm wide. 
The approximation of the respective fields of view is schematically 
shown in Fig. 1B . To minimize motion artifacts, the heart was gently 
pressed against the glass chamber wall as previously described (16, 
43). No electromechanical uncouplers were used.
1 Supplemental Material for this article is available online at the American 
Journal of Physiology-Heart and Circulatory Physiology website.
The heart was perfused with blood before the onset of LDVF; 
however, immediately before the induction of ischemia, the perfusion 
was switched to Tyrode solution with the dual purpose of ensuring 
constant composition of the extracellular milieu at the onset of LDVF 
and enhancing the voltage-sensitive signal for the purpose of better 
resolving low-amplitude signals at advanced stages of LDVF. VF was 
induced using a 9-V direct current battery 10 s to 5 min before the 
onset of global ischemia initiated by interruption of aortic perfusion. 
No perceptible differences in the measured parameters were found 
between experiments depending on the duration of VF before the 
onset of ischemia; therefore, in all experiments, the time of LDVF was 
counted from the moment when perfusion was stopped. LDVF was 
maintained for 10 min; 4-6-s-long movies were acquired every 30 s. 
After the last LDVF movie, the perfusion pump was restarted, and 
additional movies were acquired every minute during 5 min of 
reperfusion.
Analysis of optical signals. Spatial distributions of VFR, APD, and 
DI at different time points during LDVF were estimated in optical 
mapping data using custom routines developed in PV-Wave software 
(Visual Numerics, Boulder, CO). The dominant frequency of the 
Fourier spectrum was not used to estimate VFR because it did not 
reliably represent the perceived number of activations per unit of time 
at advanced stages of LDVF, when the AP is characterized by very 
short APD and long DI. Instead, we used an algorithm to detect 
individual APs in single-pixel recordings, similar to that described in 
our previous publication (16). In brief, the depolarization and repo­
larization phases of each optical AP were detected. The time points at 
which the depolarization and repolarization phases crossed a line 
drawn at the 40% level of the absolute maximum in the respective 
signal (AFmax) were determined. From these time points, APD, DI, 
and VF cycle length (VFCL) could be calculated for each cycle. The 
algorithm rejected noise based on thresholds set for APD (<10 ms), 
VFCL (<30 ms), absolute AP amplitude (<15 levels of brightness), 
and percent AP amplitude with respect to the time sequence maximum 
(<5%  of AFmax). VFR maps were created by dividing the number of 
APs by duration of the analyzed movie. Areas with no APs detected 
throughout the entire movie were considered to be inexcitable and 
having a VFR = 0. Such areas were counted for the purposes of 
determining the average VFR but were excluded from the calculation 
of average APD and DI. Singularity points were identified in Hilbert- 
transformed movies of voltage-sensitive fluorescence as points where 
all AP phases converged, as previously described (13, 39). Rotors 
were defined as singularity points that lasted for more than one cycle 
of rotation. The maximal lifespan and maximal number of rotations of 
rotors were computed for the RV and LV at 0 and 6 min of LDVF.
Statistical analysis. Within the data collected from the plunge 
needle electrodes, the time course of VFR was statistically compared 
in a 3 X 3 grid of principal locations (RV Epi, RV Mid, RV Endo, Sep 
Epi, Sep Mid, Sep Deep, LV Epi, LV Mid, and LV Endo; see Fig. 
1A). In each experiment, the RV and LV were represented by average 
values from all three electrodes in the respective chambers. Two-way 
ANOVA was performed with a post hoc Bonferroni test to make all 
36 pairwise comparisons of the VFR time course between the 9 
locations (see Supplemental Table 1). Note that the statistical signif­
icance indicated the differences between the means at all time points 
of LDVF in different locations. No conclusions regarding differences 
at individual time points were possible due to the prohibitively large 
number of required pairwise comparisons.
In the data collected from optical recordings, average values of 
VFR, APD, and DI were calculated for areas to the right (RV) and left 
(LV) of the LAD. Despite differences in the distribution of the field of 
view between the RV and LV in different experiments, the average 
values for the two areas were similar; therefore, data from all optical 
mapping experiments were combined into respective regions. Two­
way ANOVA was performed with a post hoc Bonferroni test to 
compare the time course of VFR, APD, and DI during LDVF between 
the RV and LV. Similar to the statistical treatment of the electrode
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data, the statistical significance indicated the differences between the 
mean values of measured parameters at all time points of LDVF. A 
linear regression analysis was performed to correlate the mean APD 
versus the mean VFCL and the mean DI versus the mean VFCL 
throughout all time points analyzed during LDVF. Data are expressed 
as means ± SE. Differences at P < 0.05 were considered statistically 
significant.
RESULTS
Multielectrode mapping in situ. Representative examples of 
unipolar electrograms obtained from plunge needle electrodes 
inserted into the RV, Sep, and LV are shown in Fig. 2. At 0 min 
of LDVF, VFR was relatively uniform among all locations and 
all layers. At 10 min of LDVF, a prominent Endo-to-Epi 
gradient in VFR was typically observed in both LV and RV 
free walls (Endo faster), whereas in the Sep, the fastest VFR 
was observed in Epi or Mid locations with slower VFR in the 
Sep Deep. After 3 min of LDVF, the sites of the fastest VFR 
in the RV occurred in Endo in four of five (80%) experiments; 
in one experiment, VFR was uniform across the RV wall. In 
the LV, the fastest sites were in Endo in three of five (60%) of 
experiments; in the other two experiments, Endo and Mid had 
similar VFRs, with both being faster than Epi VFR. In the Sep, 
the fastest sites were in Epi and/or Mid in 100% of the 
experiments, with Sep Deep locations being consistently 
slower than Sep Mid locations. In many cases, we observed 
what appeared to be a complete lack of activation in some 
electrograms. Such events occurred starting from —4 min of 
LDVF and were often local, so that adjacent needles or differ­
ent contacts in the same needle still reflected some activation. 
Using our criterion for inexcitability (see METHODS), local 
inexcitability was most frequently observed in LV Epi and RV 
Epi (100% and 60% of experiments, respectively). Much less 
frequent were cases of inexcitability in LV Endo, RV Endo, 
RV Mid, LV Mid, and Sep Deep locations (20% of experi­
ments in each case). Finally, inexcitability was never observed 
in Sep Epi and Sep Mid.
Figure 3 shows the average time course of VFR during the 
first 9 min of LDVF in the nine ventricular locations shown in 
Fig. 1A (RV Epi, RV Mid, RV Endo, Sep Epi, Sep Mid, Sep 
Deep, LV Epi, LV Mid, and LV Endo). Data for individual 
experiments are shown in Supplemental Fig. 2. In both Fig 3 
and Supplemental Fig. 2, the wall types are distinguished by 
different colors (LV, red; Sep, green; and RV, blue) and the 
distance from the Epi surface is indicated by different symbols 
(Epi, circle; Mid, square; Endo, triangle; and Sep Deep, X). 
Note that in Fig. 3 the VFR curves are presented redundantly 
in A -C  and D-F. Figure 3, A-C, groups the curves by wall type 
and thus facilitates a visual analysis of transmural gradients. 
Figure 3, D -F , on the other hand, groups the same curves by 
depth and thus highlights the lateral gradients (between the LV, 
Sep, and RV) at each depth.
Figure 3A shows the time course of VFR during LDVF at 
three transmural levels in the LV. Consistent with previous 
results, the difference between Endo, Mid, and Epi progres­
sively increased over time of LDVF, with LV Endo being 
consistently the fastest location. Note, however, that the largest 
gradient occurred in the outer half of the LV wall, between Mid 
and Epi. Accordingly, the time course of VFR was significantly 
different (P <  0.05) between Endo and Epi and between Mid 
and Epi but not between Endo and Mid.
Figure 3B shows the time course of VFR at three transmural 
levels in the Sep. It is important to note that the Sep Deep 
location was at approximately the same distance from Epi as 
RV Endo but at least 4 -5  mm away from any Endo surface 
(see Fig. 1A). Within the Sep, Epi and Mid VFR curves stayed 
very close together throughout the first 9 min of LDVF. After 
3 min of LDVF, VFR in Sep Epi and Sep Mid stabilized at —7 
Hz, whereas VFR in Sep Deep continued to fall, leading to a 
progressive separation of the Sep Deep curve from both Sep 
Epi and Sep Mid. This separation, however, did not reach 
statistical significance due to the relatively large variation 
between individual experiments (see Supplemental Fig. 2).
RV SEP LV
DEEP
Fig. 2. Unipolar electrograms recorded from different leads of plunge needle electrodes during long-duration ventricular fibrillation (LDVF) in a representative 
experiment. Top: 0 min of LDVF; bottom: 10 min of LDVF. Shown are recordings from the RV3 (left), Sep (middle), and LV3 (right) electrodes. See Fig. 1A 
for electrode locations and other definitions.
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Fig. 3. Time course of VF activation rate 
(VFR) in a matrix of 3 X 3 of nine principal 
locations (LV Endo, LV Mid, LV Epi, Sep 
Deep, Sep Mid, Sep Epi, RV Endo, RV Mid, 
and RV Epi) during 0 -9 min of LDVF. Colors 
indicate different wall types (LV, red; Sep, 
green; RV, blue). Symbols indicate different 
distances from Epi (Endo, triangles; Mid, 
squares; Epi, circles; Sep Deep, X). A-C: the 
nine VFR curves grouped by wall type (LV, 
Sep, and RV, respectively). D-F: the same 
nine VFR curves grouped by distance from 
Epi (Epi, Mid, and Endo/Deep, respectively). 
^Statistically significant difference between the 
VFR curves by two-way ANOVA. G: summary 
of statistically significant differences in VFR 
time courses between different locations.
Figure 3C shows the time course of VFR at three transmural 
levels in the RV. RV Mid was faster than RV Epi throughout 
the entire course of LDVF, with the difference being statisti­
cally significant (P < 0.05). However, there were no signifi­
cant differences between RV Endo and RV Mid. Thus, the 
transmural VFR gradient in RV was present mostly between 
Mid and Epi layers. Note that VFR in all RV layers reached a 
plateau after 3 - 4 min of LDVF, similar to Sep Epi and Sep 
Mid, but dissimilar to all LV layers and Sep Deep.
Figure 3, D-F, shows the same data as Fig. 3, A-C, but 
grouped by the distance from Epi. Figure 3D shows the VFR 
time course in the Epi layer of the LV, Sep, and RV. In all Epi 
locations, there was an initial decrease in VFR up to 3 min of 
LDVF, which was slightly faster in LV Epi and RV Epi than in 
Sep Epi. After that, however, VFR in RV Epi and Sep Epi 
stabilized (albeit at different levels), whereas VFR in LV Epi
continued to fall. As a result, VFR was significantly different 
between all pairs of Epi locations (P <  0.05), with Sep Epi 
being the fastest, RV Epi intermediate, and LV Epi slowest.
Figure 3E shows the VFR time course in the Mid layers of 
the LV, Sep, and RV. There was very little difference in the 
VFR time course between these locations during the first 3 min 
of LDVF. After that, the curves slightly diverged, with Sep 
Mid being the fastest, LV Mid slowest, and RV Mid in 
between. In a way, this pattern repeats the divergence observed 
in Epi locations (see Fig. 3D) but at a much lower scale. As a 
result, there were no statistical differences between VFR time 
courses in all Mid locations.
Finally, Fig. 3F  shows the VFR time course in Endo layers of 
the LV and RV and the Deep layer in the Sep. The LV Endo 
location was consistently faster than both RV Endo and Sep Deep, 
although LV Endo and RV Endo converged by 9 min of LDVF.
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The differences between LV Endo and RV Endo and between LV 
Endo and Sep Deep were statistically significant (P < 0.05). 
Figure 3G diagrammatically shows the VFR gradients in the 
directions tangential and perpendicular to the anterior ventricular 
wall. The results of all pairwise comparisons between the nine 
measured locations are shown in Supplemental Table 1.
The data presented above can be summarized as follows:
1) VFR is uniform over all locations at the onset of LDVF;
2) during LDVF, there are significant right-to-left gradients in 
Epi and Endo but not in Mid; 3) the largest transmural 
gradients in both the LV and RV develop between Mid and 
Epi, whereas the gradient between Endo and Mid is modest in 
the LV and practically nonexistent in the RV; and 4) overall, 
LV Epi exhibits the largest and Sep Epi the smallest decline in 
VFR during LDVF, so that the largest overall difference in 
VFR during LDVF was observed between Sep Epi and LV Epi. 
Figure 4 further highlights the special role of the Sep in the 
pattern of activation during LDVF, showing that in all exper­
iments the highest Epi VFR was observed either in Sep Epi or 
the adjacent RV Epi location (electrode RV1). Finally, it is 
worth noting that throughout the entire length of LDVF stud­
ied, the VFR time course was very similar in LV Endo, Sep 
Mid, and Sep Epi (see Supplemental Fig. 3). Since Sep Epi and 
Sep Mid do not have Purkinje fibers and are not adjacent to LV 
Endo in canine hearts, these data indicate that Purkinje fiber 
distribution and function may not be the main determinants of 
the VFR time course during LDVF.
Optical mapping in isolated hearts. The purpose of optical 
mapping experiments was to analyze the right-to-left and 
intrachamber gradients in VFR, APD, and DI during LDVF 
with high spatial resolution. Typical examples of VFR distri­
bution maps and individual optical recordings during LDVF 
are shown in Fig. 5. In the experiment shown in Fig. 5A , the 
field of view predominantly covered the LV and a small 
portion of RV. At the onset of LDVF, the VFR distribution was 
relatively uniform, and there were no large-scale differences 
between the LV and RV. At 8 min of LDVF, the VFR 
distribution was markedly heterogeneous, with the fastest do­
main (—4.5 Hz, green) situated in the RV and LV adjacent to 
the LAD. The largest part of the LV was activated at a VFR of 
—3 Hz (blue). Importantly, there was an area in the LV with an 
extremely low activation rate (<1 Hz, dark purple). The 
single-pixel recordings (Fig. 5A , sites a--c) were selected in 
such a way as to represent the three major frequency domains 
in the LV observed at 8 min of LDVF. At the onset of LDVF, 
the activation rate was similar between the three locations. 
However, at 8 min of LDVF, site a was the fastest, site c was 
intermediate, and in site b there was a single large-amplitude 
AP followed by a few small deflections, which are most likely 
due to electrotonus from the adjacent site c. Based on selected 
threshold criteria (see METHODS), our algorithm picked only the 
first (large) AP during the 4-s recording in site b compared with 
many more in sites a and c (asterisks in Fig. 6A). Note that site 
c, which exhibited a rhythmic series of suprathreshold APs,
Fig. 4. Epicardial distribution of VFR during LDVF in five experiments in situ (A-E). Lighter shades of grey indicate higher VFR. Note that in all experiments 
there is a local maximum in Epi VFR distribution either in the Sep or adjacent RV position (RV1) after 3 -4  min of LDVF.
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was only ~2 mm away from site b, which was barely excitable. 
Site b became completely silent by 10 min of LDVF, whereas 
the RV-Sep portion and rightmost part of the LV were still 
excitable (not shown).
In the experiment shown in Fig. 5B, the field of view 
predominantly covered the RV and a small portion of LV. 
Similar to the preceding example, at the onset of LDVF, the 
VFR distribution was relatively uniform, and there were no
0 min 8 min
JlfiJJjJX JJJX
B 0 min 10 min
1s
large-scale differences between the LV and RV. At 10 min of 
LDVF, however, the VFR distribution was extremely hetero­
geneous. The highest VFR was observed in an apical part of 
RV (~6 Hz, green). There were also two active areas in the 
more basal portions of the RV (~3 Hz, blue), whereas the rest 
of the RV and the visible region of the LV had a VFR below 
1 Hz (dark purple) or were completely inexcitable (black). 
Individual recordings from sites a-c showed similar fast acti­
vations at the onset of LDVF and striking differences at 10 min 
of LDVF. Specifically, site a exhibited fast and highly periodic 
activity, site b was completely silent, and site c was also highly 
periodic but was activated at half the rate of site a . Waves 
originating in the 6-Hz domain (green) did not propagate into 
the 3-Hz domain (blue) within the field of view. In fact, these 
two domains were separated by a thin inexcitable area (indicated 
by a white arrow in Fig. 6B) such that the waves from both 
domains converged and stopped at this area (not shown). Yet, 
sites a and c were phase locked in a 2:1 pattern, as shown in Fig. 
5C. Indeed, activation in site c followed every other activation in 
site a with a fixed time delay. Thus, unless this is a perfect 
coincidence, which is highly unlikely, site c is electrically con­
nected to site a, perhaps via an intramural excitable pathway.
A highly heterogeneous VFR distribution with patches of 
inexcitable areas in the RV and LV, as shown in Fig. 5, was 
typical for advanced stages of LDVF (after 4 -5  min of no 
perfusion). The transitions between high and low VFR could 
be very sharp, with local VFR gradients reaching 4 -5  Hz/mm 
(not shown). A common feature of VFR maps was the presence 
of the highest VFR in the RV localized near the LAD. Exam­
ples of heterogeneous VFR maps from each optical mapping 
experiment are shown in Supplemental Fig. 4. Consistent with 
the presence of areas with VFR = 0 in VFR maps, activation 
maps showed areas of no activation at advanced stages of 
LDVF (see examples in Supplemental Fig. 5D).
Figure 6 shows a quantitative analysis of the differences 
between the RV and LV that emerged during LDVF. Figure 6A 
shows that the average VFR was consistently higher in the RV 
than in the LV throughout 10 min of LDVF, with the exception 
of 0 min of LDVF. Figure 6B shows that average DI was 
longer in the LV than in the RV. Figure 6C shows that average 
APD was slightly shorter in the LV than in the RV between 2 
and 8 min of LDVF. Note that whereas DI increased quickly 
during LDVF in both the LV and RV, APD changed little with 
time of LDVF in both chambers. Finally, Fig. 6D shows 
percentages of excitable areas in the LV and RV maps as a 
function of LDVF duration. Note that after 3 min of LDVF, the
Fig. 5. Examples of VFR distribution measured in Epi optical maps in isolated 
hearts at the early and late stages of LDVF. A: experiment with predominantly 
LV optical mapping. Top, VFR maps at 0 min (right) and 8 min (left) of LDVF. 
Bottom, single-pixel recordings from sites a-c  (indicated on the respective 
VFR maps with circles). B : experiment with predominantly RV optical 
mapping. Top, VFR maps at 0 min (right) and 10 min (left) of LDVF. The 
arrow in the 10-min map indicates a thin inexcitable area (black, VFR = 0) 
separating two active areas (green, VFR— 6 Hz; blue, VFR — 3 Hz). Bottom, the 
same layout as in A . C : single-pixel recordings of sites a and c from B shown 
with an expanded time scale. Note the fixed 2:1 phase relationship between 
activations in these two locations, suggesting that sites a and c have a common 
source of excitation even though they do not communicate within the imaged 
area. Note the extremely high level of VFR heterogeneity in both the RV and 
LV at the advanced stages of LDVF.
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Fig. 6. Right-to-left differences in the time 
courses of VFR (A), diastolic interval (DI; B), 
action potential duration (APD; C), and per­
centage of excitable area (D) in Epi optical 
maps during LDVF. *Statistically significant 
difference between respective curves by two­
way ANOVA.
Duration of VF/lschemia (min) Duration of VF/lschemia (min)
percentage of the excitable area in the LV progressively de­
creased, followed by a similar decrease in the RV after an 
~1-min delay. The differences between the time courses of all 
measured parameters in the RV versus LV were statistically 
significant using two-way ANOVA (P < 0.05).
Figure 7 shows that average VFCL (inverse of VFR) was 
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Fig. 7. A and B: scatterplots of VF cycle length (VFCL) measured in the RV 
and LV at all time points of LDVF versus DI (A) and APD (B). There was a 
strong direct correlation between VFCL and DI (A) and a weak inverse 
correlation between VFCL and APD (B).
chambers at all time points during LDVF. In contrast, VFCL 
was only weakly inversely correlated with the average APD. 
Thus, VFCL was not determined by APD dispersion but rather 
by dispersion in DI, which reflects the degree of postrepolar­
ization refractoriness. It should also be noted that no functional 
relationship could be found between APD and the preceding DI 
at any stage of LDVF (not shown), which is consistent with 
previous reports (16, 19).
Stability o f reentry and breakthrough patterns in optical 
maps. Epi optical maps revealed multiple wavelets/short-living 
rotors in both chambers until relatively late stages of LDVF 
(~ 5 -6  min). During this period of time, Epi activation maps 
were extremely complex and fragmented with only rare occa­
sions of complete reentrant patterns (see Supplemental Fig. 5). 
At 0 min of LDVF, the maximum duration and number of 
rotations of reentrant circuits were larger in the RV than in the 
LV (see Table 1). At 6 min of LDVF, the maximum number of 
rotations in the RV was not different from that at 0 min LDVF, 
whereas the maximum lifespan was longer, consistent with 
prolonged VFCL at this later stage of LDVF. No reentry was 
observed in the LV at 6 min of LDVF. In 7 of 10 experiments,




Maximum Number of 
Rotations
Right ventricle
0 min of LDVF 504 ±  188 4.3 ±  1.2
6 min of LDVF 906 ±  278* 4.7 ±  1.5
Left ventricle
0 min of LDVF 166.6 ±  3.0* 1.7 ±  0.6*
6 min of LDVF No reentry No reentry
Values are means ±  SE. LDVF, long-duration ventricular fibrillation. *P < 
0.05 vs. the right ventricle at 0 min of LDVF.
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repetitive breakthrough patterns were observed in the RV close 
to the LAD at least in one of the movies recorded after 4 min 
of LDVF (see Fig. 8D). The breakthrough patterns appeared in 
approximately the same location in at least 50% of activations 
recorded in the same movie, and transitions from a break­
through to a reentrant pattern and vice versa in the same 
location were observed. Repetitive breakthrough patterns were 
not present in the RV at 0 min of LDVF and were not present 
in the LV throughout the entire duration of LDVF.
An example of transitions between focal and reentrant pat­
tern in the same location at a late stage of LDVF are shown in 
Fig. 8, A-C. Figure 8A,I shows a snapshot of a phase movie 
taken at 8 min of LDVF, which revealed a total of seven 
coexisting singularity points in the mapped area. The white 
arrowhead indicates the rotor, which was sustained for about 
seven rotations and was the dominant source in the area. The 
rotor was replaced by a breakthrough pattern in the same 
location (black arrows in Fig. 8A,2) which lasted for another
9-10 cycles. The breakthrough pattern then reverted back to 
reentry (white arrow in Fig. 8A,3). Figure 8B shows an acti­
vation map computed for the movie taken at 10 min of LDVF. 
On this map, the colors from red to magenta show a progres­
sion of wavefronts emanated by a stable and highly periodic 
focal source in the RV (black arrows in Fig. 9B). The focal 
source was situated approximately in the same site as the 
focal/reentrant source observed 2 min earlier and shown in Fig. 
8A. The waves emitted by the RV source failed to cross the 
LAD and activate the LV. However, a portion of the LV was 
activated, at a much slower rate, by a repetitive planar wave 
(white arrow in Fig. 9B), which was apparently unrelated to the 
fast source in the RV.
Figure 8C shows a unique case of stable Epi reentry ob­
served in the same experiment at 16 min of LDVF (and hence 
beyond the standard duration of LDVF analyzed in this study). 
The reentrant circuit was located in the basal RV not far from 
the LAD (counterclockwise arrow in Fig. 8C) and was sus-
A-1 656 ms A-2 2130 ms A-3 3840 ms
0 ms 166 ms 0 ms 326 ms
Fig. 8. Examples of transitions between the focal and reentrant pattern in the RV at the late stages of LDVF. A: individual frames of a phase movie at 8 min 
of LDVF. In I, several singularity points coexist in the mapped area; the point indicated by the white arrow is the leading source of activation in the mapped 
area for at least seven cycles. In 2, the reentrant source is replaced by a repetitive focal source in approximately the same location (black arrows). In 3, the focal 
source has reverted back to a repetitive reentrant source (white arrow) in approximately the same location. B : activation map at 10 min of LDVF showing a stable 
focal pattern (black arrows) in the same location as the focal and reentrant sources shown in A, 1-3. This focal source activates the RV but not the LV. The LV 
is activated by a planar wave (white arrow), which is apparently unrelated to the source in the RV. Red, early activation; magenta, late activation. The red front 
in the basal RV (B, top) shows the excitation wave generated in the previous cycle that is exiting the field of view when a new focal wave emerges. C: unique 
example of stable Epi reentry in the RV (white arrow) at a very late stage of LDVF (16 min). D : approximate locations of repetitive breakthrough patterns 
observed in 7 of 10 hearts.
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tained throughout the 6-s-long movie. Note that the reentrant 
waves did not penetrate into the LV, which was completely 
silent at this late stage of LDVF. Figure 8D shows the approx­
imate locations of repetitive breakthrough patterns observed in 
7 of 10 hearts.
DISCUSSION
This study provides an extensive analysis of heterogeneous 
electrical alterations occurring in the canine heart in response 
to the combined challenges of high excitation rate and ischemia 
during LDVF. The main finding of this study is the evidence of 
interchamber and intrachamber heterogeneities of a magnitude 
comparable to the much more studied gradients between Endo 
and Epi. In particular, our study revealed the presence of fully 
inexcitable areas interweaved with still excitable areas in both 
ventricles during the later stages of LDVF. Additionally, our 
optical mapping data complement and extend previous work by 
Kong et al. (19) showing that the right-to-left VFR gradient, 
similarly to the Endo-to-Epi VFR gradient, is largely deter­
mined by the nonuniform distribution of postrepolarization 
refractoriness amid a relatively invariant APD.
Gradients o f the activation rate and sources o f fastest 
activation during VF in globally ischemic hearts. The progres­
sive disparity of VFR between Endo and Epi of both the LV 
and RV (higher VFR in Endo) during VF in a nonperfused 
canine heart has been previously shown by several groups (5, 
27, 41). It was also documented that RV Epi was faster than 
LV Epi after 3 min of LDVF and that LV Endo was faster than 
RV Endo during the first 10 min of LDVF (5). In the rabbit 
heart, there was an Endo-to-Epi gradient in the LV, but not in 
the RV, and a right-to-left VFR gradient was present in Epi 
(42). In contrast to dog and rabbit hearts, in the pig heart, LV 
Epi was slightly faster than LV Endo and LV Epi was slightly 
faster than RV Epi at least during the first 3 min of LDVF (see 
Fig. 3 in Ref. 27). From these results, one can conclude that the 
overall pattern of VFR distribution during LDVF is complex 
and species dependent. Yet, the most striking feature is the 
consistent presence of a large Endo-to-Epi gradient in the LV 
of both dog and rabbit hearts and the absence thereof (or a 
slight inverse gradient) in the LV of the pig heart. Based on the 
principally different arrangement of the Purkinje network (con­
fined to Endo in the dog and rabbit and transmural in the pig), 
it was postulated that the transmural distribution of VFR during 
LDVF reflects the dominant role of Purkinje fibers in the 
maintenance of VF in the ischemic heart. Hence, in dog and 
rabbit ventricles, the rapid sources of VF are concentrated in 
Endo, whereas in the pig heart they are distributed throughout 
the wall thickness. More direct evidence for this hypothesis 
stemmed from experiments in which Endo ablation with Lugol 
solution eliminated the transmural VFR gradient (5, 8) or 
accelerated spontaneous VF termination in isolated LV prep­
aration (8) and from the observation of an increasing incidence 
of focal patterns in intramural layers of the porcine heart during 
LDVF (20).
Our quantification of spatial VFR gradients in the canine LV 
and RV is consistent with a previous report (27) showing the 
simultaneous presence of both Endo-to-Epi and RV-to-LV 
gradients of VFR during LDVF. In addition, we found that 
patterns of activation of the RV and LV during LDVF differ in 
several respects. First, in the RV, there are no significant
differences between Endo and Mid, and, thus, the VFR gradi­
ent is mostly present in the outer half of the RV wall. In the 
LV, however, there is a significant gradient between Endo and 
Mid as well as between Mid and Epi. Second, RV Epi main­
tains excitability for a longer time than LV Epi. Third, repet­
itive reentrant activity is present in the RV but not in the LV at 
late stages of LDVF. We also found that activation of the Sep 
(at least at its anterior junction with the RV and LV) deviates 
from the Purkinje paradigm for LDVF maintenance. In fact, the 
sites of fastest activation in the Sep were found within 5-6  mm 
from Epi, which is at least 4 to 5 mm away from the nearest 
Endo surface containing the Purkinje layer (see Supplemental 
Fig. 1). Sep Epi locations were consistently faster than sur­
rounding RV Epi and LV Epi locations (see Figs. 3 and 4). 
Moreover, throughout 10 min of LDVF, the activation rate in 
Sep Epi and Sep Mid was similar to that in LV Endo (see 
Supplemental Fig. 3B). Thus, based on the fastest VFR crite­
rion, it is possible that Sep Epi and Sep Mid layers may harbor 
sources maintaining LDVF. This possibility is confirmed by 
observations of sustained focal and reentrant sources in the 
vicinity of the RV-Sep junction in Epi optical maps (see Fig. 
8). A similar preferential clustering of sustained Epi sources 
near the Sep has been previously observed during LDVF in the 
rabbit heart (42). Those authors attributed Sep Epi break­
throughs to a possibility that sub-Endo structures such as 
papillary muscle insertions located at or near the Sep can 
anchor and stabilize intramural reentrant sources, which would 
appear as stable Epi breakthroughs.
This explanation may hold true for the case of the canine 
heart, where a large papillary muscle is located on the right 
side of the Sep. However, relatively stable reentrant circuits are 
also present on Epi of the RV-Sep junction. We think it is 
possible that the special fiber arrangement with abrupt changes 
in fiber orientation in the RV-Sep junction may favor the 
stabilization of reentrant sources in this area, especially when 
combined with the very slow conduction velocity, short APD, 
and partial cell-to-cell uncoupling present during ischemia. 
The ability of the RV-Sep junction to support high-frequency 
sources during LDVF may also be related to increased me­
chanical stretch in this area (which is often thinner than the 
lateral RV wall and Sep) resulting from the sustained RV 
pressure increase occurring during LDVF (22, 26). Due to the 
activation of mechanosensitive channels and/or modulation of 
other ionic channels and transporters, stretch promotes conduc­
tion block and reentry and may contribute to the generation of 
ectopic triggers during ischemia (17, 25). It has also been 
shown that stretch increases VFR and/or the density of singu­
larity points during normoxemic VF (6, 26) and thus poten­
tially can modulate the organization of VF in ischemic hearts. 
In conclusion, the unique pattern of activation of the RV-Sep 
junction during LDVF may be due to a combination of struc­
tural and mechanical properties of this region that set it apart 
from the adjacent RV and LV free walls. However, these 
assumptions await experimental confirmation.
Mosaic inexcitability during LDVF. A novel finding of this 
study is the highly heterogeneous pattern of electrical depres­
sion in Epi of both the RV and LV during later stages of LDVF 
(see Fig. 6). Indeed, even though on average VFR was higher 
in the RV than in the LV, in both chambers there were fully 
unexcitable regions interweaved with regions maintaining elec­
trical activity. Such areas of local inexcitability were not
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observed during LDVF in porcine hearts (16). Clearly, these 
local Epi gradients cannot be explained in terms of Purkinje 
fiber distribution and function. The mechanisms responsible 
for these local gradients remain unknown. One possible mech­
anism is related to the heterogeneous activation of ATP- 
sensitive K+ channel current (/K.ACh) secondary to mitochon­
drial depolarization during ischemia caused by opening of the 
mitochondrial inner membrane anion channel (IMAC) (1). 
During global ischemia in the guinea pig heart, an agonist of 
IMAC, FGIN-127, exacerbated the electrical depression 
caused by ischemia and induced regional inexcitability at —10 
min of ischemia. It should be noted, however, that the study by 
Akar et al. (1) did not directly demonstrated the link between 
regional inexcitability and mitochondrial depolarization. A 
study (24) using confocal microscopy to image the mitochon­
drial potential in rat hearts revealed a mosaic presence of cells 
with depolarized mitochondrial potential among cells with 
mitochondria still fully polarized. However, the cells exhibit­
ing mitochondrial depolarization appeared only relatively late 
in ischemia (—20-30 min) and were observed much more 
frequently upon reperfusion. In addition, they did not form 
macroscopically continuous regions, which could explain the 
inexcitable areas observed in our experiments. Thus, the link 
between mitochondrial depolarization and electrical depression 
in early ischemia remains unconfirmed. We cannot exclude, 
however, that the electrical depression dependent on IMAC 
channel activation is more pronounced under conditions used 
in our study (LDVF in canine hearts) than in previous studies 
using small mammalian hearts without VF. It is also possible 
that the regional inexcitability in Epi of the canine ventricles is 
promoted by partial cellular uncoupling, which may help to 
establish a sharp separation between inexcitable and excitable 
areas. Canine ventricular Epi may be more susceptible to 
uncoupling during ischemia due to lower expression of con- 
nexin43 in Epi compared with deeper layers of the ventricular 
wall (29). The inexcitable areas observed in this study may 
hamper the ability of defibrillation shocks applied during 
advanced stages of LDVF to synchronize the ventricles and 
may also facilitate the formation of reentrant circuits, which 
would reinitiate VF after shock application.
Right-to-left gradients in APD and DI during LDVF. To the 
best of our knowledge, this is the first reported analysis of 
right-to-left differences in DI and APD during LDVF in the 
canine heart. In general, VFCL reflects the local effective 
refractory period (ERP) under the assumption that the tissue is 
activated as soon as it is capable of conducting an electrical 
wave. This assumption is reasonable if conduction is not 
restricted by anatomic barriers and is sustained predominantly 
by functional reentrant circuits. With the normal availability of 
fast Na+ current (INa), the tissue is able to generate an AP 
almost immediately upon repolarization from previous excita­
tion, ERP approximates APD well, and, therefore, DIs are short 
during VF. However, as ischemia develops and causes a 
decrease in excitability, ERP extends beyond APD (postrepo­
larization refractoriness). Consequently, DIs during ischemic 
VF are prolonged (19, 28, 43). Thus, one can assume that in the 
ischemic heart, the length of DI during VF is a reasonably good 
indicator of local postrepolarization refractoriness.
Our results clearly show that the right-to-left gradients in 
VFCL are determined by gradients in DI (and, hence, presum­
ably, by postrepolarization refractoriness) amid a relatively
H1415
invariant APD over both chambers and all time points of 
LDVF (see Fig. 8). In fact, there was a slightly longer APD in 
the RV versus in the LV, which is consistent with observations 
of a gradient of the same direction observed during pacing in 
the ischemic rabbit heart (23). In any case, despite the slightly 
longer APD in the RV than in the LV, VFCL was shorter in the 
RV than in the LV. Overall, the relationship between VFCL, 
DI, and APD was very similar to that recently reported by 
Kong et al. (19). These authors showed that the transmural 
gradient of VFCL across the LV wall was due to the differ­
ences in DI amid a relatively constant APD. Thus, an Endo- 
to-Epi APD gradient observed in normoxemic canine and 
human hearts at physiological pacing rates (3, 12) is not 
present during LDVF and does not influence the VFR gradient 
in the canine heart. While it is not practically possible to 
measure ERP in a rigorous manner during the fast and irregular 
rhythms characteristic of LDVF, our rough estimates of ERP 
differences between Epi and Endo locations in the LV and RV 
paced at a relatively fast frequency of 4 Hz during global 
ischemia are consistent with the presence of ERP gradients 
both between Endo and Epi and between the RV and LV (see 
Supplemental Figs. 6-8). Taken together, the arguments above 
support the notion that both transmural and right-to-left VFR 
gradients during ischemia in the canine heart are universally 
determined by the distribution of postrepolarization refractori­
ness.
LDVF mechanism: sources versus substrate. As mentioned 
above, the focus of recent relevant studies was on the role of 
Purkinje fibers as sources of activation maintaining LDVF. The 
strongest evidence supporting the leading role of Purkinje 
fibers in the dog heart is the elimination of the transmural 
gradient after the ablation of Endo with Lugol solution and also 
earlier spontaneous termination of LDVF in isolated slab 
preparations (5, 8). As we argued above, the outer layers of the 
RV-Sep junction may be another source of fast activations 
apparently unrelated to the fast sources in Endo. Thus, the 
observation of earlier termination in ablated isolated slabs of 
the LV free wall (8) may not be applicable to whole hearts with 
an intact Sep and RV.
It should be noted, however, that the identification of the 
sources is only one aspect of LDVF. The picture of LDVF will 
remain incomplete without an understanding of the “substrate,” 
i.e., the response of the ventricles to fast sources of electrical 
activity. Regardless of whether or not Purkinje fibers are the 
predominant source of electrical waves, the question remains 
as to why the electrical depression develops faster in some 
regions of the ventricle than in others. The large left-to-right 
and intrachamber VFR gradients shown in this study are most 
likely unrelated to Purkinje fiber distribution. We argued above 
that VFR may be regarded as an important index of local 
electrical depression (and ensuing postrepolarization refracto­
riness) that appears to be highly nonuniform in the canine 
heart. During ischemia and VF, a number of ionic currents as 
well as other factors can contribute to heterogeneous electrical 
depression. It has been shown that IK,ATP activation can be 
different between Endo and Epi myocytes (10). We could not 
find any evidence of differential activation of IK,ATP in the RV 
versus in the LV during ischemia in the relevant literature. 
However, the fact that the LV simultaneously has a shorter 
APD and longer DIs than the RV during LDVF (see Fig. 7) 
would be consistent with larger IK,ATP in the LV than in the
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RV. Indeed, increased time-independent outward K+ current in 
the partially depolarized myocardium is expected to accelerate 
repolarization, on one hand, and to prolong postrepolarization 
refractoriness, on the other hand. Other K+ currents whose 
activation is enhanced under conditions of ischemia and/or a 
high rate of excitation may also be involved, such as Na+- 
activated K+ current (18). Another possible mechanism of 
heterogeneous electrical depression during LDVF is the dis­
persion in the inactivation properties of /Na. Cordeiro at al. (7) 
have recently shown that Epi cells have a more negative 
half-inactivation voltage than Endo cells. This property confers 
a greater sensitivity of ventricular Epi to electrical depression 
caused by an elevation of extracellular K+ and thus may 
contribute to the transmural VFR gradient observed during VF 
in the globally ischemic heart. Although right-to-left differ­
ences in the voltage dependence of INa inactivation were not 
reported, in the rabbit heart the right-to-left VFR gradient 
during LDVF was reproducible by elevating K+ in the nor­
mally oxygenated fibrillating heart (4), indicating chamber- 
specific differences in the sensitivity to hyperkalemia. We have 
already mentioned a possible role of mechanical stretch in the 
maintenance of fast and sustained sources in the RV-Sep area. 
It is also possible that the distribution of stretch contributes to 
the transmural gradient of VFR and excitability, since both 
experimental and computational studies (11, 17, 38) have 
indicated larger strain in Endo. In particular, right-to-left 
and/or transmural gradients in mechanical stretch may modu­
late the spatial distribution of IK,ATP activation, since a reduc­
tion in ATP content under ischemic conditions sensitizes ATP- 
sensitive K+ channels to stretch (21, 36, 37).
Although the mechanisms discussed above seem to be the 
most relevant because they are enhanced under conditions 
presented by LDVF, a number of heterogeneously distributed 
ionic channels, such as those associated with transient outward 
K+ current, the rapid component of delayed rectifier K+ 
current, and inward rectifier K+ current (33), may be involved 
in nonuniform electrical depression during LDVF.
VF evolution: comparison with previous studies. In his 
seminal work, Wiggers (40) described four different stages of 
VF in the open-chested dog: 1) undulatory or tachysystolic 
(1-2 s); 2) convulsive incoordination (15-40 s); 3) tremulous 
incoordination (2-3 min); and 4) progressive atonic incoordi­
nation, which usually starts 2-5 min after the onset of VF. This 
classification was based on the visual analysis of high-speed 
movies of cardiac contraction. In a more recent study in the 
same animal model, Huang et al. (15) distinguished five stages 
(stages i-v) during the first 10 min of VF, based on a quanti­
tative analysis of spatiotemporal dynamics of wavefronts 
extracted from multielectrode Epi maps. They found a non­
monotonic evolution of activation patterns during LDVF, with 
a transient phase of increased organization and the incidence of 
reentry between 1 and 3 min after VF onset and a rapid 
decrease in these parameters in later phases of VF. These 
authors also observed a steady decrease in the number of 
wavefronts as LDVF progressed concomitant with a steady 
increase in the number of breakhtroughs and the incidence of 
conduction block.
To the extent that it is possible to compare results obtained 
with different recording and analysis techniques, our present 
study is consistent with previous observations in several as­
pects. Similar to Huang et al. (15), we observed a transitory
increase in the occurrence of reentry between ~ 2  and 4 min of 
LDVF (see Supplemental Fig. 5, B and C). This approximately 
corresponds to Wigger’s tremulous incoordination phase, dur­
ing which he noted the presence of “contraction waves. . .cir­
cling around in very limited areas” (40). During the next stage 
(atonic incoordination), Wiggers (40) noted that some areas 
completely lost contractility, whereas in other areas, especially 
those close to large vessels and to the right side of the LAD, 
contractions still persisted. These early observations are fully 
confirmed by our optical mapping results showing a mosaic 
distribution of excited and nonexcited areas during this stage of 
LDVF, with excitability more preserved in areas close to the 
LAD and in the RV (see Supplemental Fig. 4). Similarly, 
Huang et al. (15) reported a progressive decrease in the number 
of wavefronts in LV Epi, which approached zero by 10 min of 
LDVF. Thus, different studies in dogs agree in their observa­
tion of a rapid loss of excitability in LV Epi. It is worth noting, 
however, that in porcine and rabbit hearts, LV Epi maintains 
excitability throughout the first 10 min of LDVF (16, 42). This 
difference may be due to interspecies differences in the ionic 
channel distribution/function and/or differences in the severity of 
metabolic stress caused by combined effects of ischemia and 
LDVF.
Conclusion and significance. Recent studies of LDVF have 
been focused on the role of Purkinje fibers in LDVF mainte­
nance. Our data indicate that both sources of activity and 
substrate during LDVF in the canine heart are not exclusively 
determined by the relationship between Purkinje fibers and the 
working myocardium. The pattern of activation becomes ever 
more divergent during the course of LDVF, revealing simul­
taneous differences between Endo and Epi, RV, LV, and Sep, 
and within each chamber or wall type. Regardless of whether 
or not Purkinje fibers maintain self-sustained electrical activity 
at advanced stages of LDVF, for the purposes of successful 
defibrillation and resuscitation, it is at least as important 
whether or not a critical mass of the myocardium can respond 
in a synchronous manner to an electric shock and any stimulus 
after defibrillation shock. The presence of large inexcitable 
areas in the LV and RV may affect the outcome of defibrilla­
tion shock and raises the possibility of forming reentrant 
circuits around inexcitable regions after shock and reinitiation 
of VF. Thus, future studies concerning LDVF should be more 
focused on understanding the reasons why the electrical de­
pression develops faster in some regions of the ventricle than 
in others and how electrical depression heterogeneities interact 
with the defibrillation shock.
Limitations. In our experiments, LDVF began when perfu­
sion was stopped. In a patient, the termination of perfusion may 
be more gradual. However, most likely, this difference would 
affect, at most, the first 1-3 min of LDVF. The main limitation 
of any mapping technique is incomplete coverage of the 
three-dimensional pattern of ventricular activation. However, 
the magnitude of the observed heterogeneities could only 
increase if we mapped larger regions. The thickness of the 
ventricular wall is highly nonuniform, whereas the length of 
the plunge needle electrodes used in both the RV and LV was 
fixed to accommodate the largest wall thickness in the respec­
tive chambers. Thus, in some locations, the most Endo leads 
were outside the ventricular wall. Despite our best efforts to 
identify and exclude such leads (see METHODS), an error in this 
process could have led to an underestimation of the transmural
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VFR gradient in the RV and LV. However, the fact that 
transmural gradients were still detected in both chambers and 
were consistent with a previous report (5) indicates that this 
potential problem was of limited influence. Whereas residual 
motion artifacts could have been present at the early stage of 
LDVF despite mechanical restraint, the largest interchamber 
and intrachamber gradients were observed after contractility 
was completely abolished by the ischemic process. Therefore, the 
presence of motion artifacts could not have overestimated the 
magnitude of the gradients. Other common limitations of optical 
mapping were discussed in our previous publication (16).
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RV EPI X X X X X X X
RV MID X X
RV ENDO X X X
SEP EPI X X
SEP MID X X
SEP DEEP X X
LV EPI X X X X X X X X
LV MID X X



























Online Data Supplement 
Supplemental Figure 1
Approximate position of SEP plunge needle electrode superimposed onto an MRI image 
of a canine heart. All symbols are the same as in Figure 1 of the main text.
Supplemental Figure 2
The time course of VFR in RV, SEP and LV in all 5 experiments in which plunge needle 
electrodes were used.
Supplemental Table 1.
Results of pairwise comparisons between the time course of VFR in all pairs of 9 
principal locations studied using plunge needle electrodes. Crosses indicate statistical 
significance (p<0.05) using two-way ANOVA and Bonferroni post-hoc test. Note that the 
comparisons were performed between all time points of respective VFR curves and 
indicate overall dissimilarity in the time course of VFR between any pair of locations. 
Note also that LV EPI is the only site that is statistically different from all other locations. 
Thus, LV EPI is unique in its sensitivity to the stress imposed by the combination of VF 
and global ischemia.
Supplemental Figure 3
Superimposed VFR curves from SEP MID, SEP EPI and LV ENDO (the data is he same 

























these curves closely track each other, even though SEP MID and SEP EPI are not 
adjacent to LV ENDO. These data suggest that the presence of Purkinje fibers is not the 
only determinant of VFR during LDVF.
Supplemental Figure 4
Examples of highly non-uniform VFR distribution at advanced stages of LDVF. Panels 
A-K represent different hearts. Time above the maps indicate the time of no-flow 
ischemia. The white line crossing the field of view represent LAD. Note the presence of 
completely inexcitable areas (black, VFR=0) adjacent to areas still maintaining 
fibrillatory activity. Note also that most of the time the sites with the highest VFR were 
situated either in RV or in regions of LV adjacent to LAD.
Supplemental Figure 5
Examples of LV activation maps taken at different time points of LDVF in the same 
heart. A  to D, sets of consecutive activation maps from movies taken at approximately 0, 
2, 4.5 and 10 min of LDVF, respectively. Different colors in activation maps denote 
activation times with respect to the start time. The start time in the first activation map in 
each set is chosen arbitrarily, but in subsequent maps the start time is the same as the 
latest activation time in the previous map. The range of activation times is shown in color 
bars to the right of respective maps. White arrows indicate examples of complete or 
incomplete reentrant patterns. At 0 min of LDVF (A), complete reentrant patterns are 
present, but typically do not repeat themselves. Thus, a complete reentrant pattern seen in 
























(B and C), more stable reentrant patterns could be observed. Thus, both Panels B1-B3 (2 
min of LDVF) and Panels C1-C3 (4.5 min of LDVF) show repetitive reentrant pattern in 
three consecutive activation maps (in Panel C1 it is likely that a portion of the reentrant 
circuit is outside the mapped area). At 10 min of LDVF (#), only incomplete reentrant 
pattern were observed in LV coincident with emergence of large areas of epicardium not 
invaded by excitation waves propagating in adjacent areas (white cross in Panels D1-D4). 
This was typical of LV activation after 5-6 min of LDVF. Note that, in contrast to LV, in 
RV repetitive reentrant circuits could be observed even at very late stages of LDVF (see 
Fig. 8 in the main text).
Regional differences in response to rapid pacing during global ischemia 
(Supplemental Figures 6-8)
In 4 experiments we performed rapid pacing during global ischemia simultaneously in 4 
locations: LV EPI, LV ENDO, RV EPI and RV ENDO (see Supplemental Figure 6). Six 
needles containing 10 evenly spaced unipolar electrodes were inserted in myocardium of 
both the LV and RV anterior free walls (Supplemental Figure 6A). Using the 2 most EPI 
and ENDO electrodes (see Supplemental Figure 6B), we repeatedly applied a series of 
ten S1 stimuli at CL=250 ms followed by a single extrastimulus (S2) at CL=180 ms 
throughout 10 minutes of global ischemia. The amplitudes of both S1 and S2 stimuli 

























This setup allowed us to compare the effective refractory period (ERP) in a given pacing 
location and at a given time of ischemia with 180 ms and 250 ms, based on the sequence 
of activation in adjacent electrodes. If an activation sequence followed an S1 or S2 
stimulus with a short delay and propagated away from a pacing site, we postulated that 
the ERP at that pacing site was shorter than 250 or 180 ms, respectively. If an activation 
sequence followed an S1 or S2 stimulus with a long delay and propagated towards the 
pacing site, we postulated that the ERP at that pacing site was longer than 250 ms or 180 
ms, respectively. Obviously, a complete lack of response to either S1 or S2 in the 
neighborhood of a particular pacing site indicated that ERP at that site exceeded either 
250 ms or 180 ms, respectively.
Typically, at the very beginning of ischemia (within the first minute) EPI locations had 
shorter ERP than ENDO locations. An example in shown in Supplemental Figure 7 A. 
One can see that at 9 seconds of ischemia S1 stimulus generates local responses in both 
EPI and ENDO locations with activation waves spreading from both sites and converging 
in MID. In contrast, S2 stimulus generates local response only in EPI which propagates to 
ENDO and activates the latter after a delay. However, in a short order (at 124 seconds of 
ischemia) the sequence of activation in response to S2 stimulus is reversed (see 
Supplemental Figure 7B) indicating that at this time point ENDO ERP is shorter than EPI 
ERP. At the same time, S1 stimulus still generates local responses in both EPI and ENDO 
locations with activation waves spreading from both sites and converging in MID. At 130 

























S1 stimulus in EPI, so that local response to both S1 and S2 stimuli occurs only in ENDO 
whereas EPI is activated by planar waves originated in ENDO.
In all experiments, EPI locations failed to respond to S2 stimulus earlier than ENDO 
locations in both LV and RV. We did not find a consistent difference between RV and 
LV. Pooled together, LV and RV EPI locations failed to respond to S2 stimulus at 
184M59.4 s, whereas LV and RV ENDO locations responded to S2 up to 363M149.3 s of 
global ischemia. The difference was statistically significant (p=0.022). Thus, between ~3-
6 min of ischemia, the effective refractory period (ERP) on EPI was > 180 ms, whereas 
the ERP on ENDO was <180 ms, indicating a transmural gradient in ERP.
By 10 min of ischemia, in 3 out of 4 hearts all ENDO locations followed S1 pacing 
(CL=250 ms) in 1:1 ratio. In 1 experiment, the entire ventricles responded to S1 stimuli 
in 1:2 ratio. In all 4 experiments at least some of EPI locations failed to follow S1 stimuli 
in 1:1 ratio with rate transformations in ratios 1:2, 1:3 or higher (See Supplemental 
Figure 8). There was a clear trend towards higher number of EPI sites following S1 
stimulation in RV than in LV (4.0M2.7 vs. 0.50M0.58, p=0.060). Excluding the 
experiment in which all locations failed to follow every S1 stimulus (and thus the shortest 
testing interval was 500 ms), the difference between RV and LV in the number of EPI 
sites following pacing at CL=250 ms in 1:1 manner became significant (5.3M0.58 vs.
0.7M0.58, p=0.005). In all EPI sites excitability recovered and ERP fell below 180 ms 

























Taken together, these findings indicate that during global ischemia in the canine heart 
ENDO sites are capable of following faster pacing rates than EPI sites, which is 
equivalent to an ERP gradient between ENDO and EPI. Moreover, there is a clear trend 
towards a higher degree of electrical depression in LV EPI than in RV EPI. Combining 
these observations with previously published data indicating the lack of APD gradient 
across the ventricular wall during VF/ischemia (1) and our data showing slightly longer 
APD in RV than in LV (see Figure 6C), one can make the conclusion that the ERP 
difference between ENDO and EPI is determined by the differences in post­
repolarization refractoriness rather than differences in APD. More detailed and accurate 
measurements of post-repolarization refractoriness during global ischemia will require 
specially designed hardware and will be a subject of future studies.
Supplemental Figure 6
Electrode configuration used for assessment of regional differences in ERP during global 
ischemia. A, approximate positions of 6 plunge needle electrodes in RV and LV (open 
circles denote plunge needle electrodes used for EPI and ENDO stimulation). B, 
localization of leads in designated plunge needle electrodes used for pacing.
Supplemental Figure 7
Typical examples of the activation sequences along a plunge needle electrode induced by 
an S1 and S2 stimuli applied to the most epicardial and the most endocardial pairs of 

















electrograms recorded from leads 3-8. Dashed red lines denote the direction of 
propagation. D, a diagram of the plunge needle electrode showing the leads used for 
stimulation and recording.
Supplemental Figure 8
A typical example of transmural activation patterns in response to S1-S2 stimulation in 
LV and RV at 0 and 10 min of global ischemia. Note that at 10 min of ischemia LV 
subepicardial sites (# 8, 9 and 10) show a progressive failure to follow S1 stimuli 
culminating in complete lack of response in site #10. See text for more detail.
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ROLE OF KATP CHANNEL IN ELECTRICAL DEPRESSION AND 
ASYSTOLE DURING LONG-DURATION VENTRICULAR 
FIBRILLATION IN EX VIVO CANINE HEART
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Taylor TG, V enable PW , Shibayam a J, W arren M , Zaitsev AV.
Role o f K a t p  channel in electrical depression and asystole during 
long-duration ventricular fibrillation in ex vivo canine heart. Am  J 
Physiol Heart Circ Physiol 302: H 2396-H 2409, 2012. First published 
M arch 31, 2012; doi:10.1152/ajpheart.00752.2011.— Long-duration 
ventricular fibrillation (LDVF) in the globally ischemic heart is 
characterized by transmurally heterogeneous decline in ventricular 
fibrillation rate (VFR), emergence o f inexcitable regions, and eventual 
global asystole. R apid loss of both local and global excitability is 
detrimental to successful defibrillation and resuscitation during car­
diac arrest. W e sought to assess the role o f the ATP-sensitive potas­
sium current ( I k a t p )  in the tim ing and spatial pattern o f electrical 
depression during LD V F in a structurally norm al canine heart. We 
analyzed endo-, mid-, and epicardial unipolar electrograms and epi- 
cardial optical recordings in the left ventricle of isolated canine hearts 
during 10 min o f LD V F in the absence (control) and presence of an 
I k a t p  blocker glybenclamide (60 jj iM ) . In  all myocardial layers, 
average VFR was the same or higher in glybenclam ide-treated than in 
control hearts. The difference increased with tim e of LDVF and was 
overall significant in all layers (P  <  0.05). However, glybenclamide 
did not significantly affect the transmural VFR gradient. In epicardial 
optical recordings, glybenclamide shortened diastolic intervals, pro­
longed action potential duration, and decreased the percentage of 
inexcitable area (all differences P  <  0.001). During 10 min o f LDVF, 
asystole occurred in 55.6% of control and none o f glybenclamide- 
treated hearts (P  <  0.05). In three hearts paced after the onset of 
asystole, there was no response to LV  epicardial or atrial pacing. In 
structurally norm al canine hearts, I k a t p  opening during LDVF is a 
major factor in the onset o f local and global inexcitability, whereas it 
has a lim ited role in overall deceleration o f VFR and the transmural 
VFR gradient.
adenosine 5 '-triphosphate-sensitive potassium channel; glybenclamide; 
myocardial ischemia; optical mapping
v e n t r i c u l a r  f i b r i l l a t i o n  (VF) is a major cause of sudden 
cardiac death and a common context of cardiopulmonary 
resuscitation. In the setting of out-of-hospital cardiac arrest, VF 
intervention is often delayed for at least several minutes until 
first responders arrive at the scene, detect cardiac rhythm, and 
initiate life-saving procedures. Such relatively long-duration 
VF (LDVF) is characterized by a nonuniform depression of 
electrical activity, manifested as a transmural gradient in VF 
rate (VFR) in canine (2, 6, 14, 30, 43, 56, 62, 67) and human 
(37) hearts. An extreme form of heterogeneous electrical de­
pression was observed in epicardial optical maps, where 
sharply demarcated inexcitable areas emerged within the fib- 
rillating myocardium (62). Heterogeneous loss of excitability
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may promote initiation of VF upon reperfusion of a globally 
ischemic heart (1).
Untreated, LDVF eventually degenerates into asystole, a 
complete cessation of electrical activity in the heart. In the 
context of out-of-hospital cardiac arrest, asystole is a “non- 
shockable” rhythm associated with a very poor prognosis of 
survival to hospital discharge (22, 25, 44). In recent years, the 
reported incidence of asystole as the first recorded rhythm 
during sudden cardiac arrest (SCA) has increased compared 
with the incidence of VF (8, 48). This may indicate a trend 
towards faster degeneration of VF into asystole in the clinical 
setting. Considering that the window of opportunity for suc­
cessful resuscitation is limited to —10 min after the onset of 
SCA (52), the rapidity at which electrical depression develops 
during the course of LDVF may have a significant impact on 
survival in this setting.
The factors determining the timing of local and global 
electrical standstill in the course of LDVF remain largely 
unknown. one of the most prominent mechanisms linking 
metabolic stress and electrical activity during ischemia is the 
ATP-sensitive potassium current (IKatp; Ref. 17). IKatp is 
principally regulated by the blocking effect of ATp and acti­
vating effect of MgADP but is also modulated by a plethora of 
signaling pathways (17). The complexity of IKatp regulation at 
least partially explains the difficulty to pinpoint the actual 
events and conditions that trigger opening of the channel 
during ischemia. A possible role of IKatp in the maintenance of 
LDVF was recently highlighted by Farid et al. (15). These 
authors found that blockade of IKatp in hearts explanted from 
patients with end-stage heart failure resulted in an increased 
incidence of spontaneous VF termination, an overall decrease 
in VFR, and a diminished transmural difference in VFR com­
pared with control conditions. The authors attributed these 
effects of glybenclamide to the prevention of the action poten­
tial duration (APD) shortening presumably caused by IKatp 
activation in this model of LDVF (15). Furthermore, these 
authors suggested that IKatp blockade could be a rational 
strategy to improve outcomes of SCA caused by VF. The 
importance of their results notwithstanding, the study by Farid 
at al. has left several important questions unanswered. First, 
their study was performed in hearts explanted from patients 
with end-stage heart failure, which is an extreme and terminal 
condition even within the population afflicted with this disease. 
Moreover, in these patients VF is not a predominant rhythm 
causing SCA (35); thus LDVF in these hearts may not be 
representative of the cases of SCA due to VF, which are often 
a consequence of acute triggering events occurring in hearts 
without advanced structural abnormalities (7). Second, they 
studied the effect of IKatp blockade only during the first 3 min 
of LDVF, a time window that is much shorter than the typical 
interval between collapse and initiation of life-saving proce-
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dures (54). The outcomes could be different at later stages of 
LDVF, which may be more relevant to out-of-hospital SCA. 
Third, the rhythm following VF termination was not reported. 
Clearly, if VF termination was followed by global inexcitability, 
such an outcome of /K A T P  blockade could hardly be considered 
beneficial. Lastly, APD prolongation by glybenclamide may not 
necessarily prolong the VF cycle length (VFCL). During LDVF, 
the excitation cycle lengths poorly correlates with APD and is 
largely determined by the length of diastolic intervals (DIs), which 
get progressively longer in the course of LDVF (30, 49, 62).
While ideally these questions would be addressed using 
hearts from human donors representing the general population, 
in practice this goal is hard to attain. Apart from the rarity of 
this research opportunity, it is almost impossible to control the 
history of ischemic or hypoxic exposure of human hearts 
rejected for the purposes of transplantation and made available 
for research. However, such exposure(s) may cause precondi­
tioning effects that may not affect results obtained under 
normoxemic conditions but that may alter the outcomes of the 
tested LDVF (58). With the above considerations in mind we 
were motivated to perform a study aimed to ascertain the role 
of / K A T P  in the dynamics and outcomes of LDVF occurring in 
a structurally normal canine heart, which is close to human 
heart in terms of size, ionic channel make-up and Purkinje fiber 
distribution. In our study, we assessed the effects of /K A T P  
blockade by glybenclamide on the transmural VFR gradient, 
APD derived from epicardial optical recordings, and the timing 
of the onset of local and global inexcitability in the course of 
LDVF. Contrary to the observations in explanted failed human 
hearts (15), we found that KATP channel blockade did not 
significantly alter the transmural VFR gradient but delayed VF 
termination and maintained on average a slightly higher VF 
rate compared with control despite a slight increase in optical 
APD. Additional experiments were performed to exclude the 
role of side effects of glybenclamide with respect to other 
potassium currents such as the rapid component of the delayed 
rectifier current (/Kr) and the transient outward current (/to). We 
conclude that in structurally normal hearts KATP channels are a 
major factor in the transition from a state of depressed excit­
ability to complete electrical standstill, but they have a limited 
role in the transmural VFR gradient during LDVF. These 
results underscore the important differences in the effects of 
/ K A T P  blockade in normal vs. severely failing hearts. Possible 
reasons for these differences are discussed.
MATERIALS AND METHODS
This investigation conformed to the Guide fo r  the Care and Use o f  
Laboratory Animals  published by the National Institutes o f Health 
(NIH publication No. 85-23, revised 1996). The animal protocols 
were approved by the University of U tah Institutional Anim al Care 
and Use Committee (Protocol No. 10-09005).
Study groups. A  total o f 28 dogs, 14 random source dogs (27.0 ±
1.3 kg, 9 males, 5 females) and 14 purpose-bred dogs (21.6 ±  0.8 kg, 
7 males, 7 females) were used in this study. The source o f dogs 
changed in the course o f the study due to recently enacted institutional 
mandates. Nine hearts served as the control group. Six hearts were 
treated with an J K A T P  blocker glybenclamide (GLYB; 60 ^M ). To 
exclude the possibility that the observed effects o f glybenclamide 
were confounded by partial blockade of / K r  (51), an additional six 
hearts were treated with a selective blocker o f / K r  dofetilide (DOF; 1 
^M ). To exclude the possibility that the observed effects o f glyben- 
clam ide were confounded by partial blockade o f the transient outward
potassium  current / t o  (53) (26), a group o f six hearts was treated with 
a combination o f a KATP channel opener chromakalim  (10 ^M ) and 
I t o  blocker 4-aminopyridine (1 mM; CRO + 4AP). Assuming that 
glybenclamide at a concentration o f 60 jjiM  induces a significant 
degree of / t o  blockade, our comparison between CRO + 4AP and 
GLYB groups allowed us to contrast the effects o f / K A T P  activation 
and blockade under relatively uniform  conditions o f / t o  inhibition. 
One additional heart was treated with cromakalim  only and was used 
for assessment o f the effect o f this drug on VFR under conditions of 
norm al perfusion and oxygenation.
Experimental protocol. The dogs were premedicated with aceproma- 
zine (0.1 ml/10 kg), Telazol (0.1 ml/kg), or propofol (7.45 mg/kg) and 
maintained with sodium pentobarbital (32.5 mg/kg). Intubation was 
accomplished with a cuffed endotracheal tube, and m echanical ven­
tilation was maintained at 10-15 cycles/min (tidal volume: 15-20 
cc/kg). Following isolation via midline sternotomy, the hearts were 
perfused in a Langendorff apparatus with a mixture o f blood and 
Tyrode solution as described in detail in our previous publications (27, 
68). Briefly, the blood-Tyrode mixture was oxygenated (CO2 5%-O2 
95%), heated (37°C), and filtered using standard pediatric heart 
perfusion units from various vendors. Perfusate was collected for 
recirculation with collector tubes inserted into the right and the left 
ventricles via cuts in the appendages o f the respective atria. The heart 
was then placed in a temperature-controlled bath with heated water- 
jacketed transparent glass walls. The bath was filled with warmed 
Tyrode solution, which was continuously pumped, w ithout recircula­
tion, at a rate o f 80 -150  ml/min. The oxygen content in the superfu- 
sate was removed by continuous gassing with a 95% N2/5% CO2 
mixture. The temperatures in the right ventricular cavity, superfusate, 
and water jacket were maintained at 37 ± 0.5°C during both normal 
coronary perfusion and ischemia. The gradient of temperature across 
the left ventricular wall did not exceed 1°C. In all hearts, immediately 
preceding the induction o f ischemia, the perfusion was switched to 
Tyrode solution with the dual purpose o f ensuring constant com posi­
tion of the extracellular milieu at the onset o f LDVF and enhancing 
the voltage-sensitive signal for the purpose o f improving resolution of 
low-amplitude signals at advanced stages o f LDVF. VF was induced 
using a 9V DC battery 10 s to 5 min before the onset o f global 
ischemia initiated by interruption of aortic perfusion. No perceptible 
differences in the measured parameters were found between experi­
ments with respect to the duration o f VF before the onset o f ischemia; 
therefore, in all experiments the time o f LDVF was counted from the 
moment when perfusion was stopped.
In the GLYB group, glybenclamide (60 jxM) was added to the 
recirculating blood-Tyrode mixture 2 0 -3 0  min before the onset of 
LDVF and its successful delivery to the heart was verified by observ­
ing an increase in the aortic pressure caused by the vasoconstricting 
effect o f glybenclamide (12). In this study, the aortic pressure in­
creased by 35 ±  5% after administration o f glybenclamide. In the 
DOF group, dofetilide (1 jjiM) was added to the circulating solution 10 
min prior to the onset o f LDVF in six hearts. In the CRO + 4AP 
group, crom akalim (10 jjiM) and 4-aminopyridine (1 mM) were added 
to the recirculating mixture in alternating order 20 and 10 min before 
the onset o f LDVF; in three hearts cromakalim  was added first while 
in three more hearts 4-aminopyridine was added first. Thus, in a total 
o f six hearts constituting the CRO + 4AP group, both crom akalim  and 
4-aminopyridine were present in the perfusate for > 1 0  min before the 
onset o f LDVF. In DOF and CRO + 4AP groups, brief (1-min) 
episodes of VF were induced before and 10 min after administration 
o f each drug and VFR was measured during the last 4 s of 1-min VF 
episodes. In this way, the individual effects o f all drugs on VFR in 
normally perfused hearts could be assessed. After that, VF was 
promptly terminated by a defibrillation shock with the remaining 
experimental protocol being the same as in control and GLYB groups.
In all experiments only data from the first 10 min o f LDVF were 
compared. If asystole occurred with abrupt and continued silence 
(> 6 0  s) during LDVF the right atrium, LV epicardium and LV
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endocardium were paced at 3 and 10 times end-diastolic preischemic 
threshold to determine excitability.
H igh-resolution epicardial optical mapping. Details of optical 
mapping are given in our previous publication (62). Briefly, we used 
a high-resolution electron-multiplied CCD camera (iXon DU-860D; 
Andor Technology, Belfast, UK) to image fluorescence of the voltage- 
sensitive dye Di-4-ANEPPS (Molecular Probes, Carlsbad, CA). The 
field of view covered the epicardial surface of the anterior LV 
including a portion of the left anterior descending coronary artery 
(Fig. 1). The size of the field of view varied between 40 X 40 mm and 
65 X 65 mm. To minimize motion artifacts, the heart was gently 
pressed against the glass chamber wall as previously described (27, 
68). No electromechanical uncouplers were used. Five second-long 
movies were acquired every 30 s from 0 to 10 min of LDVF. To 
minimize phototoxicity, exposure to the excitation light was limited to 
7 s per movie by means of an electronic shutter synchronized with the 
video camera.
Analysis o f  optical signals. Spatial distributions of VFR, APD, and 
DI at different time points during LDVF were estimated in optical 
mapping data using custom routines developed in PV-Wave software 
(Visual Numerics, Boulder, CO). Dominant frequency of the Fourier 
spectrum was not used to estimate VFR because it did not reliably 
represent the perceived number of activations per unit of time at 
advanced stages of LDVF when the action potential is characterized 
by very short APD and long DI. Instead, we used an algorithm to 
detect individual action potentials in single pixel recordings similar to 
that described in our previous publications (27, 62). In brief, the 
depolarization and repolarization phases of each optical action poten­
tial (OAP) were detected. The time points at which the depolarization 
and repolarization phases crossed a line drawn at 40% level of the 
absolute maximum in the respective signal (AFmax) were determined. 
From these time points, APD, DI, and VFCL were calculated for each 
cycle. The algorithm rejected noise based on thresholds set for APD 
(< 10  ms), VF cycle length (<30 ms), absolute O AP amplitude (<15 
levels of brightness), and percent O AP amplitude with respect to the 
time sequence maximum (<5%  of AFmax). VFR maps were created 
by dividing the number of OAPs by the duration of the analyzed 
movie. Areas with no OAPs detected throughout the entire movie 
were considered to be inexcitable and having a VFR = 0. The lack of
LAD
Fig. 1. Schematic representation of mapping modalities used in this study. 
Circle denotes the area imaged with the optical mapping system, including 
predominantly anterior left ventricular (LV) and a narrow region of right 
ventrice (RV; the latter was excluded from analysis). Black squares denote 
approximate positions of plunge needle electrodes (PNE 1-PNE 4). Electrodes 
were placed in the lateral LV close to the margin of the imaged area. LAD, left 
anterior descending coronary artery.
activation in continuous areas having VFR =  0 was confirmed by 
visual inspection of movies. Such areas were counted for the purposes 
of determining the average VFR and percentage of inexcitable area 
but were excluded from the calculation of average APD and DI.
Electrical recordings. Volume-conducted ECG were recorded from 
two electrodes attached to the walls of the superfusion chamber with 
ground electrode attached to the bottom. Plunge needle electrodes 
with 10 evenly spaced unipolar leads (inter-lead, distance, 1.6 mm) 
were manufactured in-house following the design developed by Rog­
ers et al. (50). The needles were placed in the lateral LV free wall 
adjacent to the optically mapped area as shown schematically in Fig.
1. The distance between needles was 10-15 mm. Unipolar electro­
grams from all contacts of the needle electrodes and volume-conduc- 
tor ECG were recorded continuously during the first 10 min of LDVF 
at a sampling rate of 1 kHz using a custom-made multichannel data 
acquisition system as described previously (57). VF termination was 
defined as the first time point at which the ECG no longer showed 
VF/VT for 20 consecutive seconds. Asystole was defined as sponta­
neous VF termination and complete electrical silence (ECG signal 
indistinguishable fromnoise withamplitude <10% ofECG amplitude 
measured at 0 min of LDVF) lasting for >20 s.
Electrode data analysis. Unipolar electrograms were analyzed 
using custom software developed in the Matlab (MathWorks, Natick, 
MA) framework. The electrograms were first filtered using a 60-Hz 
notch filter. We applied the Hilbert Transform to unipolar electro­
grams as previously described (36, 41). Hilbert transform converts 
fluctuating voltage signal into its corresponding phase so that consec­
utive cycles of activation are represented by changes in phase from 0 
to 2^. Thus the number of phase transitions from 2^  to 0 per unit of 
time gives an estimate of frequency. To decrease the influence of 
noise, the activation cycles with length <33 ms and amplitude of the 
waveform between two consecutive phase transitions <10% of the 
electrogram amplitude measured at 0 min of LDVF were excluded 
from the total cycle counts. After that, VFR was calculated as the 
average number of activations per second over 4-s intervals taken at
4 s after LDVF induction and at min 1 to 10 of LDVF. For simplicity, 
the first time point will be referred to as 0 min LDVF.
Whereas the length of the plunge needle electrodes was constant 
and designed to span the largest thickness observed in LV of the 
canine heart, the actual thickness of the ventricular wall is highly 
nonuniform. Thus in some cases plunge needle electrodes were longer 
than the wall thickness at the site of insertion. The contacts protruding 
from the ventricular wall were excluded from analysis based on the 
following criteria (62): 1) leads with signal-to-noise ratio <200%; 2) 
low VFR at 0 min of LDVF (slower by 5 Hz or more compared with 
the average VFR measured in all locations); 3) decrease of VFR to 
below 2 Hz within the first min of LDVF; and 4) observation of a 
progressively decreasing electrogram amplitude towards more distal 
leads while maintaining the same morphology as more proximal 
leads in the same needle. In the latter case, the most proximal lead 
from the group of leads with identical morphology was designated 
as the endocardial (ENDO) location in the needle. The position of 
the epicardial (EPI) lead could be easily ensured by visual inspec­
tion. In some experiments, the LV cavity was opened after the 
experiment and the positions of the ENDO leads in plunge needles 
were verified by visual inspection of the endocardium. After determi­
nation of the most distal lead in contact with the myocardial wall 
(ENDO), the mid-myocardial lead (MID) was chosen as the one 
closest to being equidistant between EPI and ENDO.
Statistical analysis. In the data collected from the plunge needle 
electrodes, the time course of VFR was statistically compared in a 
2 X 3 matrix with dimensions of experimental group (control and 
GLYB) and location (EPI, MID, and ENDO) using a two-way 
ANOVA with post hoc multiple comparisons and Bonferroni correc­
tion. In each experiment, the data from EPI, MID, and ENDO 
locations were represented by average values from all four plunge 
needle electrodes inserted in the LV lateral wall (see Fig. 1). Note that
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the statistical significance indicated the differences between the means 
at all tim e points o f LDVF in different locations. No conclusions 
regarding differences at individual time points were made due to a 
prohibitively large num ber of required pairwise comparisons. In  the 
data collected from optical recordings, average values of VFR, APD, 
D I, and percentage of inexcitable area were calculated for each time 
point during LDVF. A  two-way ANOVA was perform ed with post 
hoc multiple comparisons and Bonferroni correction to com pare the 
time courses o f these parameters between control and GLYB groups. 
Sim ilar to statistical treatm ent o f the electrode data, the statistical 
significance indicated the differences between the mean values of 
measured parameters at all time points o f LDVF. Tim ing o f asystole 
was com pared between control and G LY B hearts using a log-rank test 
applied to Kaplan-M eier survival curves. Comparisons o f VFR be­
tween multiple groups at baseline and 10 min o f LD V F were made 
using t-tests w ith Bonferroni correction for multiple pairw ise com ­
parisons. Data are given in m ean ±  SE. A  difference at P  <  0.05 was 
considered statistically significant.
Effect o f glybenclamide on the timing o f global asystole. 
Figure 2 shows examples of volume-conducted ECG in two 
control hearts (control A and control B) and one GLYB heart. 
In the control A heart, the ECG shows abrupt termination of 
VF followed by the lack of any electrical activity. In control B 
and GLYB hearts, LDVF persists for the entire 10-min inter­
val. In all cases, the event of asystole detected in volume- 
conductor ECG coincided with the lack of activity in all optical 
and electrical recordings.
Figure 3 shows the cumulative probability of asystole in the 
absence and the presence of glybenclamide (60 |xM). It can be 
seen that in the absence of the drug the likelihood of asystole 
cumulatively increased between 4 and 10 min of LDVF reach­
ing 55.6% (5 out of 9 hearts) by the end of the tested interval. 
In four out of five asystolic hearts, VF terminated abruptly. In 
one heart, VF was followed by ~30 s of ventricular tachycar­
dia at a cycle length of ~360 ms followed by asystole. In 
contrast, in the presence of 60 |xM glybenclamide asystole did 
not occur in six out of six hearts within the first 10 min of 
LDVF. The difference in the timing of asystole between 
control and glybenclamide-treated hearts was statistically sig­
nificant (P <  0.05) by log-rank test.
In three control hearts that experienced complete asystole we 
applied pacing in LV EPI, LV ENDO and right atrium follow­
ing VF termination. The stimulus strength was set at 3 times 
and 10 times preischemic end-diastolic excitation threshold. In 
two of three hearts, none of the locations elicited a response, 
while in one heart only LV ENDO responded, and only to the
largest stimulus (10 times preischemic threshold). Thus asys­
tole in these hearts was associated with profound depression of 
excitability.
Effect o f glybenclamide on the transmural VFR distribution. 
Examples of transmural unipolar electrograms can be found in 
Fig. 4. Statistical analysis of transmural VFR distribution in the 
presence and the absence of glybenclamide is presented in Fig. 
5. Figure 5, A and B , shows VFR values vs. time of no 
perfusion in different layers of LV wall (ENDO, MID, and 
EPI) in control and GLYB hearts, respectively. It is clear that 
an ENDO-to-EPI gradient in VFR was consistently present 
both in the absence and in the presence of glybenclamide. In 
both groups, most of the transmural VFR difference was 
concentrated between EPI and MID. Accordingly, both ENDO 
and MID were statistically different from EPI, but there was no 
statistical difference between ENDO and MID in both groups.
Figure 5C  shows the time course of the transmural VFR 
gradient (estimated as the difference between ENDO and EPI) 
in the two groups derived from the same data as shown in Fig.
5, A and B. In the control group, the transmural VFR gradient 
reached peak at 7 min of LDVF and decreased again by 10 min of 
LDVF, when VFR in all layers converged to very low values (see 
Fig. 5A). Interestingly, the dynamics of VFR gradient in GLYB 
group was somewhat reciprocal to that in the control group, such 
that the maximal gradient was reached at 3 min, decreased 
between 3 and 8 min, and then increased again at 10 min of 
LDVF. In any case, the overall dynamics of the VFR gradient was 
not statistically different between GLYB and control groups.
Duration of LDVF (min)
Fig. 3. Cumulative probability of asystole during 10 min of LDVF in the 
absence (solid line) and the presence (dashed line) of glybenclamide (60 jxM). 
In control ~50% of hearts experienced asystole, whereas in the presence of 
glybenclamide asystole did not occur (significantly different at P < 0.05).
R E S U L T S
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distribution of VFR in a representative control (Fig. 8, top) and 
GLYB heart (Fig. 8, bottom). A palette of colors (from red to 
black) denotes different VFRs (from 11 to 0 Hz). Progressive 
decrease in VFR can be seen in both hearts; however, in the 
control heart the VFR decline occurs much faster. Focal loss of 
excitability emerges in the center of the mapped area as early 
as 4 min of LDVF and spreads to the entire mapped area by 5.5 
min of LDVF. Later (at 8 min of LDVF), a small pocket of 
activity (VFR: —1.5 Hz) reemerges in the right ventricular- 
septal area adjacent to the LAD, but it fails to activate LV. In 
contrast, in the representative GLYB heart (Fig. 8, bottom) 
activity is maintained in the entire mapped area throughout the 
first 10 min of LDVF. Note that a heterogeneous depression of 
activity is still present, but it does not reach the critical point of 
complete inexcitability.
Figure 9 shows the results of statistical analysis of OAPs 
obtained from the LV epicardium. Figure 9, A-D, shows the 
average values of VFR, APD, DI and percent of inexcitable
E
o
Fig. 4. Representative examples of unipolar electrograms from a plunge needle 
electrode spanning the thickness of the lateral LV wall during LDVF. Control 
A (left column) shows data from a control heart in which LDVF deteriorated to 
asystole. Control B (center column) show data from a control heart which 
maintained VF for at least 10 min of ischemia. GLYB (right column) shows 
data from a heart representing the glybenclamide group. At 0 min of ischemia 
(top row), VFR is similar between the different LV layers and between the 
control A, control B, and GLYB hearts. At 5 min of ischemia (middle row) an 
ENDO-to-EPI gradient (VFR faster in ENDO) develops in all hearts regardless 
of the absence or presence of glybenclamide. At 10 min of ischemia (bottom 
row), no activity can be seen in control A heart, whereas control B heart and 
GLYB heart still maintain electrical activity in ENDO and mid-myocardial 
leads (MID) but not EPI. Note that in the control B example only 8 electro­
grams are shown because the two most distal leads of the plunge needle were 
in the LV cavity and were not in contact with the myocardium. See text for 
more detail.
Figure 6 shows the same data as in Fig. 5, but this time the 
VFR curves are grouped by myocardial layer (EPI, MID, and 
ENDO). It can be seen that VFR in GLYB group was never 
lower, but became progressively higher than in control group 
throughout 10 min of LDVF. The divergence between control 
and GLYB groups was apparent first in ENDO (at — 1 min of 
LDVF) then in MiD (at 2—3 min of LDVF) and then in EPI (at 
—4 min of LDVF). The difference in VFR between control and 
GLYB groups was statistically significant in all layers.
Effect o f glybenclamide on the epicardial VFR, APD, DI, 
and percentage o f inexcitable area. While the electrode data 
described above enabled us to estimate the effect of glybencl­
amide on VFR in transmural layers of myocardium, optical 
mapping, albeit limited to the epicardial surface, enabled us to 
assess the effect of glybenclamide on APD, DI, and the extent 
of unexcited regions during LDVF (62). Examples of single 
pixel recordings are presented in Fig. 7. Figure 8 shows spatial
Fig. 5. Transmural distribution of VFR in LV during LDVF. A and B: VFR 
time course in ENDO (■, □), MID (•, O), and EPI ( ' ,  A) in control and 
glybenclamide groups, respectively. C: ENDO-EPI VFR difference in control 
and glybenclamide groups (derived from the same data as shown in A and B). 
♦ , controls; 0 glybenclamide. *P <  0.05, significant difference between the 
curves by two-way ANOVA. Note that glybenclamide does not have a 
significant effect on the transmural VFR gradient.
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00752.2011 ‘ www.ajpheart.org
71
ROLE OF K a t p  IN LONG-DURATION VF AND ASYSTOLE H2401
Fig. 6. Effect of glybenclamide on VFR time course in different layers of LV wall. 
Data are the same as in Fig. 5, but VFR curves are grouped by layer. A-C: rep­
resent EPI, MID, and ENDO, respectively. It is seen that glybenclamide main­
tained higher VFR in all layers, the difference increasing with the time of LDVF. 
This effect was statistically significant in all layers (P < 0.05).
area as a function of LDVF duration, respectively. It can be 
seen that glybenclamide postponed VFR decline in the epicar- 
dium; at each time point starting from 2 min of LDVF VFR 
was higher in GLYB than in control groups (Fig. 9A). The 
difference in VFR between control and GLYB groups in­
creased with time reaching 1.5-2.0 Hz after 6 min of LDVF. 
Concomitant with VFR increase, glybenclamide significantly 
decreased average DI (Fig. 9B) while increasing APD (Fig. 
9C). The most dramatic effect of glybenclamide treatment, 
however, was the prevention of local epicardial inexcitability 
(Fig. 9D). On average 57% of the mapped area in LV epicar- 
dium was inexcitable in control hearts vs. only 14% in GLYB 
hearts, by 10 min of LDVF. All differences shown in Fig. 9 
were statistically significant (P <  0.001).
Possible confounding effects of glybenclmide. Figures 10 and 11 
compare the VFR data obtained in control and GLYB groups 
with the data obtained from additional groups (CRO + 4AP 
and DOF, see m a te r ia ls  a n d  M e th o d s ) ,  which served the 
purpose of addressing possible confounding effects of glyben-
clamide. In Fig. 10, VFR averaged across all myocardial layers 
was compared in the four groups during nonischemic VF (Fig. 
10A) and at 10 min of ischemic VF (i.e., LDVF; Fig. 10B). In 
addition, Fig. 10A shows VFR measured in the presence of 
CRO and 4-AP alone, which was possible in c R o  + 4AP 
group due to alternate order of the administration of the two 
drugs before the onset of LDVF (see m a te r ia ls  a n d  M e th o d s). 
Figure 11 shows the VFR time course during LDVF in the four 
groups (control, GLYB, CRO + 4AP, and DOF). The data 
from control and GLYB groups are the same as in Figs. 5 and
6. VFR time course was compared among the four groups 
during late stage LDVF (from 5 to 10 min).
The first confounding factor to address is a substantial block 
of Ito by glybenclamide at the concentration used in this study 
(26). It was shown that blockade of Ito by 4-aminopyridine has 
a differential effect on the canine epicardium and endocardium 
during myocardial ischemia (33, 34), thus raising a possibility 
that Ito could contribute to the transmural VFR gradient during 
LDVF. However, 4-aminopyridine is not selective and was 
also shown to be a potent blocker of K a t p  (24). Thus the 
effects of both 4-aminopyridine and glybenclamide can be 
confounded by blockade, to various degrees, of both Ka t p  and 
Ito. In this situation we tested the effect of 4-aminopyridine on 
VFR in the presence of K a t p  channel opener cromakalim. As 
shown in Fig. 10A, cromakalim very significantly increased 
VFR in nonischemic hearts (9.22 ± 0.27 vs. 19.00 ± 0.57 P < 
0.05). However, 4-aminopyridine did not have any significant 
effect on VFR in either untreated (9.22 ± 0.27 vs. 8.78 ± 0.40) 
or cromakalim-treated (19.00 ± 0.57 vs. 17.57 ± 0.76) hearts 
under conditions of normal perfusion (see Fig. 10A). Despite 
the fact that during nonischemic VF the hearts from CRO + 
4AP group had a much higher VFR than GLYB group, at 10 
min of ischemic VF (LDVF) the relationship was reversed, that 
is, VFR in CRO + 4AP group was significantly lower than in 
GLYB group (0.40 ± 0.21 vs. 3.66 ± 0.33, P <  0.05; see Fig. 
10B). As can be seen in Fig. 11, the reversal of the difference 
in VFR between the two groups occurred around ~ 4  min of 
LDVF. Collectively, these observations can be interpreted as 
follows: 1) Ka t p  activation increases VFR in nonischemic hearts 
but decreases VFR at advanced stages of ischemia; 2) Ka tp  
blockade by glybenclamide prevents VFR decrease when Ka tp  
channel is activated at advanced stages of ischemia; and 3) Ito 
blockade does not affect VFR regardless of opened or closed state 
of K a tp  channel. These arguments are further substantiated in the 
DISCUSSION.
Another potential confounding factor is a partial blockade by 
glybenclamide of the rapid component of the delayed rectifier 
potassium current, IK  (51). To address this issue, we treated six 
additional hearts with dofetilide (1 |xM) before the onset of 
LDVF. As can be seen in Fig. 10A, dofetilide significantly 
decreased VFR in nonischemic hearts (9.22 ± 0.27 vs. 6.51 ± 
0.24, P < 0.05). Also, at 10 min of LDVF VFR averaged across 
all layers was significantly lower in DOF group than in GLYB 
group (0.35 ± 0.29 vs. 3.66 ± 0.33, P < 0.05, see Fig. 10B). In 
fact, dofetilide caused a decrease in VFR in all layers throughout 
the entire episode of LDVF, the effect almost opposite to that of 
glybenclamide (see Fig. 11). Thus dofetilide did not reproduce the 
effects of glybenclamide in the setting of LDVF.
Finally, it should be noted that 6/6 GLYB hearts remained in 
VF, whereas only 4/9 Control, 2/6 CRO + 4AP, and 0/6 DOF 
hearts remained in VF at 10 min of ischemia. This further
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00752.2011 ‘ www.ajpheart.org
72
H2402 ROLE OF K a t p  IN LONG-DURATION VF AND ASYSTOLE
Control A  Control B GLYB
E
o
Fig. 7. Representative examples of single pixel recordings of optical action potential (OAPs) at different time points of LDVF. Control A (left column) shows 
data from a control heart in which LDVF deteriorated to asystole. Control B (center column) show data from a control heart which maintained VF for at least 
10 min of ischemia. GLYB (right column) shows data from a heart representing glybenclamide group. At 0 min of ischemia (top row), high frequency activations 
with virtually absent diastolic intervals can be seen in all presented recordings. At 5 of ischemia (middle row), the OAP from control A heart exhibits a large 
degree of electrical depression manifested as very slow VFR and short APD amid very long diastolic interval (DI). At the same time, in both control B and GLYB 
hearts the respective OAPs exhibit more robust fibrillatory activity, albeit with slower VFR and longer DIs than at 0 min of LDVF. At10 min of ischemia (bottom 
row), no activity is detectable in control A heart. In control B and GLYB hearts the fibrillatory activity is still present but VFR is slower and DIs are longer than 
at 5 min of LDVF. The large difference in the speed of electrical depression between the two selected control hearts is representative of large variation observed 
in the entire control group, which is also reflected in the large values of standard error in the measurements of DI and percentage of inexcitable area (see Fig. 
9, C and D).
supports the unique role of glybenclamide in maintaining VF in 
structurally normal globally ischemic canine hearts.
DISCUSSION
In this study we investigated the role of Katp channels in the 
evolution of LDVF in structurally normal canine heart. The 
main finding is that Katp channel blockade by glybenclamide 
significantly delayed the transition from depressed excitability 
to complete electrical standstill during LDVF. However, Katp 
channel blockade had only modest effect on the speed of VFR 
decline and the transmural VFR gradient.
Efficacy and specificity o f glybenclamide as an IKATP blocker 
during LDVF. It should be noted that efficacy of glybencl- 
amide and other sulfonylureas may be limited in the presence 
of elevated intracellular ADP concentration ([ADP]i) during 
ischemia, so that concentrations from 30 to 100 |xM may be 
required to achieve significant blockade of Katp  channels (63). 
The extent of [ADP]i elevation during acute ischemia is not 
well known and may differ between different species and/or 
experimental models. Our experiments using glybenclamide in 
concentrations ~30 |xM showed only marginal differences 
between treated and nontreated hearts (not shown) whereas 
other investigators were able to see effects of glybenclamide 
during ischemia with respect to various electrophysiological 
parameters at concentrations as low as 1-10 |xM (3, 13, 46). 
However, most of the studies using low concentrations of 
glybenclamide were performed in isolated cells or thin super­
fused preparations. In our experiments, glybenclamide was 
delivered via coronary circulation which could reduce the 
effective concentration of the drug visible to cardiac myocytes 
due to drug binding with the membranes of blood cells and/or 
endothelium (9). Furthermore, the apparently lower efficacy of 
glybenclamide in our study could be due to more pronounced 
rise in [ADP]i, presumably as a result of greater energy
imbalance during LDVF as opposed to ischemia alone. In any 
case, the concentration of glybenclamide used in our study was 
sufficient to reveal a significant role of Katp channels in the 
development of inexcitability and asystole during LDVF. 
However, we cannot exclude that the role of IKatp with respect 
to the speed of VFR decline and transmural VFR distribution 
during LDVF is larger than what can be inferred from the 
results of this study.
Whereas a relatively high concentration of glybenclamide 
(60 |xM) was necessary to achieve a sufficient blockade of 
Ka tp , this concentration could also potentially block other 
channels. Previous studies (31) have shown that glybenclamide 
can also reduce both the sodium-potassium pump (Na-K pump) 
current and L-type calcium current (ICaL) by ~  18% at 60 |xM. 
Despite the partial blockade of the Na-K pump Venkatesh et al. 
(63) have shown that during ischemia, high concentrations of 
glybenclamide (up to 100 |xM) reduces extracellular K+ accu­
mulation, suggesting Na-K pump blockade plays a limited role, 
if any. It is unlikely that partial ICaL blockade by glybencl- 
amide affected the main results of this study (delay of inexcit­
ability and asystole), since decrease in ICaL should promote 
inexcitability because during ischemia ICaL plays a larger role 
in supporting propagation in partially depolarized myocardium 
(55). One could argue that an inhibition of ICaL by glybencl- 
amide can preserve electrical activity by reducing contractility 
and thus energy expenditure during LDVF. However, glyben- 
clamide at a concentration similar to that used in this study 
(100 |xM) actually moderately increases contractility in non­
ischemic hearts and does not affect the decline in contractility 
during ischemia (e.g., see Fig. 6 in Ref. 63). The increase in 
contractility by glybenclamide was also demonstrated in iso­
lated ventricular myocytes (28). This effect occurred despite 
decrease in the peak ICaL and was associated with increase in 
intracellular calcium by a mechanism not fully understood
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Fig. 8. Representative examples of VFR distribution maps 
derived from optical mapping of anterior LV during LDVF in 
a control (top) and a glybenclamide-treated (bottom) heart. 
Labels above the maps indicate the respective time points 
during LDVF. Colors (from black to red) indicate VFR in Hz 
(from 0 to 11 Hz). Note that the overall VFR decline occurs 
faster in the control than in the glybenclamide heart. Note also 
that in the control heart inexcitable areas (black) start to emerge 
as early as at 4 min of LDVF and culminate in complete 
absence of activation by 5.5 min of ischemia. At 8 min, highly 
localized and slow activity reemerges at the RV-septal junction 
but fails to activate LV. In GLYB heart, VFR decline occurs 
slower than in control and, despite VFR slowing, the entire 
mapped area maintains excitability throughout 10 min of 
global ischemia.
6 cm
(28). Thus neither electrophysiological nor contractile factors 
associated with modest ICaL inhibition caused by glybencl­
amide can explain the outcomes of this study.
Another concern is a reported 40% reduction in IKr in the 
presence of 60 |xM glybenclamide (51). To address the poten­
tial effect of glybenclamide on IKr during ischemia, we elected
to determine what role IKr blockade would play in electrical 
depression during LDVF. Dofetilide was chosen due to its 
properties as a highly specific and effective IKr blocker: dofeti­
lide blocks almost 100% of IKr at 1 |xM and has virtually no 
effect on the slow component of the delayed rectifying potas­
sium current (5). Dofetilide shows dose-dependent block of
Fig. 9. Comparison of the time courses of VFR 
(A), DI (B), APD (C), and the percentage of 
inexcitable area (D) in epicardial optical maps 
during LDVF in control and GLYB hearts. *P < 
0.05, statistically significant difference between 
the respective curves by two-way ANOVA.
2 4
Duration o f LDVF (min)
2 4
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Ito was demonstrated only during “simulated” ischemia (33, 
34) and was exclusively based on the effects of 4-aminopyri- 
dine, a relatively nonselective potassium channel blocker. At 
millimolar concentrations needed for efficient Ito blockade 
4-aminopyridine can cause significant inhibition of IKatp (IC50 
of 2.1 ± 0.3 mM; Ref. 24).
In our study, we tested the combined effects of 4-aminopyr- 
idine and a Katp opener cromakalim. In nonischemic hearts, 
4-aminopyridine did not have any significant effect on VFR 
both in the absence and in the presence of cromakalim (see Fig. 
10A). This suggests that blockade by 4-aminopyridine of either 
Ito or Katp does not have any significant role in determining 
the excitation rate during VF. In contrast, activation of Katp 
had a dramatic effect on VFR in nonischemic hearts, increasing 
VFR almost twofold over nontreated hearts. In the course of 
LDVF the difference in VFR between CRO + 4AP and GLYB 
groups progressively diminished until the VFR curves in the 
two groups crossed over, so that VFR in CRO + 4Ap group 
became lower than in GLYB group (see Fig. 11). It is striking 
that whenever the effect of glybenclamide was detectable
Fig. 10. Comparison of VFR averaged across all myocardial layers in different 
groups during nonischemic VF (A) and at 10 min of LDVF (B). GLYB, 60 
jxM; DOF, dofetilide (1 jxM); CRO, cromakalim (10 jxM); 4-AP, 4-amino- 
pyridine (1 mM); CRO + 4AP, combination of cromakalim and 4-aminopyr- 
idine. See text for more detail.
IKATP but at much higher concentrations than what was used in 
our study (EC50 of 51 ± 1 |xM in inside-out patches, and lesser 
efficacy when dofetilide is applied outside the cell; Ref. 65). 
Comparing the effects of glybenclamide and dofetilide in our 
study suggests that potential blockade of IKr by 60 |xM gly- 
benclamide does not affect the main phenomenon, since dofeti- 
lide lowered VFR whereas glybenclamide increased VFR (see 
Fig. 11). Also, dofetilide aborted LDVF in all experiments, 
whereas glybenclamide maintained LDVF in all experiments, 
within the tested 10-min interval. It is of interest that dofetilide 
appeared to preferentially decrease VFR in ENDO (see Fig. 
11). Assuming a leading role of endocardial Purkinje fibers in 
maintaining LDVF in dog heart (56), the prominent antifibril- 
latory effect of dofetilide observed in this study could be 
explained in terms of efficient suppression of arrhythmic 
sources associated with ischemic Purkinje fibers. This intrigu­
ing possibility is beyond the scope of the current study but 
merits further investigation.
Another concern caused by the use of 60 uM of glybencl­
amide is the substantial (~60%) blockade of Ito (26). It was 
suggested that Ito plays an important role in setting up condi­
tions for heterogeneous APD distribution and reentry during 
simulated ischemia by promoting loss of the action potential 
“dome” on the epicardium, which could be prevented by the Ito 
blocker 4-aminopyridine (33, 34). Thus blockade of Ito by 
glybenclamide could, in theory, contribute to the effects of 
glybenclamide on LDVF observed in this study. It should be 
noted however, that the effects of 4-aminopyridine on APD 
during ischemia were sensitive to stimulation rates and were 
largely absent at rates > 2  Hz (the lower bound of activation 
rates observed during LDVF in our study). This can be ex­
plained by relatively slow reactivation kinetics of Ito in canine 
ventricular myocytes (32) and/or reverse use dependence of 
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Fig. 11. VFR time course during LDVF in control, GLYB, CRO + 4AP, and 
DOF groups. Data from control and GLYB groups are the same as in Figs. 5 
and 6. VFR time course was compared among the 4 groups during late stage 
LDVF (from 5 to 10 min) using a two-way ANOVA. A-C: represent EPI, 
MID, and ENDO, respectively. ^Statistical differences between individual 
groups.
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(namely, 2 -4  min after the onset of LDVF) it was opposite to 
the effect exerted by the combination of cromakalim and 
4-aminopyririne. Assuming that inhibition of Ito was at least 
the same (or larger) in CRO + 4AP than in GLYB group, the 
polar difference between these two groups can hardly be 
explained in terms of Ito blockade. Rather, this difference 
would be consistent with the idea that after 4 min of LDVF 
activation of Katp by cromakalim further promotes electrical 
depression manifested as VFR decline, whereas blockade of 
Katp  by glybenclamide prevents that effect.
Summarizing arguments above, we conclude that the main 
effects of glybenclamide observed in this study, namely, main­
tenance of higher VFR and excitable state during LDVF are 
best explained in terms of Katp blockade since among all 
known possible targets of glybenclamide only Katp channel 
opening is relevant to loss of excitability during ischemia, as 
discussed in more detail below.
I k a t p  and electrical depression during LDVF. During myo­
cardial ischemia, a number of factors promote depression of 
excitability and conduction failure including hyperkalemia, 
acidosis, and activation of IKatp (55). Opening of KATP chan­
nels during LDVF may facilitate loss of excitability in two 
ways: first, by its contribution to the level of extracellular K+ 
concentration ([K+]o) increase (66), and second, by creating 
conditions of source-sink mismatch when INa is already re­
duced due to elevated [K+]o (55). In isolated ventricular 
cardiomyocytes, complete loss of excitability can occur when 
Katp  is sufficiently activated in response to mitochondrial 
depolarization, even without any increase in [K+]o (1). We are 
not aware of any published data regarding the dynamics of 
[K+]o during LDVF. Although, in the center of the ischemic 
zone of regionally ischemic isolated canine hearts paced at 
cycle length of 350-450 ms, [K+]o reached ~ 8  mM after 8 
min of coronary occlusion (11). At that level of K+ elevation, 
~20% of unipolar electrograms in the ischemic zone exhibited 
“block” morphology (i.e., lack of negative intrinsic deflection), 
which can be interpreted as indicative of conduction block at 
the recording site. In our study, a similar percentage of inex- 
citable sites was achieved ~ 4  min earlier in the course of 
LDVF (see Fig. 9D). This comparison suggests that either the 
level of [K+]o or the level of IKatp activation, or both, could 
be considerably higher during LDVF than ischemia alone, 
perhaps due to ionic and/or metabolic consequences of very 
high excitation rate.
KATP channel activation and heterogeneities in VFR and 
excitability during LDVF. It has been shown that epicardial 
myocytes are more susceptible to the electrophysiological 
effects of ischemia than are endocardial cells, in particular with 
regard to ischemia-induced ApD shortening. Several studies 
(19, 39, 40) have implicated the higher level of Katp  channel 
expression and/or activation on the epicardium in this phenom­
enon. In contrast to those earlier studies, Farid et al. (15) 
reported a higher expression of Katp subunits in the endocar­
dium of failing human hearts, which was consistent in their 
study with preferential effect of glybenclamide (slowing of the 
excitation rate during LDVF ) in the endocardium. The authors 
attributed this effect to preferential prolongation of APD by 
glybenclamide in endocardial cells but provided very limited 
evidence to support that statement.
In our study, pretreatment with glybenclamide slightly pro­
longed ApD in the epicardium during the combination of VF
and ischemia, which is consistent with the known effect of 
IKATP blockade with respect to APD during ischemia alone. 
However, this was of little consequence for the dynamics of 
VFR. If prolongation of ApD were the only effect of glyben- 
clamide, then we would expect a prolongation of VFCL 
(hence, a decrease in VFR). On the contrary, epicardial VFCL 
shortened and VFR increased in the presence of glybencl- 
amide, despite prolongation of ApD although concomitant 
with shortening of DI. Therefore, at least in the epicardium, the 
effect of glybenclamide on VFR was determined by its effect 
on DI. Using intramural optrodes, Kong et al. (30) recently 
showed that the activation rate during LDVF in all layers of the 
ventricular wall was predominantly determined by DI amid a 
relatively constant ApD. Unfortunately, we did not have means 
to measure the effect of glybenclamide on ApD and DI during 
LDVF in intramural layers. However, extrapolating the results 
obtained with optical mapping on the epicardium, it is likely 
that the VFR increase observed in mid- and endocardial elec­
trograms in the presence of glybenclamide is also associated 
with shortening of DI.
In light of previous studies suggesting differential properties 
of Katp channels in the endocardium vs. epicardium (39, 40), 
it is surprising that Katp channel blockade did not affect the 
transmural VFR gradient in our study (see Fig. 5). If the VFR 
gradient were predominantly due to transmural differences in 
Katp activation, then blockade of this channel should have 
abolished the gradient. In fact, such abolishment was observed 
during LDVF in explanted failed human hearts (15), in stark 
contrast to our results (possible reasons for this discrepancy 
will be discussed below). The lack of effect of glybenclamide 
in our study indicates that other factor(s) are sufficient to create 
conditions for the VFR gradient during LDVF in the structur­
ally normal canine heart. Note that once a VFR gradient is 
established due to these other factors, the (presumably) higher 
availability of Katp channels in the epicardium can be offset 
by a lower value of total depolarization time in the epicardium 
due to fewer action potentials with shorter APDs. As a result, 
even though more channels are opened, the total current over a 
period of time will be small because most of the time the 
membrane potential will be close to the potassium equilibrium 
potential. Factors contributing to the transmural VFR gradient 
during LDVF may include transmural differences in properties 
of INa inactivation (10); transmural distribution of mechanical 
stress (20, 64) with attendant changes in the function of 
stretch-activated channels and other channels, including KATP 
(60, 61); lower expression of connexin 43 in the epicardium 
compared with deeper layers of the ventricular wall (47); and 
heterogeneous expression/function of several other channels 
and tranporters [for more detailed discussion, see our previous 
publication (62)].
Even though Katp channel blockade markedly reduced the 
percentage of inexcitable area, it did not remove local (at the 
scale of millimeters) heterogeneities observed with optical 
mapping in the epicardium. Such local heterogeneities in the 
degree of electrical depression during LDVF may be related to 
spatially heterogeneous elevation of [K+]o, which can be 
observed even during global ischemia (29). The reasons for 
small-scale heterogeneities in the electrophysiological effects 
of (apparently uniform) global ischemia remain unknown.
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Role o f Katp channel in asystole and outcomes of 
resuscitation. During global ischemia associated with cardiac 
arrest of any etiology, asystole should inevitably occur, if not 
intervened, as a natural step towards death. However, the 
timing and the circumstances of asystole do matter. In the 
setting of out-of-hospital sudden cardiac arrest (OHSCA), 
asystole is not treatable with defibrillation shock and is asso­
ciated with an extremely low rate of survival (23). In recent 
years, the incidence of asystole as the initial presenting rhythm 
remained the same or increased, amid a robust decrease in the 
incidence of VF (8, 48). At this point, one can only speculate 
what has caused the change in the proportion between VF and 
asystole in the OHSCA population. In most cases, the rhythm 
precipitating cardiac arrest in the out-of-hospital setting is not 
known. Recordings obtained from postmortem interrogation of 
Holter monitors, implantable cardioverter defibrillators, or im­
plantable loop recorders in selected groups of patients with 
prior history of heart disease showed that from 40 to 80% of 
these patients had VF as the terminal rhythm at the time of 
unexpected death (21, 35, 38). The incidence of VF as the 
rhythm preceding death was generally lower in patients with 
advanced stages of heart failure (35) and higherin patients with 
prior myocardial infarction (21). It should be noted that the 
high-risk sudden cardiac death patients being monitored either 
in hospital or ambulatory are likely to be different from the 
residents in the general community that have sudden cardiac 
death, often as the very first manifestation of heart disease (7). 
Thus it is very difficult to estimate at this point what proportion 
of asystole in OHSCA is due to early transition from VF to 
asystole as opposed to asystole as a culmination of severe 
bradycardia and pulseless electrical activity (45). However, in 
both scenarios the mechanism of rapid deterioration to asystole 
may involve enhanced activation of IKATp, which may affect 
not only ventricles but also atria and/or the specialized con­
ducting system of the heart. At least in the three asystolic 
hearts where we attached pacing and recording electrodes to 
the right atrium, atria did not show any spontaneous activity 
and did not respond to stimulation after VF termination. This 
observation warrants closer attention to the role of supraven­
tricular tissues in the events occurring during cardiac arrest. 
Indeed, suppression of the sinus node activity due to activation 
of /Katp (18) alone may be sufficient to prevent restoration of 
spontaneous circulation under these conditions. These assump­
tions have to be tested in future studies.
Our study shows that activation of IKatp is a major deter­
minant of asystole as the outcome of LDVF. That is, blockade 
of Katp channel supports maintenance of VF within the 
clinically relevant time window. This is consistent with a 
previous study by Tang et al. (58) using an open-chest rat 
model of resuscitation, where activation of Katp channel either 
by use of a Katp channel agonist or by ischemic precondition­
ing promoted spontaneous VF termination. In our study, how­
ever, VF termination was followed by asystole (adverse out­
come) whereas in that study it was followed by restoration of 
sinus rhythm (benign outcome). The discrepancy may be due 
to differences between species and/or experimental conditions. 
However, it brings up an important point that in the setting of 
LDVF the net effect of Katp channel activation/blockade 
depends on the balance between the effects with respect to VF 
dynamics and the effects with respect to generation and deliv­
ery of the sinus node impulses to the ventricles.
Comparison to explanted cardiomyopathic human heart. A 
recently published study by Farid et al. (15) investigated the 
role of IKatp in the dynamics and the outcome of LDVF 
induced in Langendorff-perfused hearts explanted from human 
patients with end-stage heart failure. The difference between 
our study and that by Farid et al. is quite striking; essentially, 
the results are opposite in many respects. The most important 
difference is that in our study glybenclamide prevented VF 
termination, whereas in their study this drug promoted VF 
termination in the globally ischemic heart. In our study, there 
was no major effect of glybenclamide with respect to the 
difference in excitation rate during LDVF between ENDO and 
EpI; in their study, this difference was effectively eliminated 
by glybenclamide. Lastly, in our study, there was no detectable 
effect of glybenclamide at the onset of LDVF; in their study 
that effect was profound (see their Fig. 4A).
The latter difference, in fact, may be key to the discrepant 
results. Excluding trivial explanations in terms of unintentional 
metabolic stresses associated with various stages of preparation 
preceding the actual experiment, the prominent effect of gly- 
benclamide in an essentially nonischemic heart may be related 
to the fact that the hearts at advanced stages of dilated cardio­
myopathy are metabolically compromised to such extent that 
IKATP is activated even without overt ischemia. This assump­
tion would be consistent with reports indicating severe energy 
deprivation in failing hearts (42), and a possibility that Katp 
channel regulation is altered in response to congestive heart 
failure (16).
Another factor in the difference between LDVF dynamics in 
normal vs. failing hearts (ignoring for the moment interspecies 
differences) may be related to downregulation of repolarizing 
potassium currents such as Ito and IKr in failing hearts (59). 
This may lead to a significant prolongation of APD, which in 
turn may slow down the excitation rate during VF. In agree­
ment with this conjecture, blockade of IKr with dofetilide in our 
model significantly decreased VF rate in both nonischemic and 
ischemic hearts (see Figs. 10 and 11). Moreover, dofetilide 
affected VF maintenance so that in two out of six hearts treated 
with dofetilide VF stopped spontaneously within 1 or 2 min 
after its induction (not shown), an event never observed in 
untreated canine hearts.
If the two assumptions mentioned above (downregulation of 
voltage-dependent potassium currents and an apparent upregu- 
lation of IKatp in failing human hearts) are correct, the differ­
ence between our study and that by Farid et al. could be 
explained in terms of different timing of Katp activation in the 
two models and varying role of IKatp in LDVF dynamics 
depending on the stage of ischemia. Our data show that when 
Katp is deliberately activated, its effect changes in the course 
of LDVF, which might depend on the magnitude of other 
detrimental factors of ischemia such as extracellular potassium 
accumulation. Namely, Katp activation increases VFR in the 
early stage (3-4 min) and decreases VFR at the late stage 
(5-10 min) of LDVF (see Fig. 11). Based on the effects of 
Katp blockade by glybenclamide, it appears that the principal 
difference between the normal canine heart and failing human 
hearts is the level of Katp activation at the early stage of 
LDVF: high in failing human hearts vs. low in normal canine 
hearts. Note that the study by Farid et al. (15) was limited to 
only the first 3 min of LDVF, the time frame when Katp 
activation is expected to increase VFR and, conversely, Katp
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blockade is expected to reduce VFR if Katp channel is acti­
vated. Note also that in failing human hearts the very existence 
of sustained VF may require Katp activation to overcome the 
antifibrillatory effect of dramatic APD prolongation caused by 
downregulation of repolarizing potassium currents. In this 
regard, it is interesting to note that prevalence of VF as the 
rhythm causing cardiac arrest is low in patients with advanced 
stages of heart failure compared with other cardiac conditions 
(21, 35, 38).
Clinical implications. Together with previous publications, 
our study underscores the very complex role of Katp  channel 
in cardiac arrest. While in the structurally normal canine heart, 
Katp  channel blockade supports maintenance of VF in glob­
ally ischemic heart (this study), in failing human heart the 
effect is exactly opposite: VF termination (15). The latter 
outcome is good only if it is followed by restoration of 
spontaneous rhythm, but is lethal if it is followed by asystole. 
Katp  channel activation can promote loss of excitability (this 
study) and postreperfusion arrhythmias (1), yet upon resusci­
tation and reperfusion enhanced Katp  channel activation can 
also afford better recovery of hemodynamics and, ultimately, 
survival (58). Future therapeutic strategies aimed at improving 
the outcomes of cardiac arrest must therefore address the 
challenge of separating the adverse effects of Katp  channel 
activation from the protective ones.
Limitations. Limitations related to the reduced blocking 
efficacy of glybenclamide in the presence of elevated [ADp]i 
(63) and potential blockade of IKi, Ito, and other nonspecific 
effects have been thoroughly addressed above. Other common 
limitations of the ex vivo model of LDVF, plunge needle 
electrodes, and optical mapping are discussed in our previous 
publications (27, 62).
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DOES THE COMBINATION OF HYPERKALEMIA AND KATP 
ACTIVATION DETERMINE EXCITATION RATE GRADIENT 
AND ELECTRICAL FAILURE IN THE GLOBALLY 
ISCHEMIC FIBRILLATING HEART?
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excitation rate gradient and electrical failure in the globally ischemic fibrillating heart?’ Am J 
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Taylor TG, Venable PW , Booth A, G arg V, Shibayama J , Zaitsev
AV. Does the combination of hyperkalemia and KATP activation determine 
excitation rate gradient and electrical failure in the globally ischemic fibril­
lating heart? Am J  Physiol Heart Circ Physiol 305: H903-H912,2013. First 
published July 19, 2013; doi:10.1152/ajpheart.00184.2013.— Ventricular 
fibrillation (VF) in the globally ischemic heart is characterized by a 
progressive electrical depression manifested as a decline in the VF 
excitation rate (VFR) and loss of excitability, which occur first in the 
subepicardium (Epi) and spread to the subendocardium (Endo). Early 
electrical failure is detrimental to successful defibrillation and resus­
citation during cardiac arrest. Hyperkalem ia and/or the activation of 
A TP-sensitive K + ( K a t p )  channels have been implicated in electrical 
failure, but the role of these factors in ischemic VF is poorly under­
stood. W e determined the VFR-extracellular K + concentration 
([K +]o) relationship in the Endo and Epi of the left ventricle during 
VF in globally ischemic hearts (Isch group) and normoxic hearts 
subjected to hyperkalem ia (HighK group) or a combination o f hyper­
kalem ia and the K a t p  channel opener crom akalim  (HighK-Crom 
group). In the Isch group, Endo and Epi values o f [K +]o and VFR 
were compared in the early ( 0 - 6  min), m iddle (7-13 min), and late 
(1 4 -2 0  min) phases o f ischemic VF. A  significanttransm ural gradient 
in VFR (Endo >  Epi) was observed in all three phases, whereas a 
significant transmural gradient in [K + ]o (Epi >  Endo) occurred only 
in the late phase o f ischemic VF. In the Isch group, the VFR decrease 
and inexcitability started to occur at much lower [K +]o than in the 
H ighK group, especially in the Epi. Com bining KATP activation with 
hyperkalem ia only shifted the V FR -[K +]o curve upward (an effect 
opposite to real ischemia) w ithout changing the [K +]o threshold for 
asystole. W e conclude that hyperkalem ia and/or KATP activation 
cannot adequately explain the heterogeneous electrical depression and 
electrical failure during ischemic VF.
extracellular potassium accumulation; myocardial ischemia; ventric­
ular fibrillation; ATP-sensitive potassium  channel; asystole
h e t e r o g e n e o u s  e l e c t r i c a l  d e p r e s s i o n  and the eventual loss of 
excitability occurring in the course of cardiac arrest are major 
adverse outcomes determining the incidence of reperfusion 
arrhythmias (1) and asystole, with the latter usually being the 
point of ultimate failure in resuscitation practice (10). In the ex 
vivo blood-perfused canine heart, simulated cardiac arrest 
produced by a combination of ventricular fibrillation (VF) and 
global ischemia causes a prominent transmural gradient in the 
VF rate (VFR) followed by the emergence of inexcitable areas 
in the epicardium (Epi), which spread across the ventricular 
wall and culminate in global asystole within a clinically rele­
vant timeframe (32, 34). The transmural VFR gradient is also 
present in explanted human hearts subjected to global ischemia
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and VF (9). Given the similarity between the canine heart and 
human heart, understanding the mechanisms of heterogeneous 
electrical depression in the canine model may help to improve 
the outcomes of resuscitation from cardiac arrest in patients, 
based on mechanistic knowledge.
Electrical depression during ischemia without VF has been 
studied for many years, and the classical teaching posits that 
the main factor determining excitability during ischemia is the 
elevation of the extracellular K+ concentration ([K+]0; hyper­
kalemia), which leads to depolarization of the resting potential 
and a subsequent reduction in the availability of Na+ channels 
for activation (30). Moreover, because Na+ channel inactiva­
tion occurs at more negative potentials in the Epi than in the 
endocardium (Endo), even a transmurally uniform increase in 
[K+]o can bring about a selective depression of Epi action 
potentials and transmural frequency-dependent conduction 
block (6). Thus, assuming that the primary sources of high- 
frequency activation during ischemic VF are harbored by Endo 
Purkinje fibers (8), global uniform hyperkalemia may be suf­
ficient to explain the VFR gradient during ischemic VF. How­
ever, this possibility has not been tested in experiments. The 
second factor implicated in the loss of excitability during 
ischemia is activation of ATP-sensitive K+ (KATP) channels, 
which, in theory, can oppose sarcolemmal depolarization 
caused by the opening of Na+ channels to the degree at which 
spread of excitation becomes impossible, leading to so-called 
“sink block” (1). Moreover, the two factors (hyperkalemia and 
KATP activation) in theory can be synergistic, such that in the 
presence of KATP activation, conduction block would occur at 
lower [K+]0 than hyperkalemia alone (30). To the best of our 
knowledge, however, such synergism has not been tested in 
experimental studies.
Cardiac arrest secondary to VF presents a more complex 
context than ischemia alone because the high excitation rate of 
VF aggravates metabolic challenge by increasing energy de­
mand (16) and can potentially contribute to ionic imbalances 
that develop in the course of ischemia. For example, it was 
shown that the high excitation rate present during atrial fibril­
lation causes a moderate but detectable elevation of [K+]0 even 
in the presence of coronary circulation (19). It is thus possible 
that VF in globally ischemic hearts would aggravate hyperka­
lemia, but the time course of [K+]o elevation in ischemic VF 
has not yet been reported.
The relationship between ionic alterations caused by isch­
emia and the excitation rate of VF is complex and remains 
controversial. The VF cycle length, the inverse of VFR, is 
correlated with the duration of the refractory period, which, in 
turn, is determined by the sum of the action potential duration 
and the duration of the period after repolarization during which
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Na+ channels recover from inactivation. The latter period, 
termed postrepolarization refractoriness, is extremely short 
under normal conditions but becomes a prominent component 
of the refractory period and a major determinant ofVFR during 
ischemia (15, 34). Hyperkalemia causes a decrease in VFR (4, 
17, 26), most likely due to an increase in postrepolarization 
refractoriness (26). In the rabbit heart, a moderate increase in 
[K+]o (to 8 mM) appeared to be sufficient to reproduce the 
decrease in VFR caused by low-flow ischemia (4); however, 
the actual [K+]o during ischemia was not measured, and the 
case of no-flow ischemia was not tested in that study.
If, indeed, hyperkalemia were sufficient for determining 
VFR during ischemic VF, this would leave no role for the 
direct effect of increased K atp  current. However, blockade of 
K atp  channels has been shown to modulate VFR during 
ischemic VF in the canine heart (32) and failing human heart 
(9). Of interest, the effects of the K atp  blocker glybenclamide 
on ischemic VFR were somewhat opposite in the two above­
mentioned studies. In explanted failing human hearts, glyben- 
clamide eliminated the transmural VFR gradient and facilitated 
the termination of ischemic VF (9). In contrast, in the ex vivo 
canine heart, glybenclamide had little effect on the transmural 
VFR gradient but postponed the termination of ischemic VF 
(32). The disparate outcomes of K atp  blockade in these studies 
could be related to differences in the (unknown) ischemic level 
of [K+]o, if the assumption of synergism between K atp  acti­
vation and hyperkalemia with regard to the reduction of excit­
ability (30) is correct. It also cannot be excluded that the 
outcomes were confounded by the off-target effects of glyben- 
clamide, although many of the possible nonspecific effects 
were ruled out in the canine model (32). Thus, the role of K atp  
activation in VFR dynamics and loss of excitability during 
ischemic VF remains controversial.
This study was designed to test the hypothesis that hyper­
kalemia and/or K atp  activation can explain the transmural 
VFR gradient and loss of excitability observed during VF and 
no-flow ischemia in the ex vivo blood-perfused canine heart. 
The results of our study showed that even though a transmural 
[K+]o gradient is present during ischemic VF, hyperkalemia 
alone cannot reproduce the VFR suppression observed during 
ischemic VF, especially in the Epi. Moreover, pharmacological 
K atp  activation alone or in combination with hyperkalemia 
produced an effect opposite to that of real ischemia: a VFR 
increase instead of a VFR decrease. These results suggest the 
presence of yet unknown but powerful ionic mechanisms of 
electrical depression during ischemic VF not mediated by 
hyperkalemia or K atp  activation. Possible additional/alterna­
tive mechanisms are discussed.
METHODS
This investigation conformed with the National Institutes of Health
Guide fo r  the Care and Use o f  Laboratory Animals (NIH Pub. No. 
85-23, Revised 1996) and was approved by the Institutional Animal 
Care and Use Committee o f the U niversity of U tah (protocol No. 
10-09005).
Experimental protocol. A  total of 36 dogs (12 mongrel dogs and 24 
purpose-bred dogs, weight: 24.6 ±  0.7 kg, 20 male and 16 female) 
were euthanized for this study. Animals were premedicated with 
aceprom azine (0.4 mg/kg), propofol (8 mg/kg), or Telazol (9 mg/kg), 
and a deep plane o f anesthesia was maintained with pentobarbital in 
all dogs (initial dose: 50 mg/kg, additional doses as needed to 
m aintain deep anesthesia for the duration of surgery, < 1  h). Hearts
were exposed via a midline sternotomy and rapidly excised for 
perfusion on a Langendorff apparatus with a mixture o f heparinized 
blood and Tyrode solution as previously described (12, 37). After 
isolation, hearts were placed in either a vapor cham ber or immersed in 
Tyrode superfusion to maintain an Epi temperature o f 37 ±  1°C. 
Twenty-six hearts were subjected to 20 min o f ischemic V F by 
inducing V F with a 9-V battery 10 s before the onset o f global 
ischemia initiated by the interruption o f aortic perfusion (Isch group). 
In these hearts, [K + ]o increased naturally during ischem ia and was 
measured using K +-sensitive electrodes (see below). In the remaining 
10 hearts, V F was induced the same way, and normal oxygenated 
perfusion was maintained in the fibrillating heart while [K +]o was 
varied between 4 and 15 mM by altering [K + ] in the perfusate. In five 
o f these hearts, hyperkalemia was the only factor tested (HighK 
group). In the rem aining five hearts, 2 0 -3 4  jxM crom akalim  (a K a t p  
channel opener) was administered before [K + ]o was increased 
(HighK-Crom group). In the HighK and HighK-Crom groups, [K +] 
was increased stepwise by adding 1-3 ml of 600 mM  KCl solution at 
a tim e to the recirculating blood-Tyrode mixture while the resulting 
[K +] in the perfusate was measured every 2 -3  min using a NOVA 8 
ion analyzer (Nova Biomedical, W altham, MA). A  VFR measurement 
was accepted for analysis if it was bracketed by two venous [K +]o 
measurements within 0.5 mM of each other, and the average of the 
two [K + ]o values was used for analysis.
K +-sensitive electrodes and [K +]o measurements. K +-sensitive 
electrodes were prepared following as close as possible the process 
described by Johnson et al. (13). However, the electrodes manufac­
tured in this fashion turned out to be extremely fragile, with many not 
surviving the experimental protocol. To improve our success rate, the 
prepared electrodes were then housed in a 20-gauge hypodermic 
needle with an aperture exposing the sensing part of the K +-sensitive 
electrode to the interstitial fluid (Fig. 1, A  and B). The depth o f the 
K + -sensitive electrode could be adjusted by sliding the thin polymer 
tubing (arrow in Fig. 1 A ) along the shaft o f the needle. The assembled 
K + -sensitive electrode and housing are referred to as “K + needle" 
below.
K + needles were calibrated both before and after the experiment 
using 3 and 10 mM  KCl solution; any electrode that showed a voltage 
shift outside the range o f 30 ±  4 mV before or after the experiment 
was excluded as damaged, and the data collected was discarded. 
Figure 1C shows an example calibration o f Endo and Epi K + needles. 
Note that both electrodes showed stable measurements over 30-min 
periods in both 3 and 10 mM  KCl solution with an —30-mV shift 
between solutions. The inset in Fig. 1C  shows the rapid (in the order 
of seconds) response o f the K + needles to the transition from 3 to 10 
mM solution. M illivolt values were converted to millimolar values 
using the Nernst equation [for details of the calibration, see Johnson 
et al. (13)]. Since the calibration constant could be slightly different 
pre- and postexperiment, we used the average o f the pre- and post- 
experimental calibration values for conversion purposes. In addition, 
the response o f K + needles placed in hearts was tested by adding a 
bolus o f 600 mM KCl solution to the recirculating blood-Tyrode 
mixture. Figure 1D  shows an example of recordings from Endo and 
Epi K + needles (squares and triangles, respectively) verified by 
measurements using a blood ion analyzer (large Xs). The initial value 
o f [ K + ]q in the perfusate was 2.2 mM. The indicated target concen­
tration was calculated based on the estimated dilution factor. The two 
vertical dashed lines indicate the tim ing o f bolus injection and wash­
out. W ashout was performed by replacing —700 ml o f the K +- 
enriched perfusate with an equivalent amount o f a surplus blood- 
Tyrode mixture. Since all o f the blood with elevated [K +] could not 
be removed (due to the limited volume of the blood-Tyrode mixture), 
the final [K +] remained elevated (5.4 mM) compared with before the 
K + bolus (2.2 mM). Note, however, that during steady-state condi­
tions both before and after the K + bolus there was a close match 
between [K +] values obtained by K + needles and the blood ion 
analyzer.
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Fig. 1. Custom-made K+-sensitive electrodes. A: K+-sensitive electrodes were enclosed in a 20-gauge hypodermic needle that contained a window (white box) 
that exposed the K+ sensor to the myocardial tissue. The polymer tubing (arrow) could be moved along the shaft of the needle to adjust the position of the K+ 
sensor at the desired distance from the epicardial (Epi) surface. B: close up of the sensing part of the K+ needle indicated by the white box in A. This design 
provided both adjustable depth and protection for the delicate sensor. C: example of calibration of endocardial (Endo) and Epi K+ needles. Note that both 
electrodes showed stable measurements over 30-min periods in both 3 and 10 mM KCl solution with an —30-mV shift between solutions. The inset shows the 
rapid (in the order of seconds) response of the K+ needles to the transition from 3 to 10 mM solution. D: response of Endo (squares) and Epi (triangles) K+ 
needles placed in a heart to a bolus of 600 mM KCl solution added to the recirculating blood-Tyrode mixture. The indicated target concentration was calculated 
based on the estimated dilution factor. The two vertical dashed lines indicate the timing of bolus injection and (partial) washout. Note that during steady-state 
conditions both before and after the KCl bolus, there was a close match between extracellular K+ concentration ([K+]o) values obtained by K+ needles and those 
obtained using the blood ion analyzer (large Xs).
3 mM 10 mM 3 mM
K + needles were placed in the anterior left ventricular (LV) free 
wall. Epi K + needles were manufactured to have the sensor reliably 
submerged into the tissue, and the actual depth o f the Epi [K + ]o 
m easurement was —3 mm from the epicardial surface. The depth of 
the Endo [K + ]o measurement could not be determined at the moment 
o f the needle insertion due to the trabeculated structure of the LV 
Endo (in our estimates, the thickness o f the LV wall varied between
5  mm  at the thinnest part and 20 mm  at locations where the papillary 
muscles were attached to the LV free wall). Thus, it was not possible 
to have a fixed depth o f the sensing aperture in Endo K + needles. To 
address the irregular thickness o f the LV free wall and to make sure
that the sensing portion o f the K + needle was located close to the 
Endo surface, we used two complementary approaches. First, we 
performed “pacing threshold mapping” using one of the multicontact 
plunge needle electrodes used for recording unipolar electrogams 
across the LV wall (see below). In  essence, we applied pacing stimuli 
to consecutive pairs of adjacent leads (starting from the most Endo 
leads: 1  and 2, 2  and 3, etc.) and measured the end-diastolic threshold 
for excitation. Based on the observation that Endo pacing thresholds 
were typically the lowest across the LV wall and very high in the LV 
cavity (not shown), the pacing cathode location yielding the lowest 
excitation threshold between 5 and 16  mm from the Epi surface was
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considered to be the best estimate for the Endo location. W ith this 
estimate, the depth o f the sensing window on the Endo K + needle was 
adjusted by sliding the Epi cuff (see arrow in Fig. 1A) along the shaft 
o f the needle, and the needle was inserted within 2  m m  o f the 
multicontact electrode used for the pacing mapping. Second, to obtain 
the actual position o f sensors in Endo K + needles, we exposed the LV 
Endo after finishing our experimental protocol and visually deter­
mined the distance o f the sensing portion o f the K + needles from the 
Endo. The accepted Endo [K + ]o measurements were collected at a 
distance o f 1 -6  mm from the Endo surface. One to three Epi K + 
needles and one to three Endo K + needles were used in each 
experiment, with the goal o f having at least one measurement from 
both the Endo and Epi after discarding any electrodes not meeting our 
requirements for calibration and the intramural position o f the sensor. 
In those experiments in which two or (rarely) three acceptable K + 
recordings were obtained either from the Epi or Endo, the data from 
these individual measurements were averaged to represent the respec­
tive layer in that particular experiment.
Electrical recordings and analysis. Plunge needle electrodes with 
10 evenly spaced unipolar leads (interlead distance: 1.6 mm) were 
manufactured in house following the design developed by Rogers et 
al. (27). Ten needles were placed across the anterior surface of the 
heart, and three needles in close proxim ity to the K + needles were 
chosen for analysis. The distance between needles was 10-15  mm. 
Unipolar electrograms from all contacts of the needle electrodes were 
recorded continuously during the first 20 min o f ischemic VF at a 
sampling rate of 1 kHz using a custom -made multichannel data- 
acquisition system (31). Unipolar electrograms were analyzed using 
custom  software developed in the M atlab (M athworks, Natick, M A) 
framework. Electrograms were first filtered using a 60-Hz notch filter 
including several shorter harmonics. W e applied the H ilbert transform 
to unipolar electrograms as previously described (18, 23, 32). Briefly, 
the H ilbert transform  converts a fluctuating voltage signal into its 
corresponding phase so that consecutive cycles of activation are 
represented by changes in phase from —2 ^  to 2 ^ . Thus the number of 
phase transitions from 2 ^  to —2 ^  gives an estimate of frequency. To 
decrease the influence o f noise, activation cycles w ith a length o f < 33  
ms and amplitude of the waveform between two consecutive phase 
transitions o f < 10%  o f the electrogram amplitude measured at 0 min 
o f ischemic VF were excluded from the total cycle counts. After that, 
VFR was calculated as the average number o f activations per second 
over 4-s intervals taken at 4 s after ischemic VF induction and at 
m inutes 1 -20  of ischemic VF. For simplicity, the first tim e point is 
referred to as 0 min o f ischemic VF. Local tissue was considered 
inexcitable if  V FR was 0 Hz (no detectable activations). The percent­
age of Endo or Epi leads that were inexcitable was determined at each 
tim e point of ischemia.
W hereas the length of the plunge needle electrodes was constant 
and designed to span the largest thickness observed in the LV o f the 
canine heart, as previously mentioned the actual thickness o f the 
ventricular wall is highly nonuniform. Thus, in some cases, plunge 
needle electrodes were longer than the wall thickness at the site of 
insertion. In the beginning o f this study, we used our elaborate set of 
criteria to exclude the contacts protruding from the ventricular wall 
based on the analysis of the electrograms that we previously described 
(34). However, in the vast m ajority o f experiments, we determined the 
relationship between plunge needle length and LV wall thickness by 
visual inspection and wall thickness measurements after opening the 
LV cavity at the end o f the experiments, simultaneous with determ in­
ing the depth of sensor location in Endo K + needles.
Plots o f  VFR and percentage o f  inexcitable sites versus [ K +]o- 
VFR and the percentage o f inexcitable sites in the Endo and Epi were 
plotted against measured [K +]o for all three experimental groups 
(Isch, HighK, and HighK-Crom  groups). Data were grouped into 
increments o f 1 mM [K + ]o for comparison. In some experiments from 
the HighK and HighK-Crom groups, [K + ]o measurements were 
sparse and were apart by > 1  mM. In these cases, VFR and the
percentage of inexcitable sites for intermediate [K +]o values were 
linearly interpolated. In addition, in some early experiments from the 
H ighK and HighK-Crom  groups when full asystole was observed at 
[K +]o between 10 and 15 mM, higher levels o f [K +]o were not tested. 
In those cases, we assumed that VFR would remain at 0 Hz and that 
the percentage o f inexcitable sites would rem ain at 100%, for all 
[K +]o above the highest [K +]o for which asystole was actually 
observed.
Statistical analysis. All curves were compared using two-way 
ANOVA. The tim e course o f VFR and [K + ]o during ischemic VF was 
compared separately for three phases: early ( 0 - 6  min), m iddle (7-13 
min), and late (1 4 -2 0  min) ischemia. Data are given as means ±  SE. 
Differences o f P  <  0.05 were considered statistically significant.
RESULTS
Time course o f [K+]0, VFR, and the occurrence o f inexcit­
ability during ischemic VF. Figure 2A shows the time course of 
[K+]o elevation in the Endo and Epi during ischemic VF. 
Extracellular K+ accumulation started immediately upon the 
onset of ischemic VF and monotonically increased over the 
entire 20-min ischemic interval. The total increase (A[K+]o) 
was greater in the Epi than in the Endo (8.3 vs. 6.6 mM). 
However, the Epi-to-Endo difference was statistically signifi­
cant only during the late phase of ischemic VF (14-20 min). 
This relationship persisted when the Endo [K+]o measurements 
used for analysis were limited only to those collected within 
0 -3  mm from the Endo surface (not shown). The transmural 
difference in VFR (Fig. 2B) was much more pronounced than 
the difference in [K+]o and was statistically significant 
throughout all three phases of ischemic VF, consistent with 
previous studies (8, 34, 36). When measurements with VFR = 
0 were excluded from analysis, the transmural VFR difference 
was overall similar and remained statistically significant 
throughout all three phases of ischemic VF (not shown). Figure 
2C shows the percentage of electrodes with undetectable elec­
trical activity (thus deemed inexcitable according to the formal 
criterion; see m e t h o d s )  as a function of ischemia duration. As 
shown in Fig. 2C, the prevalence of inexcitable sites steadily 
increased during ischemic VF in both the Endo and Epi, but at 
a much higher rate in the Epi than in the Endo. The transmural 
difference in this parameter was statistically significant during 
all three phases of ischemic VF. Note that the largest Endo- 
to-Epi difference in VFR and excitability was observed during 
the middle phase of ischemic VF (7-13 min), after which time 
point these parameters converged, indicating nearly complete 
electrical suppression by 20 min of ischemia.
Relationship between [K+]o and VFR under various exper­
imental conditions. To assess the role of hyperkalemia in the 
progressive VFR decline and eventual inexcitability during 
ischemic VF, we compared the relationship between VFR and 
[K+]o during ischemic VF (Isch group), normoxic VF in the 
presence of hyperkalemia (HighK group), and normoxic VF in 
the presence of hyperkalemia in combination with the KATP 
channel opener cromakalim (HighK-Crom group). In normoxic 
experiments, [K+]o was varied between 4 and 15 mM. Note 
that in ischemic hearts, the elevated K+ concentration was 
achieved naturally, whereas in all other experiments it was 
adjusted by adding boluses of KCl to the perfusate (see 
m e t h o d s ) .
Figure 3 shows examples of transmural unipolar electro­
grams recorded at approximately normal [K+]o (3.7-4.3 mM;
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left) and at high [K+]o (9.1-9.4 mM; right) in the three 
experimental groups (from top to bottom: Isch, HighK, and 
HighK-Crom groups). Figure 3, top left, shows electrograms 
obtained at 0 min of ischemic VF when the level of [K+]o was 
3.7 mM. Figure 3, top right, shows electrograms obtained at 7 
min of ischemic VF when the level of [K+]o was 9.1 mM in the
D u ra tio n  o f  Is c h e m ia  (m in )
Epi and 9.3 mM in the Endo. As was the typical situation at 0 
min and between 5 and 9 min of ischemic VF (see Fig. 2A), in 
this example, there was no significant difference between 
[K+]o in the Epi and Endo. As shown in Fig. 3, at 0 min of 
ischemia and [K+]o = 3.7 mM, there was no perceptible 
difference in VFR between the Epi and Endo. In contrast, at 7 
min of ischemia and [K+]o ~  9 mM, there was a drastic 
difference in VFR between the Epi and Endo, despite the 
relative uniformity of [K+]o. In fact, the outer half of the LV 
wall did not have detectable activations at all (VFR = 0).
Figure 3, middle, shows a representative example of trans­
mural unipolar electrograms from a HighK heart subjected to 
[K+]o = 3.7 mM (left) and [K+]o = 9.3 mM (right). As shown 
in Fig. 3, middle, at both levels of [K+]o, VFR was uniform 
across the ventricular wall and the actual VFR was virtually 
unaffected by the increase in [K+]o from 3.7 to 9.3 mM. Figure 
3, bottom, shows a representative example of transmural uni­
polar electrograms from a HighK-Crom heart subjected to 
[K+]o = 4.3 mM (left) and [K+]o = 9.4 mM (right). As shown 
in Fig. 3, bottom, activation of KATP channels by cromakalim 
induced a huge and transmurally uniform increase in VFR 
compared with the absence of the drug. Note that VFR re­
mained exceedingly high even when [K+]o was raised to 9.4 
mM, with no appreciable transmural VFR gradient. Moreover, 
note the striking contrast between VFR during real ischemia 
(Fig. 3, top right) and VFR during hyperkalemia in combina­
tion with KATP activation (Fig. 3, bottom right), despite the 
same level of [K+]o.
Figure 4A shows the statistical summary of the VFR-[K+]o 
relationship in all three experimental groups. The different 
colors represent the different experimental groups; open trian­
gles and solid squares represent Epi VFR and Endo VFR, 
respectively. The diagram shown in the inset in Fig. 4A shows 
relevant pairwise comparisons. The vertical brackets indicate 
statistically significant difference between the same layer in 
different experimental groups; the horizontal brackets indicate 
statistically significant difference between the Endo and Epi in 
the same experimental group. As shown in Fig. 4, in the HighK 
group (red), an appreciable decrease in VFR in both the Endo 
and Epi occurred only at [K+]o exceeding 8 mM and VFR 
approached zero at [K+]o between 12 and 14 mM. Even though
Fig. 2. Time course of [K+]o (A), ventricular fibrillation (VF) rate (VFR; B), 
and the percentage of inexcitable sites (%Inexcitable; C) during 20 min of 
ischemic VF. The open triangles and filled squares represent the Epi and Endo, 
respectively. The vertical dashed lines denote the early, middle, and late phases 
of ischemic VF. A: [K+]o progressively increased in both the Epi and Endo 
throughout 20 min of ischemic VF. Note that the difference between Endo and 
Epi [K+]o was statistically significant (P < 0.05) only during the late phase of 
ischemic VF. B : time course of VFR decline. VFR decreased faster in the Epi 
than in the Endo, creating a prominent and statistically significant Endo-to-Epi 
difference during all phases of ischemic VF. The magnitude of the VFR 
gradient eventually decreased, as both Epi and Endo VFR values converged to 
zero by 20 min of ischemic VF. C: progressive increase in the percentage of 
inexcitable sites. The Epi showed a more rapid onset and greater extent of local 
inexcitability compared with the Endo, but both Endo and Epi locations 
approached 100% inexcitability by the end of 20-min episodes of ischemic VF. 
The Endo-to-Epi difference in the percentage of inexcitable sites was statisti­
cally significant during all phases of ischemic VF. Note the discrepancy 
between the dynamics of the [K+]o gradient and the gradients of VFR and 
excitability: the largest transmural difference in the electrical parameters was 
observed when there was no transmural difference in [K+]o, and vice versa. 
*P <  0.05; **P <  0.0001.
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Fig. 3. Representative transmural unipolar electro­
grams from globally ischemic hearts (Isch group), 
normoxic hearts subjected to hyperkalemia (HighK 
group), and normoxic hearts subjected to a combina­
tion of hyperkalemia and the ATP-sensitive K+ 
(KATP) channel opener cromakalim (HighK-Crom 
group) (top to bottom) at approximately normal [K+]0 
(left) and elevated [K+]o (right). Epi and Endo VFR 
values are shown next to the respective electrogram 
recordings. Note that at [K+]o close to normal (3.7­
4.3 mM), there were no appreciable transmural VFR 
gradients in any group, but KATP activation in the 
HighK-Crom group caused a dramatic increase in 
VFR (bottom left). At high [K+]o (9.1-9.4 mM), a 
prominent VFR gradient (with Epi VFR = 0) was 
observed only in the Isch group (top right) but not in 
the HighK or HighK-Crom groups. This suggests that 
the ischemic VFR gradient and regional inexcitability 
are not caused by hyperkalemia or KATP activation.
V FR  = 8.3 Hz
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Endo VFR appeared to be slightly higher than Epi VFR at each 
tested [K+]o, the difference was not statistically significant. In 
the Isch group (blackin Fig. 4), the relationship between [K+]o 
and VFR was profoundly different from that in the HighK 
group. First, at each [K+]o, VFR in the Isch group was lower 
than the respective VFR in the HighK group. Second, in the 
Isch group, there was also a large and significant difference in 
the sensitivity of VFR to [K+]o between the Epi and Endo. 
Note that the average Epi VFR was much lower than the Endo 
VFR in the range of [K+]o between 6 and 9 mM. Also, 
uniquely among all groups, the average Epi VFR in the Isch 
group was very slow (<  1 Hz) starting from a concentration of 
[K+]o equal to 8 mM. This made a stark contrast with the
HighK group, in which at 8 mM [K+]o, Epi VFR was barely 
different from that observed at normal [K+]o.
The combination of hyperkalemia and KATP activation by 
cromakalim (HighK-Crom group; blue in Fig. 4) poorly repro­
duced the VFR-[K+]o relationship observed during ischemia. 
KATP activation caused a massive increase in VFR, which was 
maintained at all [K+]o between 4 and 11 mM, in contrast to 
VFR slowing observed in the Isch group. Even though in the 
HighK-Crom group there was a trend of slower VFR in the Epi 
than in the Endo, especially at [K+]o between 7 and 8 mM, the 
transmural VFR difference was not statistically significant.
Figure 4B shows the statistical summary of the relationship 
between [K+]o and the percentage of inexcitable LV locations
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[K+]0 (mM)
[K+]0 (mM)
Isch ENDO  
-A- Isch EPI
HighK E N D O  HighK-Crom ENDO
H ig h K E P I -A- H ighK-Crom EPI
Fig. 4. Statistical analysis of VFR (A) and the percentage of inexcitable sites 
(B) as functions of [K+]o in the Isch, HighK, and HighK-Crom groups (black, 
red, and blue, respectively). In each group, the Epi and Endo are represented 
by open triangles and filled squares, respectively. The insets in both A and B 
indicate relevant pairwise comparisons that yielded statistically significant 
difference (P < 0.05). The vertical brackets indicate differences between 
experimental groups in a given myocardial layer; the horizontal brackets 
indicate differences between the Endo and Epi in the same experimental group. 
A: VFR as the function of [K+]o. VFR in the Isch group was lower, whereas 
VFR in the HighK-Crom was higher, than VFR in the HighK group at all 
[K+]o between 4 and 11 mM. Transmural differences in VFR were statistically 
significant only in the Isch group. Note that hyperkalemia combined with KATP 
activation did not reproduce the [K+]o-VFR relationship observed during 
ischemia. B: percentage of inexcitable sites as a function of [K+]o. Note the 
difference between the Isch group and the two normoxic groups (HighK and 
HighK-Crom groups). In the Isch group, inexcitable sites appeared at relatively 
low [K+]o, and there was a large difference in the percentage of inexcitable 
sites between the Epi and Endo at intermediate levels of [K+]o. In contrast, 
both the HighK and HighK-Crom groups started to exhibit a loss of excitability 
only at [K+]o above 10 mM, and there was no transmural difference in the 
percentage of inexcitable sites. Note that the upper limit of excitability in all 
experimental groups and myocardial layers was at [K+]o —14—15 mM, a level 
consistent with the inactivation of fast Na+ channels, which are necessary to 
maintain propagation of cardiac impulse (30).
(VFR = 0) in all tested groups. Note that this information is 
somewhat related to the relationship between [K+]o and VFR 
shown in Fig. 4A, especially given the fact that sites with VFR = 0 
were included in the average VFR values shown in Fig. 4A . 
Yet, the results shown in Fig. 4B underscore the uniqueness of 
the ischemic data, especially in the Epi, in that during ischemic 
VF loss of excitability occurred at very modest levels of [K+]o.
Note that in the Epi, almost 50% of recorded locations were 
inexcitable at [K+]o as low as 6 mM. In contrast, both HighK 
and HighK-Crom groups showed a significant loss of excit­
ability only at [K+]o above 12 mM, thus approaching the 
canonical level of K+-induced inexcitability (30). It is of 
interest that KATP activation did not enhance the loss of 
excitability in the presence of hyperkalemia, despite the theo­
retical possibility of a synergistic relationship between these 
two factors with respect to electrical depression (30).
DISCUSSION
VF is a frequent cause of sudden cardiac arrest and, in 
combination with ensuing global myocardial ischemia, deter­
mines the context of cardiopulmonary resuscitation and other 
life-saving procedures. VF evolving in globally ischemic 
hearts (sometimes termed long-duration VF) is a highly dy­
namic process featuring progressive transmural dispersion of 
VFR (8, 34, 36), which, at least in part, reflects the transmu- 
rally heterogeneous increase in postrepolarization refractori­
ness (15, 34). This increase is unbounded and culminates in a 
complete loss of excitability first in the LV Epi and subse­
quently in the rest of the ventricles (32, 34). Total loss of 
excitability (asystole) is in many cases the early point of no 
return after out-of-hospital cardiac arrest. Regional inexcitabil­
ity can contribute to postreperfusion lethal arrhythmias (1), 
which is a major complication of cardiac arrest in the aftermath 
of successful defibrillation (33).
Despite the obvious significance of progressive electrical 
depression in the course of ischemic VF, little is known about 
the major determinants of this phenomenon. Shaw and Rudy 
(30) used a numeric model to analyze the relative roles of 
hyperkalemia, acidosis, and KATP activation in conduction 
failure during ischemia. In this study, elevation of [K+]o to 
— 14 mM was fully sufficient to cause conduction block. 
Acidosis did not have a significant additional effect, but a large 
degree of KATP activation (20% channel availability assuming 
an intracellular ATP concentration of 0.5 mM) lowered the 
threshold [K+]o necessary to cause conduction block from 14 
to 10 mM. From this, it would be reasonable to assume that 
elevated [K+]o and a massive activation of KATP channels are 
major determinants of electrical failure during ischemic VF.
Hyperkalemia. To the best of our knowledge, our study is 
the first to measure the progressive accumulation of [K+]o 
during ischemic VF. We found a larger K+ efflux in the Epi 
than in the Endo, but the difference was significant only in the 
late phase of ischemic VF (14-20 min). We can compare these 
results only to previous studies performed in nonfibrillating 
hearts. In an in situ canine model of regional ischemia (20, 21), 
there was no transmural difference in [K+]o, and the total K+ 
accumulation in the Epi and Endo during 20 min of left anterior 
descending coronary artery (LAD) occlusion was similar to 
that observed in the Endo after 20 min of ischemic VF in our 
study (—9-10 mM). In another study (7) using isolated blood- 
perfused canine hearts, [K+]o was measured in the regionally 
ischemic myocardium at a depth of 5 mm from the Epi surface 
during pacing at a normal heart rate. In that study, at the end of 
an 8-min LAD occlusion period, the level of [K+]o in the 
ischemic zone reached —8 mM, which was very close to both 
Endo and Epi values of [K+]o observed at the same duration of 
ischemia in our study (see Fig. 2B). Those authors also mea-
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sured the incidence of inexcitability as the percentage of 
unipolar electrograms exhibiting “monophasic” morphology 
and found that after 8 min of ischemia, only ~25% of record­
ing sites were inexcitable (see Fig. 5A in Ref. 7). In our case, 
the degree of inexcitability was drastically different between 
the Endo and Epi. Whereas in the Endo the percentage of 
inexcitable sites at 8 min of ischemia (28%) was similar to that 
observed by Coronel et al. (7) in the midmyocardium, in the 
Epi at the same time point of ischemia, it was much larger 
(63%). In stark contrast to ischemic conditions, raising [K+]o 
to the level of 8 mM during normal perfusion in our study 
never caused inexcitability in any layer of the LV wall, and 
even the effect with respect to VFR was minimal (see Fig. 4A). 
These results disagree with those obtained during ischemic VF 
in the isolated rabbit heart, where an elevation of [K+]o to 8 
mM in normoxemic hearts reproduced the decrease in VFR 
observed during ischemia (4). Apart from the differences in 
species, another important difference between the rabbit study 
and our study is the degree of ischemia, which was complete 
(no flow) in our experiments and was only partial (remaining 
flow at 15% of normal) in the study by Caldwell et al. (4).
Because Na+ channel inactivation occurs at more negative 
potentials in the Epi than in the Endo, even a transmurally 
uniform increase in [K+]o can cause differential electrical 
depression in the Epi and Endo, leading, in particular, to the 
inability of the Epi to follow a rapid rate of excitation waves 
coming from the Endo (6). If this effect were significant in our 
study, we would expect that uniform hyperkalemia due to an 
elevation of [K+]o in the perfusate would induce the transmural 
difference in VFR and/or the percentage of inexcitable sites. In 
fact, neither of these occurred in our study. Hyperkalemia in 
normoxemic hearts caused a transmurally uniform VFR de­
cline at [K+]o above 8 mM, culminating in a transmurally 
uniform loss of excitability when [K+]o exceeded 12-14 mM. 
Thus, it is unlikely that the differential properties of Na+ 
channel inactivation (6) contribute significantly to the trans­
mural differences in VFR and excitability observed during 
ischemic VF.
Katp channels. The timing, conditions, and electrophysio- 
logical consequences of KATP activation during real ischemia 
in intact hearts remain as controversial now as three decades 
ago, when the channel was first discovered (25). While the 
principal role of KATP channels in ischemic action potential 
duration shortening appears to be undisputable, its potential 
contribution to decreased membrane excitability and conduc­
tion failure during ischemia is far less clear. In their theoretical 
analysis of factors influencing conduction failure during early 
ischemia, Shaw and Rudy (30) concluded that the contribution 
of KATP activation to conduction failure is limited unless the 
degree of activation of this channel is very large, which would 
require intracellular ATP concentration to reach very low 
(submillimolar) levels, much below what is typically observed 
within the first 10-15 min of ischemia. However, since it is not 
possible to directly measure activation of KATP channels in 
intact tissues during ischemia, and because the regulation of 
this channel is dependent on a number of metabolites besides 
ATP, the possibility of any degree of KATP activation during 
early ischemia remains open. Akar et al. (1) asserted the role of 
KATP channel opening as the primary mechanism of ischemic 
inexcitability by an experimental demonstration of “metabolic 
sink block” resulting from KATP activation secondary to mito­
chondrial depolarization (1). Noteworthy, in isolated ventricu­
lar cardiomyocytes, complete loss of excitability can occur 
without any increase in [K+]o, provided that the KATP channel 
is sufficiently activated in response to mitochondrial depolar­
ization (1, 22).
Since hyperkalemia alone failed to reproduce the [K+]o- 
VFR relationship observed during ischemic VF, we tested the 
possibility that in the presence of a strong activation of KATP 
channels, the [K+]o-VFR relationship observed during nor- 
moxic VF would approach more closely the relationship ob­
served during ischemic VF. However, this was not the case. 
The KATP opener cromakalim caused a dramatic increase in 
VFR in the range of [K+]o between 5 and 10 mM, which was 
opposite to the effect of ischemia. Also, cromakalim did not 
decrease the critical [K+]o at which excitability is lost (it 
remained in the range of 12-14 mM). The concentration of 
cromakalim used in this study is expected to activate ~50% of 
the channels (24), which exceeds even what Shaw and Rudy 
(30) considered to be a result of extreme anoxia (20% of 
channels available). Yet even such an extreme level of KATP 
activation failed to cause VFR suppression or loss of excitabil­
ity up to [K+]o of 12 mM, the concentration at which ~40% of 
the Endo locations and ~80% of the Epi locations exhibited 
loss of activity during ischemic VF (see Fig. 4B). These 
observations speak against the principal role of KATP activation 
in electrical depression during ischemic VF, somewhat contra­
dicting the concept of metabolic sink block (1) and our own 
previous finding that the blockade of KATP channels by gly- 
benclamide slightly postponed VFR decline and the emergence 
of local and global inexcitability during ischemic VF (32). To 
reconcile these apparent discrepancies, we suggest that KATP 
activation does contribute to electrical depression during ischemic 
VF, but perhaps only in the presence of other ischemic factors 
yet to be established.
Possible additional factors. The Na+-activated K+ (KNa) 
channel could theoretically contribute to electrical depression 
in the course of ischemic VF. This channel has conductance 
even larger than that of KATP channels (35), and, thus, the 
consequences of its activation during ischemia could be similar 
to those of Katp  activation [i.e., sink block (1)]. The effects of 
KATP and KNa activation could be synergistic with respect to 
electrical depression. Even though the available experimental 
evidence speaks against functional expression of KNa channels 
in the sarcolemma of canine ventricular myocytes (28), one 
cannot exclude that the lack of functioning KNa channels in 
single canine myocytes is a consequence of the cell isolation 
procedure.
As Shaw and Rudy (29) pointed out, the ability of KATP 
channels to oppose the excitatory Na+ current depends very 
much on the driving force for K+ at the foot of the action 
potential, in other words, on the deviation of the resting 
potential (V-est) from the K+ equilibrium potential (EK). As­
suming, as they did, that during ischemia Vrest is close to EK 
(and therefore the magnitude of the KATP current to oppose the 
Na+ current is small), the effect of KATP activation on excit­
ability should be limited. The difference between Vrest and EK 
depends on the magnitude of inward leak currents present 
during diastole. Assuming that the ischemic K+ leak is due to 
an increased conductance through K+-selective channels (cur­
rently the most accepted theory), Carmeliet (5) postulated the 
necessity of a substantial inward leak to explain the presence of
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significant rate-independent K+ efflux, observed even after the 
cessation of electrical activity (14). Note that in our experi­
ments, Epi [K+]o continued to rise throughout 20 min of 
ischemia, even though the average Epi VFR was already close 
to zero at 10 min of ischemia (see Fig. 2). Whereas the Endo 
had a much higher VFR, the level of K+ accumulation was 
lower in the Endo than in the Epi, clearly indicating that the 
frequency of excitations did not influence the intensity of K+ 
efflux.
The extent to which Vrest during ischemia can deviate from 
Ek remains controversial. Kleber (14) showed that these two 
parameters, separated by 7 -8  mV under normal conditions, 
converge to within 1 mV after 6 -7  min of ischemia. However, 
an intriguing study by Blake et al. (3) suggests that in the 
ischemic canine heart, the relationship between Vrest and Ek is 
frequency dependent, such that in the presence of an increased 
excitation rate (180 vs. 90 beats/min), depolarization of Vrest 
significantly exceeds that predicted by the ischemic level of Ek. 
Clearly, these conditions are relevant to the case of ischemic VF, 
where the excitation rate is initially in excess of 300-400 
beats/min. Those authors showed that a Ca2+ infusion had a 
similar effect and that the two factors combined enhanced 
deviation of Vrest from Ek during ischemia. This suggests a 
possibility that the effect of rapid activations on Vrest during 
ischemia is mediated via an attendant increase in the intracel­
lular Ca2+ concentration. The depolarizing effects of metabolic 
inhibition on Vrest were observed in spontaneously beating 
chick embryo myocytes (11) and adult rat ventricular myocytes 
subjected to cyanide (2) but not in adult mammalian ventricular 
myocytes subjected to a mitochondrial uncoupler (1, 22). The 
mechanisms of depolarizing effects of metabolic stress that are 
not related to hyperkalemia remain largely unknown and war­
rant further studies.
Conclusions. This is the first study to measure [K+]o accu­
mulation during ischemic VF. Comparison with published data 
obtained in the same species suggests that the presence of VF 
during ischemia has little impact on the rate of K+ efflux 
compared with ischemia alone. Moreover, the higher level of 
[K+]o in the sub-Epi than in the sub-Endo, despite the opposite 
distribution of the VFR, further supports the relative indepen­
dence of ischemic K+ efflux from excitation rate.
This study tested, and rejected, the hypothesis that the VFR 
decline and loss of excitability during ischemic VF in the 
canine heart can be explained in terms of “canonical” factors of 
electrical depression, hyperkalemia and KATP activation, by 
showing a great disparity in the relationship between [K+]o and 
VFR in the absence of ischemia (with or without a KATP 
agonist), on the one hand, and the presence of ischemia, on the 
other hand. The alternative mechanisms of electrical depres­
sion during ischemic VF remain wide open for speculation but 
may include enhancement of inward leak currents, which could 
promote sarcolemmal depolarization beyond the level induced 
by extracellular K+ accumulation.
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CHAPTER 6
P-ADRENERGIC STIMULATION AND HIGH EXCITATION RATE 
MUTUALLY PROMOTE HETEROGENEOUS ELECTRICAL 
FAILURE AND VENTRICULAR FIBRILLATION IN THE 
GLOBALLY ISCHEMIC RABBIT HEART
6.1 Abstract
Ventricular fibrillation-induced sudden cardiac arrest (VF-SCA) is a leading killer in the 
U.S. Left untreated, VF-SCA is characterized by a progressive and heterogeneous decline in 
electrical activity culminating in asystole and death. The defining features of VF-SCA are high 
excitation rate and ischemia. In addition, due to current treatment guidelines combined with 
spontaneous release of catecholamines, P-adrenergic stimulation (P-AS) is greatly enhanced 
during VF-SCA. Taken together the combination of high excitation rate and P-AS could exacerbate 
metabolic challenge during ischemia leading to an increased propensity for recurrent arrhythmias 
and asystole, and is correlated with decreased survival probability. Here, I hypothesized that high 
excitation rate and P-AS would promote electrical failure and the effects would be synergistic. In 
addition, I hypothesized that the detrimental effects of P-AS and high excitation rate would be 
mediated by activation of ATP-sensitive K+ channels ( K a t p )  or Na+-sensitive K+ channels (KNa).
Thirty-one rabbit hearts were isolated on a Langendroff apparatus and subjected to 30 
minutes of global ischemia under six interventions whose parameters consisted of high (200 ms 
or tachy-pacing) or low (300 ms) pacing rate, presence or absence of the P-adrenergic agonist 
isoproterenol (Iso, 30 nM), and presence or absence of K+ channel blockers (10 ^M glybenclamide 
to block / ka t p  and 0.3 ^M R56865 to block /KNa). The groups were defined as 1) 300ms, 2) 200ms,
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3) 300ms_Iso, 4) 200ms_Is0, 5) 200ms_Is0_Glyb, and 6) 200ms_Is0_R56. All hearts were 
treated with the electromechanical uncoupler BDM (20 mM) and stained with the voltage 
sensitive fluorophore Di-4 ANEPPS. Optical mapping was performed on the anterior surface of 
the hearts and the signals were processed to obtain measurements of the maximum upstroke 
velocity of the APs (dV/dtmax), percent of excitable area (%Excitable), and APD at 80% 
repolarization (APD80).
I found that 200ms and 300ms_Is0 accelerated the rate of dV/dtmax decline, loss of 
excitability, and APD80 shortening in both the left (LV) and right (RV) ventricles during ischemia 
where 300_Is0 had a greater effect than 200ms in loss of excitability only. Furthermore, the 
combination of tachy-pacing and p-AS (200ms_Is0) exacerbated electrical decline in all three 
parameters compared to either intervention alone. Surprisingly, neither 200ms_Is0_Glyb nor 
200ms_Is0_Rg6 was able to rescue the detrimental effects of tachy-pacing and p-AS 
(200ms_Is0) when dV/dtmax and % excitable area were compared. Expectedly, 200ms_Is0_Glyb 
and 200ms_Is0_Rg6 both rescued APD80 shortening compared to 200ms_Is0 with 
200ms_Is0_Glyb having a larger rescuing effect and 200ms_Is0_Rg6 having an effect only in the 
RV. In addition to the detrimental effects on electrical failure, I found that both tachy-pacing and 
p-AS promoted the initiation of VF during ischemia and a strong correlation between the onset of 
electrical failure and VF (R2=0.76) was found.
I conclude that tachy-pacing and p-AS—individually and combined—promote electrical 
failure and induce the propensity for lethal arrhythmias. Furthermore, my results point to 
mechanism of arrhythmogenesis mediated primarily by the formation of reentrant substrate 
during ischemic heart disease rather than abnormal automaticity.
6.2 Introduction
Lethal ventricular tachyarrhythmias associated with acute myocardial ischemia remain 
one of the leading causes of death in developed countries [1-4]. Despite the long history of 
research and speculation, the exact mechanisms triggering such arrhythmias, and ventricular 
fibrillation (VF) in the first place, remain controversial. A  m ajor controversy is related to whether
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VF in the ischemic heart is triggered/maintained by mechanisms related to abnormal impulse 
formation, such as early and delayed afterdepolarizations (EADs and DADs), or abnormal 
impulse propagation (unidirectional conduction block leading to self-sustained reentry). Once 
induced, VF leads to cardiac arrest and global myocardial ischemia, in which a complex 
bidirectional relationship takes place, such that ischemia modulates the dynamics of fibrillatory 
waves [51], whereas the high excitation rate associated with VF may aggravate the metabolic 
challenge [80] and ionic disturbances [92] caused by ischemia. To a large extent, this complex 
relationship determines the ability of countershocks and cardiopulmonary resuscitation (CPR) to 
restore sinus rhythm and spontaneous circulation in the aftermath of VF-induced sudden cardiac 
arrest (VF-SCA).
A  prominent factor of myocardial ischemia and VF-SCA is a large increase in interstitial 
concentration of catecholamines [86, 93]. In particular, interstitial norepinephrine increased 
about a 7-fold during VF-SCA in an anesthetized pig, and progressed to over an ioo-fold increase 
after defibrillation and reperfusion mimicking life-saving procedures in out-of-hospital cardiac 
arrest [86]. It is well established that beta-adrenergic stimulation (p-AS) increases the incidence 
of VF in the context of myocardial ischemia. These effects were usually explained in terms of 
“non-reentrant” mechanisms (EADs and DADs) downstream of increased cellular Ca++ load, 
based on experiments in isolated cardiomyocytes partially reproducing ischemic conditions [94]. 
However, such implications have always been controversial, as in many studies a sufficiently 
“severe” simulated ischemia abolished DADs and EADs [94, 95]. While the possible effects on 
impulse propagation were postulated in terms of a “slow response” hypothesis (i.e., p-AS 
promotes extremely slow conduction driven exclusively by L-type Ca++ current against the 
backdrop of significant hyperkalemia [96], the relevance of this mechanism to the conditions of 
real ischemia have never been demonstrated. On a more general note, little is known with regard 
to the effect of p-AS on conduction in the context of real ischemia.
It was noted that the anti-arrhythmic effect of beta-blockade is more pronounced at an 
increased rate of excitations [97]. Of interest, it was shown that slowing the heart rate below the 
normal physiological level by ivabradine reduced the incidence of postreperfusion VF and also
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delayed the ischemia-induced slowing and block of conduction [98]. Both tachycardic rhythm and 
p-AS are likely to impose additional metabolic demand on the ischemic heart, and potentially 
aggravate ATP depletion. Activation of ATP-sensitive potassium channels ( K a t p )  was implicated in 
pro-arrhythmic heterogeneous APD shortening during ischemia [99], as well as in ischemic loss 
of excitability and postischemic VF presumably mediated by conduction failure (“metabolic sink 
block”) [82]. Theoretically, the sodium-sensitive potassium channel (KNa), which is also sensitive 
to [ATP] [75] may contribute to “metabolic sink block,” as this channel should be activated under 
conditions of ischemia and high excitation rate.
Based on the above, I hypothesized that an increased heart rate and p-AS may promote 
synergistically ischemic derangements of conduction and excitability, thus forming substrate for 
VF due to formation of reentrant pathways. I also hypothesized that these effects might be 
mediated via metabolically sensitive K+ channels. I used an isolated heart model of global 
ischemia, in which the propagation of electrical waves can be scrutinized using high resolution 
optical mapping and the relative effects of a high excitation rate and p-adrenergic stimulation on 
conduction can be dissected with relative ease.
My study offers a radically new mechanism linking beta-adrenergic stimulation and VF in 
the ischemic heart. I show, for the first time, that beta-adrenergic stimulation promotes, 
synergistically with tachy-pacing, highly heterogeneous electrical depression and conduction 
failure in the globally ischemic heart, which correlates in time with the onset of VF driven by 
reentrant circuits. This suggests that the proarrhythmic effect of p-AS in ischemic hearts may be 
mediated via abnormal conduction rather than abnormal automaticity. Unexpectedly, I found 
little or no role of metabolically sensitive K+ channels in electrical failure due to p-AS, negating a 
significant involvement of the metabolic sink block mechanism. I speculate that the observed 
synergism between high excitation rate and p-AS with respect to electrical depression may 
contribute to major adverse outcomes of VF-SCA, such as persistent/recurrent VF, pulseless 
electrical activity, and asystole. This provides further support to the idea that p-adrenergic 
blockade may be beneficial in the context of VF-SCA [86].
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6.3 Methods
This investigation conformed with the National Institutes of Health Guide fo r the Care 
and Use o f Laboratory Animals (8th Edition, 2011) and was approved by the Institutional Animal 
Care and Use Committee of the University of Utah (Protocols No. 12-09005 and 13-0005).
6.3.1 Langendorff-Purfused Rabbit Hearts
Adult New Zealand white rabbits of either sex (15 male and 16 female, weight 1.5 to 3.0 
kg) were euthanized by sodium pentobarbital (130 mg/kg, i.v.) and heparin (1 ml, 10,000 USP) 
was given to prevent clotting. Hearts were rapidly excised, cannulated on a Langendorff 
apparatus and perfused with Tyrode’s solution (130 mM NaCl, 24 mM NaHCO3, 1.2 mM 
NaH2PO4, 1.0 mM MgCL, 5.6 mM glucose, 4.0 mM KCl, 1.8 mM CaCL and 0.1 g/L albumin), 
gassed with an O2/CO2 mixture (adjusted to maintain pH at 7.4) at a fixed rate of 30 ml/min. The 
mitral valve was disrupted by inserting a drainage tube into the LV via a small cut in the left atrial 
appendage to prevent buildup of LV pressure due to venous efflux through Thebesian veins. 
Hearts were immersed in Tyrode’s superfusion solution and temperature in the right ventricular 
(RV) cavity and the superfusion solution was maintained at 37.0±0.5 °C. The volume-conducted 
ECG was monitored continuously throughout the protocol.
After 15 minutes of stabilization, the electromechanical uncoupler 2,3-Butanedione 2- 
monoxime (BDM, 20 mM, Sigma-Aldrich, St. Louis, USA) was administered and continued for 
the rest of the duration of the experiment. About 10 minutes before the ischemic episode, hearts 
were stained with a bolus of the voltage-sensitive dye di-4-ANEPES (3 ml of 10.4 ^M solution, 
Life Technologies, Carlsbad, CA, USA). Global ischemia was initiated by cessation of aortic 
perfusion and maintained for 30 minutes, followed by reperfusion. During global ischemia the 
temperature of the superfusate was maintained at 37.0±0.5 °C and the oxygen pressure in the 
superfusate was maintained at below ~40 mmHg by gassing the solution with a N2/CO2 gas 
mixture (adjusted to maintain pH at 7.4).
Pacing at either normal (CL = 300 ms) or fast (CL = 200 ms) rates (at 3 times end- 
diastolic excitation threshold) was performed using two pairs of Ag/AgCl plate electrodes
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(diameter, 3 mm) positioned at the endocardial and the epicardial surface of the lateral right 
ventricular (RV) and left ventricular (LV) free wall. The relatively large size of the pacing 
electrodes, the application of the current across the ventricular wall, and the relatively large 
amplitude of the stimulus ensured efficient capture during ischemia, when excitability was 
progressively diminished. Pacing was started 2-3 minutes before ischemia.
6.3.2Experimental groups
A  total of six experimental groups were used in this study. In the 300ms group (n= 5), 
which served as the control, the hearts were paced at a CL=300 ms and no drugs (except BDM) 
were used. In the 200ms group (n=5), the hearts were paced at a CL=200 ms. In the 300ms_Is0 
and 200ms_Is0 groups (n= 5 and 6, respectively), the hearts were paced at CLs of either 300 or 
200 ms in the presence of the p-adrenergic agonist isoproterenol (30 nM, Sigma-Aldrich, St. 
Louis, USA). In the 300ms_Is0_Glyb group (n= 5), the hearts were paced at a CL of 200 ms in 
the presence of p-adrenergic agonist isoproterenol (30 nM) and I ka t p  blocker glybenclamide (10 
^M, Sigma-Aldrich, St. Louis, MO, USA). Glybenclamide was administered 10 minutes before 
ischemia. In the 300ms_Is0_Rg6 group (n= 5), the hearts were paced at a CL of 200 ms in the 
presence of p-adrenergic agonist isoproterenol (30 nM) and IKNa blocker R56865 (0.3 ^M, 
courtesy of Johnson & Johnson Pharmaceutical Research & Development, L.L.C., New 
Brunswick, NJ, USA). R56865 was administered 30 minutes before ischemia.
6.3.3 Optical mapping
Hearts were fully immersed in Tyrode’s solution inside the imaging chamber to maintain 
the temperature at 37°C both during normoxic perfusion and no-flow ischemia. Optical mapping 
of changes in transmembrane voltage (optical action potential, OAP) was performed using an 
EMCCD camera (iXon DU-860D, Andor Technology, Belfast, UK) with a 6 mm objective lens, at a 
resolution of 64 X 64 pixels and frame interval of 2 ms. The voltage sensitive dye di-4-ANEPPS 
was excited by a 532 nm green solid-state laser (Coherent, Santa Clara, CA, USA). The imaging
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area was 3 x 3 cm encompassing the entire anterior view of the right and left ventricles (see 
Figure 2.2C in Chapter 2). Emitted fluorescence was collected using either a 640±40 nm or 
605±32 nm bandpass filter. Five-second long movies were acquired 2-3 minutes before ischemia, 
at each minute from 0 to 30 minutes of ischemia, and during 20 minutes of reperfusion 
(reperfusion movies were used only to check recovery of electrical activity). Data acquisition was 
performed using a custom software package (Alexey Zaitsev and Paul Venable) written in Java 
and using libraries from Micro-Manager open source microscopy software (Vale Lab, University 
of California in San-Francisco, USA) and NetBeans open source program development framework 
(netbeans.org, Oracle, Redwood City, CA, USA).
6.3.4 Data Processing and Analysis
The software program Scroll (Sergey Mironov, Center for Arrhythmia Research, 
University of Michigan, USA) was used for interactive analysis of movies and single pixel 
recordings, and also for manual selection of the mapped regions exclusive to RV and LV in each 
heart. All other analysis routines were written by Alexey Zaitsev using PV-WAVE software (Rogue 
Wave Software, Boulder, CO). I defined the area to the right of the LAD as RV and the area to the 
left of LAD as LV (Figure 2.2C Chapter 2). The optical recordings were background-subtracted, 
inverted and filtered in space and time as previously described [51]. The maximal time derivative 
of the OAP upstroke (dV/dtmax) was determined in each OAP of each single pixel recording in each 
movie. The average values of dV/dtmax in each pixel were corrected for the background 
fluorescence. Specifically, dV/dtmax in the brightest pixel (fluorescence level Fmax) remained 
unhanged, whereas in all other pixels the value of dV/dtmax was multiplied by the ratio of Fmax 
over F in the given pixel. This procedure compensated for the variation in dV/dtmax due to 
nonuniform illumination and staining as well as curvature of the heart that cause deviation from 
the focal plane. The corrected values of dV/dtmax were used to compute the average values for RV 
and LV and were plotted as a function of ischemia duration.
In order to detect the loss of excitability in individual locations in RV and LV, I applied a 
minimum dV/dtmax criterion. The criterion was selected by trial and error and was just above
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twice the level of the dF/dt of noise in the movies in which the full loss of excitability was 
undoubted, as was the case in all movies recorded in the 200ms_Iso group at 30 minutes of 
ischemia. All movies analyzed for this study were carefully inspected to ensure that the computed 
inexcitable areas matched reasonably well the visually observable areas lacking propagating 
waves. The percent of pixels with dV/dtmax values above the threshold (percent of excitable areas) 
was computed in the RV and the LV and plotted as the function of ischemia duration. Action 
potential duration was computed in OAPs at the level of 80% of repolarization (APD80). Average 
values of APD80 were computed for RV and LV and plotted as the function of ischemia duration. 
In experiments using isoproterenol a substantial motion artifact was present up to 3 minutes of 
ischemia despite the presence of BDM. This motion artifact had little effect on dV/dtmax but 
significantly distorted the measurement of APD80. In addition, in all but one experiments VF 
spontaneously occurred at some point in ischemia. APD80 was compared between different 
experimental groups only in the time window in which such comparison was valid. The lower 
limit of this window was 3 minutes of ischemia, and the upper limit was the latest time point in 
ischemia at which at least 3 hearts in each experimental group still maintained regular paced 
rhythm. This time point was 8 minutes of ischemia.
6.3.5 Statistical analysis 
The time course of dV/dtmax, percent of excitable area, and APD80 were compared using a 
two-way ANOVA with Tukey posthoc test for multiple comparisons. The statement of significant 
difference in this case meant the significant separation between curves not time points. The time 
at which 50% of the mapped region in RV or LV lost excitability and the time of VF initiation were 
compared between groups using a one-way ANOVA followed by Tukey posthoc test for multiple 




6.4.1 Tachypacing and p-AS Mutually Promote the Progressive 
Decline in dV/dtmax and the Emergence of Inexcitable Areas 
Figure 6.1 summarizes the statistical analysis of dV/dtmax and inexcitability data in four 
groups: 300ms, 200ms, 300ms_Iso and 200ms_Iso. All left-hand Panels describe RV, all right- 
hand panels describe LV. Panels A  and B show the time course of dV/dtmax during ischemia in RV 
and LV, respectively. One can see that in both chambers the slowest decline in dV/dtmax occurs in 
the 300ms group (control). In both chambers, the dV/dtmax decline in 200ms and 300ms_Iso 
groups is accelerated, by a similar degree, as compared to that in the 300ms group. This suggests 
that both tachycardia and p-AS, applied separately, promote electrical depression during 
ischemia. Lastly, the dV/dtmax decline is further accelerated in the 200ms_Iso group. The 
combination of tachycardia and p-AS led to a dramatic shift of the curve to the left as compared to 
the 300ms group (control). Among all the pairs formed out of the four groups shown in Figure 
6.1A-B, only the difference between 300ms_Iso and 200ms did not reach statistical significance.
Panels C and D of Figure 6.1 show the percent of excitable area as the function of 
ischemia duration in RV and LV, respectively. One can see that the overall relationship between 
the experimental groups is similar to that observed in the time course of dV/dtmax shown in Figure 
6.1A-B. Specifically, there was a progressively faster loss of excitable epicardial locations from 
300ms to 200ms to 300ms_Iso to 200ms_Iso groups. I can conclude that p-AS promotes 
inexcitability more than tachy-pacing.
Panels E and F of Figure 6.1 show the average time of ischemia at which 50% of the mapped 
area in the RV and LV, respectively, lost excitability. The data are derived from the graphs shown 
in Figure 6.1, C and D, respectively, and seems to be a convenient way to compress the time- 
dependence of excitability loss during ischemia. Note that in all of the 300ms experiments more 
than 50% of the RV remained excitable at 30 minutes of ischemia at which time the ischemic 
protocol was finished; this precluded an accurate estimate of the time at which the 50% loss in 
excitable sites in RV actually occurred. Because of this, the time of 50% loss in excitable sites in 
























Figure 6.1: The effects of excitation rate and p-AS on the progressive decline in dV/dtmax and 
percent excitability during ischemia. The right column shows data for RV and the left shows data 
for LV. A -B . normalized dV/dtmax vs. time of ischemia in 300ms (black), 200ms (red), 
300ms_Iso (blue), and 200ms_Iso (green) in the RV and LV, respectively. Both tachy-pacing and 
p-AS independently promote dV/dtmax deterioration during ischemia while the combination 
further increases the rate of AP upstroke decline. C -D . Percent of excitable tissue on the 
epicardial surface vs. the duration of ischemia in the RV and LV, respectively. Similar to the 
effects on dV/dtmax, tachy-pacing and p-AS independently promote electrical failure. The effects of 
p-AS are greater than tachy-pacing where the effect on dV/dtmax was not different between the two 
interventions. The combination of tachy-pacing and p-AS mutually promotes electrical failure. In 
panels A-D * indicates comparisons with p<0.05. E-F. Time to 50% inexcitability in the RV and 
LV, respectively. Note that the value for 300ms in RV was truncated to 30 minutes in some 
experiments hence biasing the comparisons against difference from other interventions. 
Nevertheless, in both the RV and LV tachy pacing tended to accelerate the time to 50% 
inexcitability in ischemia though it did not reach significance. Both 300ms_Iso and 200ms_Iso 
significantly reduced time to 50% inexcitability compared to 300ms (* p<0.05). The combination 
of tachy-pacing and p-AS also significantly reduced time to 50% inexcitability compared to both 
200ms and 300ms_Iso (+ and #, respectively, p<0.05).
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significance of the difference between 300ms and 200ms groups observable when the entire 
curves were compared (in Figures 6.1C and 6.1D) was no longer present when the time of 50% 
excitability loss is compared between these two groups (in Figures 6.1E and 6.1F). This is most 
likely due to reduced power of the test, because only one data point is used from each experiment, 
as opposed to over 30 time points used in the comparison of the entire curves. Nevertheless, the 
comparison of the time of 50% reduction in excitable area captures the main features of the 
phenomenon. Namely, it shows that in both chambers p-AS promotes the loss of excitability, 
which is further potentiated by tachycardia. Curiously, at least in the LV the effects of tachycardia 
and p-AS appear to be almost exactly additive (Figure 6.1F). Specifically, tachycardia (200ms vs. 
300ms) accelerates the loss of excitability by ~5 minutes, and p-AS (300ms_Is0 vs. 300ms) 
accelerates the loss of excitability by ~11 minutes. The acceleration induced by the combined 
intervention (200ms_Is0 vs. 300ms) is ~17 minutes, which is close to the sum of the effects 
induced by the individual interventions.
Figure 6.2 is redundant with Figure 6.1, but juxtaposes RV and LV curves in one graph, in 
order to highlight the interchamber differences in the development of electrical depression under 
various experimental conditions (300ms, 200ms, 300ms_Is0 and 200ms_Is0). Summarizing 
Figure 6.2, both the decline in dV/dtmax and the development of inexcitability occurs faster in LV 
than in RV in all of these groups. The difference in the time course of dV/dtmax in each 
experimental group is small, but statistically significant. Regarding the time course of the loss of 
excitability, it is significantly different between the RV and LV in the 200ms, 300ms_Is0 and 
200ms_Is0 groups, but not in the 300ms group. The latter observation is easily explained by the 
fact that most of the time both RV and LV are 100% excitable in this group (Figure 6.2B). If only 
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Figure 6.2: Effects of tachy-pacing and P-AS on the heterogeneous deterioration of electrical 
activity in the RV and LV. Shows the same data as in Figure 6.1 but grouped to compare RV and 
LV. A , C , E, G  present dV/dtmax data for all four groups and B , D, F, H present data for percent 
excitable area in all four groups. Note that an interchamber difference in time course is present in 
all groups in both dV/dtmax and % excitability (* p<0.05). In the 300ms group the difference 
between RV and LV was not significant when all time points were considered but was different 
during the last 5 minutes of ischemia. This can be explained by the fact that under conditions of 
the 300ms group inexcitability did not develop in either chamber until late in ischemia. Note that 
neither tachy-pacing, P-AS nor the combination appeared to modulate the interchamber 
difference in electrical failure wherein the LV experienced a higher rate of electrical decline than 
the RV.
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6.4.2 The Effects of Tachypacing and p-AS on APD Shortening 
and Electrical Failure During Ischemia
Despite the use of BDM, which almost completely removed motion artifact in 
isoproterenol-free hearts, the addition of isoproterenol substantially increased contraction and 
significantly distorted the repolarization phase of the optical action potentials in normoxemic 
hearts. In all groups the magnitude of motion artifact subsided during ischemia due to ischemic 
contraction failure. After careful inspection, I judged that after 3 minutes of ischemia (inclusive) 
the motion artifact was sufficiently suppressed by BDM in all groups. The upper limit of the 
ischemic time window during which the APD measurement was meaningful was determined by 
the onset of VF occurring in close to 100% of experiments, but at different time points in different 
groups (see below). The latest time in ischemia for APD measurement was determined as the time 
point at which at least 3 hearts in each experimental group were still free of VF, and this time 
point was 8 minutes of ischemia. Thus, the comparisons of APD between different groups were 
carried out for the time window between 3 and 8 minutes of ischemia. On the other hand, the 
comparisons between the RV and LV in individual groups were carried out taking into account all 
ischemic time points at which regular paced rhythm was maintained in that particular group (see 
Figure 6.3, C-F).
Figure 6.3 summarizes the statistical analysis of APD in four groups: 300ms, 200ms, 
300ms_Iso and 200ms_Iso. Panels A  and B show the time course of APD80 during ischemia in 
the RV and LV, respectively. As mentioned above, in each group the measurements were 
performed for all ischemic time points at which at least 3 hearts remained in regular paced 
rhythm. So, indirectly, Figure 6.3 conveys the information that the onset of VF occurred at very 
different time points in different groups (earliest in the 200ms_Iso group and latest in the 300ms 
group, see more below). The two vertical dashed lines indicate the time window (3-8 minutes of 
ischemia) during which the comparison between groups was performed. One can see that both 
pacing rate and p-AS affected APD dynamics during ischemia. Assuming that at 3 minutes of 
ischemia (the earliest point of measurement) the APD values were not far from the preischemic 
values, it can be see that p-AS caused a large decrease in APD at the higher pacing rate.
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Figure 6.3: The effects of tachy-pacing and p-AS on APD80 during ischemia. Note 0 to 3 minutes 
of APD80 data are not shown due to motion artifact in the optical signal in isoproterenol treated 
groups; furthermore, curves continue only as long as three hearts in each group did not 
experience VF (see methods for details). Also note that intergroup comparisons were only made 
for the time points in which at least three hearts were available for comparison in each group, 
specifically 3 to 8 minutes. Comparisons between chambers were made for all time points with an 
n of at least 3 without the occurrence of VF in each group. A -B . APD80 vs. duration of ischemia in 
the RV and LV, respectively. The relationship between treatment groups is similar in the RV and 
LV. Both tachy-pacing and p-AS significantly shorten APD80 at all time points between 3 to 8 
minutes and the combination of tachy-pacing and p-AS exacerbates APD80 shortening further. It 
is indirectly apparent from this graph that tachy-pacing and p-AS independently and combined 
tend to accelerate the occurrence of VF during ischemia. C -F . The interchamber difference in 
APD80 is significant only in the 300ms and 200ms groups. Suggesting that p-AS diminishes 
interchamber differences in APD80 shortening. It can also be seen that in all groups VF appears to 
occur at an APD80 around 35 to 70 ms; yet, in 300ms APD80 remains at this shortened duration 
for several minutes. This suggests that APD80 shortening may be a contributor to VF induction 
during ischemia but is not the primary mechanism. Asterisks denote comparisons with p<0.05.
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It also seems that the speed of APD shortening during ischemia is the fastest when 
tachycardia and p-AS are combined (green curves in Figure 6.3). It is of interest then that in the 
LV the shortest values of APD80 measured in all groups before the onset of VF were similar 
(between 35 and 70 ms). However, note that in 300ms group (black triangles in Figure 6.3B) 
APD80 stayed around the minimal value for at lest 6 minutes without initiation of VF. Thus, the 
short APD in the LV may be a necessary, but probably not sufficient condition of VF initiation. In 
the RV, the APD80 values measured before the onset of VF was very different among the different 
experimental groups (see Figure 6.3A). In both chambers, the APD80 time course was significantly 
different in all pairwise comparisons between groups with the exception of the comparison 
between 200ms and 300ms_Iso, which did not yield statistical significance.
Panels C to F of Figure 6.3 show the same APD80 curves as in Panels A  and B, but 
rearranged to highlight the difference between the RV and LV in each group (300ms, 200ms, 
300ms_Iso and 200ms_Iso, respectively). One can see that a large RV-to-LV APD80 gradient 
develops in the 300ms group starting from 7 minutes of ischemia (Figure 6.3C). In the 200ms 
group, an APD80 gradient of the same direction develops earlier, starting from 4-5 minutes of 
ischemia, but is smaller in magnitude (Figure 6.3D). p-AS decreased the magnitude of the APD80 
gradient at both pacing frequencies (Figure 6.3, E-F), and almost fully eliminated it in the 
200ms_Iso group. The right-to-left APD80 gradient was statistically significant in the 300ms and 
200ms groups, but not in the 300ms_Iso and 200ms_Iso groups.
6.4.3 Role of K a t p  and KNa in Electrical Depression Produced by the 
Combination of Tachy-Pacing and p-AS During Ischemia 
The data presented above indicate that the combination of tachy-pacing and p-AS during 
ischemia had mutually potentiating effects in terms of aggravated electrical depression and APD 
shortening. Both of these effects could be mediated by activation of K a t p  channels, perhaps due to 
enhanced metabolic demand and accelerated ATP depletion under the double challenge of anoxia 
and increased work of ionic pumps [98]. The possible role of K a t p  channels in electrical failure 
during ischemia can be due to enhanced extracellular K+ accumulation and/or due to the
106
enhanced sink for the excitatory current leading to source-sink mismatch and conduction failure 
(so called metabolic sink block [82]. KNa is another metabolically sensitive channel that might 
play a role under conditions of ischemia and tachycardia (see more in Discussion). Therefore, I 
performed experiments in which I applied a K a t p  channel blocker glybenclamide (10 ^M, 
200ms_Iso_Glyb group) or KNa blocker R56865 (0.3 ^M, 200ms_Iso_R56 group). The results of 
these tests are shown in Figures 6.4, 6.5 and 6.6. Note that the data from the 200ms_/so group 
shown in Figures 6.4, 6.5 and 6.6 is the same as shown in Figures 6.1, 6.2, and 6.3. Since the K+ 
channel blockers were used only against 200ms_/so group, I deemed is was easier to understand 
the data if the analysis of the interaction between tachy-pacing and P-AS was presented separately 
from the analysis of the KATP and KNa role in electrophysiological alterations caused by the 
combination of tachy-pacing and P-AS.
Figure 6.4 shows the result of the statistical analysis of dV/dtmax and inexcitability data in
3 groups: 200ms_Iso, 200ms_Iso_Glyb and 200ms_Iso_R56. The layout of this figure is the 
same as in Figure 6.1. All left-hand Panels describe RV, all right-hand Panels describe LV. Panels 
A  and B of Figure 6.4 show the time course of dV/dtmax during ischemia in RV and LV, 
respectively. One can see that in both chambers blockade of KATP by glybenclamide had no effect 
on the dynamics of the dV/dtmax during ischemia. Rather unexpectedly, R56865 accelerated 
dV/dtmax decline during ischemia in both chambers; this effect, however, was statistically 
significant only in the RV.
Panels C and D of Figure 6.4 show the percent of excitable area as the function of 
ischemia duration in RV and LV, respectively. One can see that the overall relationship between 
the experimental groups is similar to that observed in the time course of dV/dtmax shown in Figure 
6.4, A-B. However, perhaps due to the threshold nature of excitability loss, the difference between 
groups is augmented. As a result, some effect of KATP in terms of postponing the loss of excitability 
becomes apparent in the RV (see the separation between the green and the pink curves in Figure 
6.4C), but the difference between 200ms_Iso and 200ms_Iso_Glyb still does not reach statistical 
significance. In the LV, the effect of KATP with respect to development of inexcitability is fully 


































Figure 6.4: Do K a t p  and KNa activation contribute to the detrimental effects of combined tachy- 
pacing and p-AS during ischemia? A -B . Effects of K a t p  and KNa blockade on dV/dtmax during 
ischemia in the RV and LV, respectively. 200ms_Iso_R56 accelerates deterioration of AP 
upstroke compared to 200ms_Iso in the RV (p<0.05). C -D . Percent excitability is left shifted in 
200ms_Iso_R56 compared to 200ms_Iso and 200ms_Iso_Glyb in both the RV and LV 
(p<0.05). E-F. Time to 50% inexcitability in each group for the RV and LV, respectively. Time to 
50% inexcitability is shortened in 200ms_Iso_R56 compared to 200ms_Iso_Glyb (* p<0.05). 
K a t p  blockade appears to play little or no role in mediating the accelerated electrical failure due to 
tachy-pacing and p-AS during ischemia. Surprisingly, KNa blockade with R56865 further 
accelerated electrical failure compared to tachy-pacing and p-AS. The effects of R56865 may be 
explained by its effect on INa, which would exacerbate source-sink mismatch and promote 
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Figure 6.5. Role of K a t p  and KNa in the interchamber difference in time course of electrical failure 
during ischemia. Shows the same data presented in Figure 6.4 but arranged to compare RV and 
LV. A , C , E show dV/dtmax vs. duration of ischemia. B , D , F show % excitable area vs. duration of 
ischemia. Interchamber differences are significantly different in all groups for both % excitable 
area and dV/dtmax except in 200ms_Iso_R56 where dV/dtmax does not reach significant 
difference. Overall, K a t p  and KNa appear not to be a significant factor in determining interchamber 
differences. The lack of significant difference in 200ms_Iso_R56 dV/dtmax between the RV and 
LV is likely due to the significant depressant effect compared to 200_Iso, which was limited to the 
RV thus diminishing the difference between RV and LV. This may be due to differential functional 
expression of KNa or Na+ channels between the RV and LV.
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Figure 6.6: Do K a t p  and KNa contribute to the shortening effects of tacy-pacing and p-AS on APD80 
during ischemia? Intergroup comparisons were limited from 3 minutes since motion artifact 
contaminated the first 2 minutes of APD80 measurements in isoproterenol treated hearts and 8 
minutes since VF occurred in a large number of hearts after this time point (see text for details). 
A -B . Comparison of APD80 vs. duration of ischemia in 200ms_Is0, 200ms_Is0_Rg6, and 
200ms_Is0_Glyb groups (* p<0.05). Notice that both R56865 and glybenclamide rescue APD80 
shortening, and the rate of shortening, compared to 200ms_Is0. Furthermore, in C -E  APD80 in 
the RV vs. the LV is only significantly different in the R56865 treated groups. These findings 
suggests that 1) both K a t p  and KNa are being blocked by these interventions and 2) the effect of KNa 
blockade is larger in the RV than in the LV. The second observation points again to the presence 
of differential functional expression of KNa between the RV and LV. Also note that, indirectly, 
these plots suggest that prevention of APD80 shortening by glybenclamide and R56865 does not 
delay the occurrence of VF (see Section 6.4.5 for details).
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terms of the accelerated development of inexcitability, which appears to be larger in the RV. In 
fact, the fraction of excitable area as a function of time is significantly different in the 
200ms_Is0_Rg6 group as compared to both the 200ms_Is0 and 200ms_Is0_Glyb groups.
Panels E and F of Figure 6.4 show the average time of ischemia at which 50% of the 
mapped area in RV and LV, respectively, lost excitability. The data are derived from the graphs 
shown in Figure 6.4, C and D. As mentioned in relation to Figure 6.1 above, the power of the 
ANOVA test involving only the time points of 50% loss of excitability is less than the power of the 
test comparing all the time points. As a result, only the difference between the 200ms_Is0_Rg6 
and 200ms_Is0_Glyb groups is statistically significant. This is probably due to the fact that the
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(weak) effect of glybenclamide is opposite to that of R56865, and the small addition to the 
contrast provided by glybenclamide is just sufficient to reach statistical significance.
Figure 6.5 is redundant with Figure 6.4, but juxtaposes RV and LV curves in one graph, in 
order to highlight the interchamber differences in the development of electrical depression in 
three experimental groups (200ms_Iso, 200ms_Iso_Glyb and 200ms_Iso_R56). Summarizing 
Figure 6.5, in all three groups the electrical depression occurred earlier in the LV than in the RV. 
Glybenclamide apparently slightly increased the difference between the RV and the LV, whereas 
R56865 did not seem to have any effect.
It should be noted that R56865 has blocking effect with respect to the sodium channel 
[100-102], which may confound the interpretation of the findings of this study. This issue will be 
fully addressed in the Discussion taking also into account the APD data shown in Figure 6.6 
below. In any event, the data shown in Figures 6.4 and 6.5 suggests that K a t p  channels make little 
or no contribution to the aggravated electrical depression caused by the combination of 
tachycardia and P-AS.
6.4.4 Role of K a t p  and KNa in APD Shortening Produced by the 
Combination of Tachy-Pacing and P-AS During Ischemia 
Figure 6.6 summarizes the statistical analysis of APD in three groups: 200ms_Iso, 
200ms_Iso_Glyb, and 200ms_Iso_R56. Panels A  and B show the time course of APD80 during 
ischemia in RV and LV, respectively. The two vertical dashed lines indicate the time window (3-8 
minutes of ischemia) during which the comparison between groups was performed. It can be seen 
that in the 200ms_Iso group (green) APD80 quickly declines during ischemia in both chambers, at 
a similar rate. Blockade of K a t p  channels with glybenclamide (200ms_Iso_Glyb group, pink) 
dramatically slows down the APD80 decline in both chambers between 3 and 9 minutes of 
ischemia. The effect of R56865 appears to be different in the RV vs. the LV. Namely, in the RV 
there was a large and statistically significant difference between the 200ms_Iso and 
200ms_Iso_R56 groups at all time points between 3 and 8 minutes of ischemia (measurements 
later in ischemia were precluded due to the onset of VF). In contrast, in the LV the difference
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between 200ms_Iso and 200ms_Iso_R56 groups was minimal between 3 and 7 minutes of 
ischemia, and only increased at the 8th minute of ischemia (see Figure 6.6B). It is unlikely that 
this “last minute” change in the R56865 effect is indicative of an increased KNa role at the 8th 
minute of ischemia. It is more likely that at this point slowing of the upstroke of the OAP due to 
electrical depression started to contribute to the APD leading to APD prolongation. In fact, this 
effect could have explained the plateauing or even the increase in APD80, which occurred right 
before the onset of VF at least in one chamber in each group. In particular, this phenomenon was 
observed in the 300ms group (RV and LV, see Figure 6.3C), 200ms group (RV, see Figure 6.3D), 
200ms_Iso group (LV, see Figure 6.3B), 200ms_Iso_Glyb (RV and LV, see Figure 6.6D), and 
200ms_Iso_R56 (LV, see Figure 6.6B).
Panels C to F of Figure 6.6 show the same APD80 curves as in Panels A  and B, but 
rearranged to highlight the difference between the RV and LV in each group (200ms_Iso, 
200ms_Iso_Glyb and 200ms_Iso_R56, respectively). One can see that in the 200ms_Iso group 
the right-to-left gradient is very small and not statistically significant. Glybenclamide tends to 
increase the gradient, yet it remains not statistically significant. Finally, R56865 significantly 
increases the difference in APD80 between the RV and the LV.
In summary, KATP channels appear to contribute significantly to the progressive APD 
shortening under the combined conditions of ischemia, tachycardia and P-AS in both ventricular 
chambers, whereas KNa contributes significantly only in the RV, increasing the interchamber 
difference in APD80.
6.4.5 The Relationship Between VF Initiation and Electrical 
Depression Under Different Experimental Conditions 
In my experimental model VF occurred during ischemia in all groups with almost 100% 
probability. The exception was: one heart in the 200_Iso_R56 group. Overall, the conditions that 
accelerated electrical depression also promoted earlier initiation of VF. Figure 6.7 shows the time 
at which VF started in all experimental groups. One can see that both tachycardia (200ms group) 
and P-AS (300ms_Iso group) applied individually significantly shortened the time to VF as
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Figure 6.7: Time to spontaneous induction of VF in all six interventions. Note that comparisons 
with glybenclamide and R56865 were only made between groups with both tachy-pacing and p­
AS (namely, 200ms_Iso, 200ms_Iso_R56, and 200ms_Iso_Glyb). Symbols indicate differences 
at p<0.05 from 300ms (*), 300Iso (+), and 200ms_Iso_R56 (#). Both tachy pacing and p-AS, 
individually and combined accelerated the time to spontaneous VF induction compared to 
300ms. R56865 significantly accelerated the time to VF compared to both 200ms_Iso and 
200ms_Iso_Glyb. W hile glybenclamide treatment slightly delayed VF onset it did not reach 
significance. This may be due to the significant delay in APD80 shortening as a result of treatment 
suggesting that while APD80 may not be the primary predictor of VF onset, it may be a 
contributor.
compared to the control (300ms group). The combination of tachycardia and p-AS group) 
shortened the time to VF even more. Glybenclamide (200ms_Iso_Glyb group) was unable to 
antagonize the VF-promoting effect of the tachycardia/p-AS combination, and R56865 
(200ms_Iso_R56 group) further shortened the time to VF during ischemia.
I tested the relationship between electrical depression in the LV (which occurred earlier 
than in the RV under all conditions, see Figures 6.2 and 6.5) and VF initiation. In Figure 6.8, I 
plotted the time of VF initiation vs. the time at which 10% of the mapped region of LV became 
inexcitable. One can see the emergence of LV inexcitable regions is strongly correlated with the 
time of VF onset when all the groups are pooled together (R2=0.76, p<0.00i). It is of interest that 
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Figure 6.8: Local electrical failure as a predictor of spontaneous VF induction. Time to 10% 
inexcitability appears to be highly predictive of the time to spontaneous VF induction R2=0.76. 
The most significant deviation comes from three hearts in the 200ms group where VF occurs 
before inexcitability. This large separation within a single group is reminiscent of the dichotomy 
in the timing of asystole observed in canine hearts under VF, global ischemia, and the absence of 
isoproterenol [80]. The separation in time to VF in the 200ms group suggests the existence of a 
bifurcation point in the stress response to tachy-pacing under ischemia. Mechanisms mediating 
this bifurcation may be important in understanding the mechanism of VF induction.
6.5 Discussion
The major findings of this study can be summarized as follows. To my knowledge, this is 
the first study to show the depressant effect of p-AS on conduction and excitability in the ischemic 
myocardium. Moreover, this effect was potentiated by tachycardia and also correlated with the 
initiation of ischemic VF. Lastly, the mutual depressant effect of p-AS and tachycardia on 
conduction and excitability was not antagonized by the K a t p  channel blocker glybenclamide 
(despite a large effect with respect to the APD) and was promoted by the (nonselective) KNa 
blocker R56865; which was unexpected considering both rate and p-AS would theoretically 
increase Na+ influx and accumulation during ischemia. The unexpected outcome, however, may 
be explained by the off-target effects of R56865, most importantly by the blocking effect with 
respect to the fast sodium channel which is potentiated at depolarized potentials [102] expected
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during ischemia. Despite these nonselective effects of R56865 I likely observed a substantial effect 
on IKNa as evidenced by decreased APD shortening compared to tachy-pacing and P-AS at least in 
the RV (see Figure 6.6A and B).
6.5.1 Relevant Effects of P-AS on Ion Channels 
in the Ischemic Myocardium
Myocardial ischemia is associated with large increases in the interstitial levels of 
epinephrine and norepinephrine. These increases are independent of plasma catecholamines. The 
excessively high local norepinephrine concentrations are combined with an enhanced 
responsiveness of the myocyte to catecholamines. According to Schomig et al., myocardial 
ischemia of 15 minute duration may result in a 100-fold increase in the interstitial catecholamine 
concentrations, a 2-fold increase in functionally coupled a-adrenoceptor, and a 30% increase in P- 
adrenoceptors [93]. In the study involving a porcine model of VF-SCA, interstitial 
norepinephrine increased 6-fold during VF, and progressed to an over 100-fold increase after 
defibrillation and reperfusion mimicking life-saving procedures in out-of-hospital SCA [86].
As reviewed by Carmeliet [103], P-AS results in stimulation of a number of ionic currents, 
whereas only a few are reduced. Kindly referring the interested reader to the full review [103], I 
postulate here that the most relevant affected currents are the fast Na+ current, the slowly 
activating delayed-rectifier K+ current ( I ks) ,  the L-type Ca++ current (Ioa,L) and K a t p . It was shown 
that both Na+ channel conductance and voltage-dependent availability curves are significantly 
shifted in the hyperpolarized direction by isoproterenol, the effect mediated by cAMP-dependent 
phosphorylation [104]. In depolarized cells during early ischemia the negative shift of the 
inactivation curve could add to the inhibition of the Na+ current, with concomitant reduction in 
dV/dtmax and slowing/block of conduction. However, in another study a (slight) inhibitory effect 
of isoproterenol with respect to INa at depolarized potentials could be observed only at 
unphysiologically high concentration of 1 ^M [105], 30 times higher that the concentration used 
in this study. Thus, it remains uncertain whether this mechanism made a significant contribution 
to the acceleration of electrical depression and inexcitability induced by P-AS in my study.
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IKs could potentially contribute to the accentuated electrical depression caused by the 
combination p-AS and tachycardia in my study because this current is enhanced by p-AS and also 
accumulates at higher excitation rates [106]. Thus, the significant presence of this current at the 
beginning of the action potential could increase the electrical sink and cause source-sink 
mismatch similar to the proposed role of K a t p  [82]. However, this assumption remains highly 
speculative, as I found nothing in the literature pointing to such a possibility. However, I ks is 
likely to contribute to the enhanced APD shortening caused by p-AS in my study (see Figure 6.3).
p-AS increases peak Ica,L and slows inactivation, both effects leading to an increased Ca++ 
loading of cardiomyocytes. In addition, p-AS upregulates Ca++ uptake into the sarcoplasmic 
reticulum (SR), increases SR Ca++ content, Ca++-induced SR C++ a release, and the amplitude of 
the intracellular Ca++ transient [103]. The effects of p-AS with respect to ICa,L gating clearly cannot 
explain either the decreased excitability and electrical failure, or the APD shortening observed in 
this study. However, increased peak ICa,L and prolonged sustained current can contribute to 
arrhythmias mediated by EADs, whereas increased SR Ca++ loading and SR Ca++ release can 
contribute to arrhythmias mediated by DADs (the proarrhythmic mechanisms of p-AS in the 
ischemic heart are discussed further below).
p-AS can enhance activation of IKATP, most likely indirectly, as a result of ATP depletion 
due to ATP consumption by a stimulated Na+-K+ pump, by enhanced cAMP synthesis (see 
Carmeliet in [103] and possibly by Ca++ pumps. I observed a dramatic shortening of APD in the 
presence of p-AS stimulation during ischemia at both pacing rates, but especially at the higher 
rate (CL=200ms, see Figure 6.3). Based on my data, K a t p  was responsible for about 50% of APD 
reduction occurring in 200ms_Iso group between 3 and 8 minutes of ischemia (see Figure 2.2A).
6.5.2 p-AS and Electrical Depression During Myocardial Ischemia 
My study revealed a depressant effect of p-AS on conduction and excitability in ischemic 
myocardium. Of interest, the depressant effect of p-AS was additive (if not synergistic) to that of 
the increase in pacing rate, but the effect of p-AS as compared to the effect of the decrease in cycle 
length from 300 to 200 ms appeared to be stronger. For example, in the LV the increase in pacing
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rate decreased the time to 50% of inexcitability by approximately 5.5 minutes, whereas p-AS 
without increase in the pacing rate decreased the time to 50% of inexcitability by approximately 11 
minutes. The two interventions combined decreased the time to 50% of inexcitability by ~17 
minutes, which is almost exactly the sum of the effects of individual interventions (see Figure 
6.1F). The pattern of electrical depression was highly nonuniform but with a similar pattern in all 
groups, such that LV experienced earlier depression than RV. I previously observed a similar 
pattern of nonuniform electrical depression in the epicardium of the RV and the LV of globally 
ischemic, fibrillating canine hearts [51]. The nonuniform electrical depression was first 
manifested as local slowing in VF rate (VFR), which eventually progressed to full loss of 
excitability in some regions while adjacent regions still maintained fibrillatory activity (see Figure 
1.5) [51]. In the present study I analyzed the dV/dtmax as the index of local excitability. dV/dtmax 
reflects primarily the availability of Na+ channels [103], but in the syncytium depends also on the 
source-sink relationship, so that a decreased sink (e.g., due to partial cellular uncoupling) may 
cause an increase in dV/dtmax [107]. The canonical mechanism for reduction in Na+ channel 
availability and dV/dtmax, as well as the complete loss of excitability during ischemia is the 
increase in the extracellular level of [K+] [79, 108]. However, in my previous study I showed that 
the level of [K+]o actually attained in the globally ischemic fibrillating canine heart is too low to 
explain the observed degree of electrical depression and inexcitability [92]. Also, the depressant 
effect of isoproterenol observed in this study is difficult to explain in terms of accelerated [K+]o 
elevation, since this beta-agonist was previously shown to reduce [K+]o during global ischemia 
[109]. Also, the blockade of KATP, one of the major sources of ischemic K+ leak by glybenclamide, 
had virtually no effect on the electrical depression, speaking against the primary role of [K+]o in 
this phenomenon.
A  mechanism which could explain the synergism in the effect of p-AS and tachy-pacing 
with regard to the depression of excitability is the potential presence of a transient inward leak 
current (Iti) which is suggested in Carmiliet’s comprehensive review [103] and demonstrated in 
isolated myocytes by Clusin et al. [110]. In essence, a small inward leak current would depolarize 
the resting membrane potential (Vrest) away from the K+ reversal potential (Ek). Such a current
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would simultaneously reduce source current through INa inactivaiton and increase sink currents 
through increased K+ driving force. The combination would lead to source-sink mismatch and 
hence electrical failure. Clusin points to the likely role of the Na+-Ca++ exchange as the molecular 
identity since I ti is abolished by low extracellular Na+ or Ca++.
6.5.3 P-AS and Ischemic Arrhythmias
It is well established that P-AS increases incidence of VF in the context of myocardial 
ischemia and infarction and that P-adrenergic receptor antagonists reduce the incidence of 
ischemic arrhythmias and sudden cardiac death [93, 97, 103, 111, 112]. The proarrhythmic effects 
of P-AS are usually explained in terms of “nonreentrant” mechanisms (EADs and DADs) 
downstream of increased Ioa,L and/or prolonged APD, or increased SR Ca++ load and/or 
spontaneous SR Ca++ release (for the sake of space, I will not discuss these diverse mechanisms in 
more detail here) [94, 112-116]. It should be noted, however, that when it comes to ischemic 
conditions, the evidence that EADs or DADs are responsible for arrhythmogenesis mediated by P­
AS is limited and controversial. Essentially, the promotion of EADs and DADs by P-AS was 
observed only under conditions of hypoxia [94, 114], which poorly represents real ischemia since 
at least two critical factors (KATP activation and hyperkalemia) are absent. More ”severe” ischemic 
conditions, including hyperkalemia and a relatively complete metabolic inhibition (causing KATP 
activation) abolish EADs and DADs [94, 95]. While the possible effects of P-AS on impulse 
propagation in ischemic myocardium were postulated in terms of a “slow response” hypothesis 
(i.e., P-adrenergic stimulation promotes extremely slow conduction driven exclusively by L-type 
Ca++ current against the backdrop of significant hyperkalemia [96], the relevance of this 
mechanism to the conditions of real ischemia has never been demonstrated. One potential flaw of 
this hypothesis would be whether the diastolic Ca++ accumulation known to occur during 
ischemia [103] would cause sufficient Ca++ dependent inactivation of ICa,L to prevent the slow 
response.
Thus, a careful analysis of the literature leaves us with a relative vacuum regarding the 
mechanisms that explain the proarrhythmic effects of P-AS in the context of acute but complete
118
myocardial ischemia. The observation of the temporal correlation between the initiation of 
ischemic VF and the emergence of inexcitable regions (see Figure 6.1) may help to fill this void by 
offering a mechanism for VF initiation (and possibly reinitiation after defibrillation shock) which 
is due to a highly heterogeneous electrical depression and conduction block, possibly downstream 
of increased intracellular Ca++ load and activation of a depolarizing current formerly associated 
with the entity of Iti [110].
6.5.4 Relevance to the outcomes of VF-SCA 
While the precise mechanism for the enhanced electrical failure due to p-AS is unclear, 
the findings of this study confirm the conclusion in the recently published retrospective analyses 
on clinical epinephrine use (an a- and p-adrenergic agonist) [42-44]. These studies have found 
that while epinephrine appears to improve return of spontaneous circulation (ROSC) during 
resuscitation long-term survival to hospital discharge is decreased compared to patients not 
treated with epinephrine. Presumably, epinephrine treatment enhances ROSC through increased 
inotropy promoting blood flow and hence reperfusion. Indeed, as I observed isoproterenol 
treatment enhanced contraction sufficiently to counteract the effects of BDM leading to 
significant motion artifact in the initial few minutes of my ischemic protocol (see Methods Section 
6.3.4). Given that a major concern postresuscitation is recurrent disrhythmias and 
hemodynamics problems [117], I can speculate that epinephrine treatment may exacerbate these 
rhythm disorders leading to decreased long-term survival. Another consideration is whether or 
not accelerated electrical failure can lead to increased myocardial death following reperfusion. 
This is a topic currently under investigation [128]. The overall conclusion for clinical treatment of 




Decreasing mortality from VF-SCA is a complex and multifaceted problem. The 
complexity is made more evident to the reader through the studies contained in the preceding 
chapters. The entire work described herein is dedicated to the single detail of electrical failure in 
VF-SCA and does not even touch upon contractile failure, metabolomics deterioration, cell death, 
or the process of resuscitation. Despite the limited scope, the body of work contained in this 
manuscript represents a substantial step forward in understanding the pattern and mechanisms 
of electrical failure in VF-SCA.
7.1 Complex VF Gradients and Electrical Failure 
The pattern of electrical failure is complex (Chapter 3) and includes not only the 
previously described transmural gradient in electrical activity [45-50] but also manifests as 
heterogeneous depression between the LV, RV, and septum. Furthermore, on the surface of the 
heart, large gradients (up to 4 Hz/mm) develop including regions of electrical silence. 
Interestingly, the decrease in excitation rate and the occurrence of inexcitability appears to be a 
function of increased postrepolarization refractoriness rather than a consequence of APD 
shortening (which I showed was relatively modest during VF-SCA). As time spent in VF-SCA 
elapses the complexity of the pattern increases eventually leading to accumulation of inexcitable 
areas, culminating in global asystole. It is likely that this increasing heterogeneity and the 
development of regions with conduction block lead to reentry upon defibrillation resulting in
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Refibrillation and lack of success in resuscitation explaining, in part, the progressive increase in 
mortality as a function of time following initiation of VF-SCA (see Chapter 1). In addition to the 
published work in Chapter 3, I observed a dichotomy in the timing of asystole [80, 118, 119] 
wherein approximately 50% of canine hearts experienced asystole prior to 10minutes of VF-SCA 
(early asysotle, EARLY ASYS) and the remaining hearts reached asystole at greater than 20 
minutes (late asystole, LATE ASYS). It is of interest to ask 1) what are the mechanisms by which 
heterogeneities in electrical failure develop during VF-SCA, 2) what promotes EARLY ASYS and is 
it correlated to decreased survival (see Section 7.2.1.1), and 3) would reducing heterogeneities 
during VF-SCA result in greater success during resuscitation (see Section 7.2.1, Future Work).
7.2 Mechanisms of Electrical Failure 
Having established the phenomenology of electrical failure in VF-SCA I sought to answer 
the first question. What are the mechanisms by which heterogeneities in electrical failure occur? 
Also, what causes electrical failure in general during VF-SCA? I first tested the roles of previously 
hypothesized mechanisms of electrical failure namely K a t p  opening and hyperkalemia [79, 82].
7.2.1 I k a t p , Hyperkalemia, and Glycolysis 
In Chapter 4 evidence was presented concerning the role of K a t p  opening in 
heterogeneous electrical depression and failure. KATP blockade delayed the heterogeneous 
electrical depression and failure on the EPI and eliminated the occurrence of asystole during the 
first 10 minutes of VF-SCA. An interesting note to this story is that KATP blockade prevented the 
occurrence of EARLY ASYS in canine hearts, but the pattern of electrical depression and failure 
was similar in K a t p  blocker treated hearts to that observed in LATE ASYS hearts [118]. This 
suggests that the occurrence of EARLY ASYS is modulated by IKATP. Interestingly, two 
interventions promote the occurrence of EARLY ASYS. One is treatment with the I k a t p  activator 
cromakalim (Chapter 4), the other is the application of high serum glucose [80]. These 
observations point to the importance of glycolysis in modulating electrical failure. The work by 
Shibayama et al. showed that in EARLY ASYS hearts there was greater lactate accumulation early
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in VF-SCA [80]. Combined with the finding by Weiss and Shine that glycolytic ATP is the key 
regulator of I k a t p  [81] it is plausible that increased serum glucose promotes early lactate 
inhibition of glycolysis leading to accelerated depletion of ATP resulting in I KATP activation and 
EARLY ASYS. Further evidence for the role of glycolytic ATP can be found in an abstract 
published by Venable et al. where the timing of asystole and mitochondrial potential 
depolarization were measured. Venable et al. found that the application of Na+-Iodoacetate, a 
glycolysis inhibitor, greatly accelerated the occurrence of asystole and mitochondrial 
depolarization in leporine hearts [120]; thus, pointing to the likely role of glycolytic ATP in 
maintaining not only electrical activity but also mitochondrial potential. Despite the importance 
of I KATP observed in Chapter 4, pharmacological KATP activation greater than what is expected 
during VF-SCA based on bulk tissue [ATP]i via cromakalim did not cause electrical failure (see 
Chapter 5). Indeed, the work contained in Chapter 5 not only shows lack of electrical failure from 
pharmacological KATP activation but also shows that hyperkalemia alone is not sufficient to 
reproduce the pattern of electrical depression observed during VF-SCA. In addition, the 
combination of supramaximal KATP activation and hyperkalemia is also insufficient to produce the 
degree and pattern of electrical depression seen during VF-SCA. Furthermore, measurements of 
[K+]o accumulation during VFSCA show that [K+]o accumulates more rapidly in EARLY ASYS 
hearts [119] again pointing to activation of K+ currents such as K a t p . Taken together these findings 
point to an additional mechanism, or mechanisms, modulating electrical failure and the 
important role of glycolysis in maintaining electrical excitability during VFSCA. The relationship 
between KATP/hyperkalemia and glycolysis warrants further investigation.
7.2.2 Excitation Rate and P-Adrenergic Stimulation 
During the search to determine the additional mechanisms at play in electrical failure 
during VF-SCA I observed that in leporine hearts high excitation rate and P-AS promoted 
electrical failure, separately. In addition, I found that the effects of high rate and P-AS were 
synergistic whereby the combination promoted greater electrical failure that either intervention 
alone (Chapter 6). These findings have profound implications for current clinical practice in
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resuscitation from VF-SCA. Namely, the administration of epinephrine to promote ROSC may be 
detrimental since p-AS increases the excitation frequency of VF [87]. Interestingly, the 
detrimental effects of high rate and p-AS were not abolished by K a t p  channel blockade. In fact, an 
effect of I k a t p  blockade was not observed in electrical failure. Furthermore, blockade of iKNa using 
the compound R56865 caused acceleration of electrical failure, although this detrimental effect 
may be due to the effects of R56865 on I nb  [100-102]. The lack of rescue from I k a t p  and IKNa 
blockade point again to additional mechanisms at play in electrical failure during VF-SCA, likely 
not through modulation of K+ flux.
7.3 Future Work
7.3.1 Mechanisms of Electrical Failure: Inward Leak Current 
This dissertation shows that the traditional theories for electrical failure during ischemia 
(hyperkalemia and I k a t p)  are insufficient to explain the complex patterns of VF and electrical 
failure observed during VFSCA. The study by Blake et al. provides an interesting insight into a 
potential mechanism for electrical failure [89]. Blake et al. showed excitation rate plays a role in 
electrical deterioration during regional ischemia by measuring the deviation of Vrest from the 
estimated E k . It was also shown that the application of high [Ca++]o and high rate was synergistic 
in promoting Vrest deviation from Ek. By returning to the GHK equation (Equation 2) it is clear 
that for Vrest to deviate from E k  either gNa, gCa, gCl, or other ion conductance for an inward current 
must be greater than zero. The consequences of such a current can be profound and 2-fold. First, 
as illustrated in Figure 7.1 (lower row) a small inward leak current can depolarize Vrest slightly, 
leading to a substantial decrease in Na+ channel availability due to the sharp downward slope of 
the sigmoid in this voltage range: in effect, reducing source current. Second, if Vrest is greater than 
E k  due to Na+ and/or Ca++ conductance being greater than zero there is an increase in em f for K+ 
efflux: in effect, increasing sink current. A  small inward leak current can exacerbate source-sink 
mismatch by both decreasing source and increasing sink and promote electrical failure. The 
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F ig u re  7.1: The consequences of inward leak current on electrical excitability. The upper row is a 
reproduction from Figure 1.4 showing the effects of hyperkalemia on the AP through effects on 
Na+ channel availability. The lower row illustrates the consequences of a small Na+ or Ca++ leak 
current. A  small inward leak current can depolarized Vrest slightly but, due to the location on the 
sigmoidal curve, result in a relatively large reduction in INa availability. Furthermore, Vrest 
depolarization away from Ek leads to greater em f for K+, in essence, increasing sink. A  small 
inward leak current can lead to increased source-sink mismatch and electrical failure.
While Blake et al. [89] show a deviation between estimated Ek and Vrest during high 
pacing rate and Ca++ administration, Kleber et al. [121] shows no deviation between Vrest and Ek 
during ischemia. Yet both Blake and Kleber present an estimated Ek (due to the difficulty in 
measuring intracellular K+ concentration). Perhaps the most convincing evidence in favor of a 
deviation between EK and Vrest during ischemia is the work by Weiss and Shine [122] where in a 
quiescent wedge preparation [K+]o accumulation was observed during ischemia: [K+]o 
accumulation cannot occur without K+ efflux and K+ efflux cannot occur without an em f for K+, 
which requires that Ek and Vrest are not equal. In addition to the work in whole heart and tissue 
preparations described above, Clusin et al. [110] showed in chick embryonic myocytes a sustained 
inward current in response to pharmacological metabolic challenge. Furthermore, Clusin et al. 
found that this sustained inward current was modulated by altering extracellular Ca++ or Na+ 
concentrations. This finding points to the possible roles of the Na+-Ca++ exchange (NCX), or 
potentially a combination of ischemic effects on ICaL, or I n&- For example, ischemia has been 




indicate that the late-INa is not likely the identity of the inward leak current but the possible role 
of NCX remains to be tested. Interestingly, studies have found detrimental effects of Ca++ 
administration during resuscitation in patients in VF-SCA—hence Ca++ is not recommended by 
the ACLS guidelines for patients found in VF except under special circumstances [124].
Another intriguing possibility for the identity of the inward leak current is the 
development of nonspecific sarcolemmal leak during ischemia. Liu et al. speculated on the 
occurrence of this phenomenon due to the accumulation of lysophosphatidylcholine during 
ischemia leading to the formation of nonselective pores in the sarcolemma [125, 126]. While the 
idea of nonspecific leak is an attractive one, my preliminary results using a nonionic copolymer 
surfactant, Poloxamer 188 (Sigma-Aldrich), were not promising. Furthermore, an abstract 
published by Sciuto et al. [127] attempted to detect the occurrence of sarcolemmal permeability 
during Ischemia using confocal imaging of fluorphores which fluoresce when bound to 
ribonucleic and nucleic acids but found no evidence of sarcolemmal permeability during 
ischemia. Overall, it appears that the inward leak current is likely modulated by a Ca++ dependent 
mechanism, which is in agreement with my finding that p-AS promotes electrical failure since the 
primary action of p-AS is the upregulation of Ca++ signaling and cycling. Furthermore, it is known 
that during ischemia, [Ca++]i is elevated [103] and hence would activate NCX forward mode 
producing an inward current. Given the discussion concerning the existence and potential sources 
of inward leak currents, future work should focus on these mechanisms and determining if and 
how they contribute to electrical failure during VF-SCA.
7.3.2 Additional Projects
Identifying and elucidating the role of the inward leak current is the most obvious next 
step. Nevertheless, there are several important and exciting projects that can be developed 
moving forward from this dissertation. In Section 7.2.1, I discussed the potential importance of 
glycolysis in determining the outcomes of electrical failure in VF-SCA. There are several points of 
interest. In terms of epidemiology, 1) is there a similar outcome in timing of asystole in the 
human population and 2) can increased prevalence of metabolic disorders like diabetes mellitus
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[128] explain the increased incidence of asystole [36-39]? This work would require a large clinical 
dataset with a cross-disease investigation into the risk of VF-SCA and survival following the event. 
On the other hand, projects probing the physiological relationship between glycolysis, glycolytic 
ATP, and electrical activity can be investigated. For example, the regulation of IKATP through 
subsarcolemmal ATP derived from glycolysis during ischemia could potentially be investigated 
using techniques such as total internal reflection fluorescence imaging (TIRF) combined with an 
ATP sensitive fluorophore in isolated myocytes during simulated ischemia in the presence or 
absence of pharmacological modulators of glycolysis. In addition to the continued investigation of 
the pathophysiology of VF-SCA, it is also critical to begin the investigation of electrical recovery 
during resuscitation whereby based on the physiological understanding of electrical failure in VF- 
SCA I can begin to design interventions to apply during resuscitation that will significantly 
improve outcome: in the case of electrical recovery, to specifically reduce postreperfusion 
arrhythmias. Clearly, there are still years, if not decades, of work ahead in order to understand the 
physiology of VF-SCA and resuscitation.
7.4 Overall Summary and Significance 
This dissertation represents the first body of work in which a systematic examination of 
traditionally accepted hypotheses (hyperkalemia and IKATP activation) for electrical failure in VF- 
SCA were tested. The result was that neither mechanism individually or combined was sufficient 
to explain the pattern or degree of electrical failure in VF-SCA. What was discovered was the 
dependence of electrical failure on both excitation rate and P-AS. While the findings of this 
dissertation do not provide any direct evidence to change clinical treatment of VF-SCA it does 
point toward crucial questions that should be studied further in clinically relevant models. First, 
this dissertation provides direct evidence that P-AS promotes electrical failure. Since in the 
clinical setting, asystole (i.e., electrical failure) is correlated with much higher mortality, 
epinephrine treatment may be detrimental. Indeed, the literature on the benefits of epinephrine 
treatment during resuscitation point towards the same conclusion [42-44, 86]. Second, although 
more indirect, this dissertation calls into question the use of glucose as a treatment during VF-
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SCA. While glucose infusion has been shown to improve cerebrovascular protection during 
resuscitation [129, 130] evidence presented in this dissertation points towards a potentially 
detrimental effect on cardiac electrical activity [80]. Furthermore, the potential interplay between 
outcomes in VF-SCA and metabolic disorders (especially those that raise serum glucose) point 
toward the necessity for a better understanding of the relationship between diabetes and cardiac 
arrest. Overall, this dissertation simultaneously provides insight into detailed physiological 
mechanisms of electrical failure, deepens the need for a system’s physiology approach to 
understand the interplay between electrophysiology and metabolism, and point’s toward the need 
for cross-disease and cross-specialty approaches to the treatment of VF-SCA.
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